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Abstract 
Liposomes represent one of the major forms of modern particulate drug delivery. When 
administered, the phospholipid bilayer of the liposomes protects the encapsulated drug cargo from 
degradative enzymes whilst also providing a physical barrier that minimizes negative side effects 
associated with the administration of toxic compounds. As a mainstream particulate drug delivery 
system, four factors influence the efficacy of liposomes. These are the maximization of 
encapsulated drug concentration, evasion of immune system responses, site-specific accumulation 
and efficiency of drug release. In all four respects, the lipid composition of the liposome largely 
influences its efficacy. This thesis is focused on characterization of the E. coli mechanosensitive 
channel of large conductance (MscL), with a view to its implementation as a nanovalve candidate to 
address the issue of liposomal drug release efficiency. The studies conducted here were aimed at 
understanding the mechanisms required to activate MscL in small unilamellar liposomes via 
membrane deformation through the exposure of MscL proteoliposomes to L-!-
lysophosphatidylcholine (LPC). 
To test the release of a reporter molecule through activated MscL channels, the fluorescent 
dye 5,6-carboxyfluorescein (carboxyfluorescein), a compound that fluoresces heavily when diluted, 
was used. It was determined that MscL can function as a nanovalve for the release of a model 
cargo, when the channel is activated via induced tension caused by the incorporation of LPC into 
the lipid bilayer. The subsequent release efficiency of carboxyfluorescein via MscL was influenced 
by several factors, namely the number of incorporated MscL channels, lipid composition of the 
proteoliposomes and degree of membrane tension applied. Variation in LPC acyl chain length 
enables the adjustment of applied membrane tension. These factors ultimately affected the net 
release of carboxyflourescein from MscL-liposomes. 
It has also been speculated that an increase in membrane curvature is capable of affecting 
MscL activity. This effect was investigated using differently size extruded MscL proteoliposomes 
(50 nm and 100 nm diameters). When stressed with LPC, it was observed that 50 nm zero protein 
liposomes had a lower spontaneous leakage compared to its larger 100 nm zero protein liposome. 
However, the net fluorescence release of both MscL-liposome sizes were similar indicating that 
reducing liposome size, which results in a higher degree of intrinsic membrane curvature, did not 
affect MscL activity, but rather minimized liposome leakage. 
In order to investigate MscL incorporation, MscL orientation was investigated using cryo-
electron tomography, which showed that MscL is orientated in a “right-side-in” orientation. These 
studies also revealed that MscL-liposomes generated using the extrusion methods employed were 
not uniformly sized. Based on these results, further studies were conducted to identify conditions 
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that facilitated the generation of uniformly-sized MscL-liposomes, in order to enable future efflux 
assays and high-resolution structural studies. Various ionic conditions and lipid compositions were 
trialled as possible methods to produce and isolate MscL-liposomes within a specific size range. It 
was observed that cations exhibited a larger influence on MscL-liposome stability compared to 
anions and the interactions between lipids and ion types tested resulted in a variety of effects, which 
ranged between the production and isolation of small liposomes (~50 nm), through to liposome 
aggregation and liposome fusion. It was determined that a mix of soy azolectin and chicken egg 
azolectin was capable of producing MscL-liposomes with a narrow size distribution.  
As soy azolectin is the most widely used lipid mixture in MscL functional studies; it was 
thus used as a basis for the majority of studies conducted here. Some attempts were made to analyse 
the lipid content of the proteoliposomes, and in particular to analyse batch-to-batch variation in 
azolectin lipid content, but more detailed analyses are likely to be required in the future in order to 
determine which lipids affect efflux and produce more uniform MscL-liposome sizes. The 
information obtained will aid in the development of uniformly sized unilamellar MscL-liposomes, 
which are capable of releasing up to 70% of encapsulated cargo within a four-hour time period 
following membrane deformation. 
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1.1 Drugs 
In modern medicine, drug-based therapeutics are widely applied. A drug can be a synthetic 
or organic small molecule that is administered for a therapeutic benefit to the patient. In mammalian 
cells, typical protein targets for a drug molecule include ionotropic and metabotropic receptors, 
enzymes and transporters. A large majority of drug compounds act on these protein targets with a 
few exceptions such as those that target DNA, cell wall constituents or proteins of invading 
microoganisms and cancers. In order to work, drugs must achieve sufficient concentrations at a 
target site. The effective concentration of a drug is affected by its translocation to a specific site (via 
blood flow and diffusion through membranes) and drug metabolism (where drug compounds are 
metabolised and eliminated) (Rang, Dale et al. 2007). 
The cardiovascular system allows for the long-range distribution of drugs within the body 
(Avram, Krejcie et al. 2004). The localization of drugs into target cells requires the diffusion of the 
drug across the membrane of the cell. Diffusion from the extracellular to the intracellular 
compartment can occur through passive diffusion across the lipid membrane, use of aqueous pores 
formed by aquaporins, transmembrane carrier proteins (which bind to a molecule in the 
extracellular region and undergo a conformational change and releases the drug in the intracellular 
compartment) and pinocytosis (a form of endocytosis) (Ratain and Plunkett Jr. 2003). 
Drug metabolism involves two phases, phase I and phase II. Both phases, which although 
often, need not occur sequentially (Ekins, Andreyev et al. 2005, Coleman 2010). Phase I reactions 
involve the oxidation, reduction or hydrolysis of a drug compound, which often results in a 
chemically reactive compound that may be more toxic or carcinogenic than the original drug 
compound (Ratain and Plunkett Jr. 2003, Rang, Dale et al. 2007). The product of phase I, which is a 
result of the addition of a chemically reactive group such as hydroxyl serves as a point of attack for 
phase II reactions, which are synthetic and involves conjugation, resulting in an inactive compound 
(Williams, Hyland et al. 2004, Ekins, Andreyev et al. 2005). The products of each phase decreases 
lipid solubility thereby increasing renal elimination (Ratain and Plunkett Jr. 2003, Wickremsinhe, 
Bao et al. 2013). 
1.1.1 Targeted Drug Delivery 
The route of administration of a drug (e.g. oral, intravenous, inhalation, percutaneous, etc.) 
affects the concentration available in the blood plasma. For example, an orally administered drug 
would have to avoid breakdown from the stomach acid and penetrate the intestinal mucosa, which 
may also have enzymes that inactivate the drug. This is not the case with intravenous injections, 
which are the fastest and most certain route of administration whereby a drug will be transported 
systemically after injection. However, most administered therapeutic drugs are continuously 
  3 
metabolized and decrease in concentration over time, resulting in only a small portion of the overall 
administered drug reaching a target site. Furthermore, adsorption by other tissues also affects the 
bioavailability of the drug at the target site. The development and use of certain drug delivery 
methods have been employed to improve the drug’s translocation and retention in the body. Among 
these are the use of prodrugs and liposomes. 
Prodrugs are compounds that are pharmacologically inactive and activate after they have 
been metabolised (Albert 1958). This allows prodrugs to selectively target specific cells with 
specific cellular functions or improve the oral bioavailability of a drug through increased adsorption 
through the gastrointestinal tract (Rang, Dale et al. 2007). Examples of these drugs are 
cyclophosphamide (Arnold, Bourseaux et al. 1958), levodopa (Carlsson, Lindqvist et al. 1957) and 
zidovudine (Horwitz, Chua et al. 1964, Mitsuya, Weinhold et al. 1985). Cyclophosphamide is a 
drug that requires metabolism by the liver (Huang, Raychowdhury et al. 2000) to activate its 
chemotherapeutic properties thus allowing cyclophosphamide to be administered orally as it will 
not damage the gastrointestinal tract (Rang, Dale et al. 2007). Levodopa is a neurotransmitter 
precursor that activates after passing through the blood-brain barrier whereas its activated dopamine 
form cannot pass through this barrier (Carlsson, Lindqvist et al. 1957, Udenfriend, Weissbach et al. 
1957) and zidovudine is phosphorylated in cells containing reverse transcriptase thereby only 
conferring selective toxicity to HIV infected cells (Mitsuya, Weinhold et al. 1985). 
Liposomes are the most extensively studied and common form of drug delivery systems. 
They are used to minimize toxicity whilst maintaining the efficacy of a drug and modifications to 
the liposomal surface can allow it to be target-specific. Liposome technology with current and 
future methods of improvement are introduced in this chapter, with the thesis directed toward the 
characterization of MscL based nanovalves for future use as a drug release mechanism. 
Furthermore, current cost estimates for the development of a drug compound that is a new 
molecular entity and bring it to market ranges between US $500 million to US $2 billion (Adams 
and Brantner 2006, Paul, Mytelka et al. 2010). The profitability of pharmaceutical companies is also 
affected by the 20-year lifetime of patents on a drug of which several years would have been used 
for research, clinical trials and regulatory approvals. After the lapse of a patent, entry of generic 
drugs onto the market is allowed thus increasing competition with the pharmaceutical company that 
originally developed the drug. The development of improved delivery systems for already existing 
drugs is thus seen as a better investment as it may permit continued benefits to the pharmaceutical 
company producing it (Langer 1990). The ability of liposomes to satisfy target-specificity, drug 
retention and as a method for drug delivery emphasizes their importance in modern medicine. 
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1.2 Liposomes 
The phospholipid bilayer vesicle or “liposome” was initially described as an in vitro model 
for studying biological membranes. In 1972, Gregoriadis and co-workers proposed the idea of using 
them as drug carriers in modern medicine (Gregoriadis and Ryman 1972). Liposomes can consist of 
naturally occurring biocompatible phospholipids, which can act as a physical barrier to protect its 
encapsulated drug cargo from degradative enzymes as well as minimize the negative side effects 
from the administration of toxic compounds. 
Today, liposomes are one of the most extensively studied and advanced drug delivery 
systems available (Schwendener 2007, Chang and Yeh 2012) and are widely used in the 
administration of highly toxic compounds. The encapsulation of these drugs within liposomes 
allows the drug to maintain its efficacy whilst minimizing its toxicity when compared to the drug’s 
free form. Examples of such compounds are those used in chemotherapy such as anthracyclines, 
Doxorubicin, Daunorubicin (Wolff 2003) and Taxol® (O'Shaughnessy 2003). Liposomes are also 
used to administer the highly toxic antifungal agent Amphotericin B (Ng, Wasan et al. 2003). It is 
worth noting that liposomal drug delivery systems have been used in vaccines against hepatitis A 
(Gluck 1992, Gluck, Mischler et al. 1992, Usonis, Bakasenas et al. 2003, Bovier 2008) and 
influenza (Gluck, Mischler et al. 1994, Conne, Gauthey et al. 1997, Lay, Callejo et al. 2009, Even-
Or, Joseph et al. 2011) as well as carriers for gene therapy (Felgner, Gadek et al. 1987, Jeschke and 
Klein 2004, Sharif, Hynes et al. 2012). Furthermore, liposomes also provide a high degree of bio-
compatibility and are capable of protecting its encapsulated cargo from degradative enzymes, 
thereby increasing the drug’s mean residence time within the body (Chang and Yeh 2012). 
1.2.1 Lipids and Liposomes 
Lipids are amphiphiles, consisting of a hydrophilic head group and a hydrophobic tail. They 
are of varying geometric shapes due to differences in the size of the phospholipid head group and 
the length and volume occupied by the lipid tails. The geometric shapes of the lipid molecules are 
described in Figure 1.1 and are best described by their critical packing parameter, which can be 
defined by the formula 
P = V/la 
Where P is the critical packing parameter, V is the molecular volume occupied by the lipid chains, a 
is the area occupied by the head group and l is the length of the lipid chain (Genc, Ortiz et al. 2009). 
A P value of 0.1 – 1 for a lipid yields a cone shape that is capable of forming curved bilayers (Genc, 
Ortiz et al. 2009). The lower the P value, the more defined the lipid cone, and with increasing P 
values the more cylindrical the lipid (Genc, Ortiz et al. 2009). A P value greater than 1 forms an 
inverted hexagonal (HII) phase, which forms an inverted micelle with hydrophobic tails facing 
towards the bulk solution and hydrophilic heads facing inwards towards an internal reservoir (Genc, 
  5 
Ortiz et al. 2009). Figure 1.1 summarizes the geometric shapes of several lipid examples as well as 
the structures formed by these lipids. 
 
Figure 1.1. Geometry of lipid molecules and the structural preferences 
of its resulting lipid bilayer. The critical packing parameter is directly 
proportional to the area of the lipid headgroup (a) and inversely proportional 
to the tail length of the lipid chain (l) and the volume occupied by the lipid 
chain (V). Figure taken from (Israelachvili 2011), permission obtained from 
Elsevier. 
 
The packing of lipids into lipid bilayers is a spontaneous process due to their amphiphilic 
nature. Through the second law of thermodynamics, which states that, “In a spontaneous process, 
there is an increase in the entropy of the universe” (Zumdahl and Zumdahl 2006), the ordering of 
the lipid molecules into a lipid bilayer decreases its entropy but also increases the entropy of the 
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water molecules in the system. Through electrostatic attraction based on a dipole-dipole interaction 
between water molecules and lipid headgroups, there is also a layer of ordered water around the 
lipid bilayer. 
Liposomes can be described as associating colloids that self assemble in closed spherical 
structures in aqueous media. This resulting colloidal system consists of a dispersed phase (the 
liposomes), and a continuous phase (the solution). Formation of liposomes is not 
thermodynamically stable, as they tend to aggregate and fuse over time, eventually precipitating 
into stacks of infinite lipid bilayers (Lasic 1990). There are several factors that affect liposome 
stability such as pH, temperature, surface charge, addition of cholesterol, hydrolytic degradation 
over time and degree of unsaturation in the acyl chain length of the lipid, to name a few examples. 
As a majority of these factors fall outside the scope of this thesis, the factors addressed here are in 
relation to liposome stability through the use of different ions and lipid composition, both of which 
affect the surface charge of the liposomes and the fluidity of the lipid bilayers. 
Many biological membranes contain a net negative surface charge (Lipids). In water, the 
surface charge of liposomes can be positive, negative or contain a mixture of both charges 
depending on the type of lipids used. Electrostatic repulsion is experienced by like charges and 
attraction can exist between liposomes containing a mixture of both surface charges. The use of 
counterions can stabilize the system, however, no general model for liposome colloidal stability 
exists due to the complex nature of a lipid bilayer, which contains protrusions, undulations as well 
as rotational movements of the lipid molecules. This adds to the difficulty of determining conditions 
that will prolong liposome stability. 
The Derjaguin-Landau-Verwey-Overbeek (DLVO) theory, which states that the stability of 
the system is governed through the attractive van der Waals forces and the repulsive electrostatic 
force (Derjaguin and Landau 1941, Verwey and Overbeck 1948), is used extensively in colloidal 
and bicolloidal science. This theory has had much success describing particle distances within 
nanometer ranges, however, a deviation of the theory has been observed at surface distances of <40 
Å leading to the discovery of hydration forces (Chapel 1994, Vigil, Xu et al. 1994, Molina-Bolivar, 
Galisteo-Gonzalez et al. 1999, Sabin, Prieto et al. 2006, Israelachvili 2011). These theories will be 
discussed in more detail in Chapters 4 and 5. 
1.2.2 Lipid Considerations for Liposome Applications in Medicine 
Lipids play an important role in the production and use of liposomal drug delivery systems. 
As depicted in Figure 1.1, the lipids used to generate liposomes can affect the curvature of the 
liposome and thus its size. Bilayer forming lipids that form highly ordered, tightly packed 
arrangements, or a gel state, are preferred as leakage of liposomal content is minimized (Maurer, 
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Fenske et al. 2001). This is compared to liquid-crystalline state lipids that form less ordered and less 
tightly packed lipid bilayers (Maurer, Fenske et al. 2001), which have reduced drug retention. 
The phase transition temperature of the lipids used determines the stability and packing of 
the lipid bilayer. Changing of a lipid from the highly ordered, tight packing gel state to the less 
ordered and less tightly packed liquid-crystalline state can be achieved at the lipid’s phase transition 
temperature. Table 1.1 provides some examples of lipids and their corresponding transition 
temperature and enthalpy. 
 
Table 1.1 Phase transition temperature (Tc) and enthalpy (AH) of 
phospholipids from gel to liquid crystalline states. c denotes Cis, # gives the 
position of the double bond. Table reproduced from (Cullis, Fenske et al. 1996) 
with permission from Elsevier. 
Lipid Head Group Tail Length Tc±2°C AH±1kcal/mol 
Phosphatidylcholine 12:0/12:0 -1 3 
Phosphatidylcholine 14:0/14:0 23 6 
Phosphatidylcholine 16:0/16:0 41 8 
Phosphatidylcholine 16:0/18:1c#9 -5  
Phosphatidylcholine 16:1 c#9/16:1c#9 -36 9 
Phosphatidylcholine 18:0/18:0 54  
Phosphatidylcholine 18:1c#9/18:1c#9 -20 9 
Phosphatidylethanolamine 16:0/16:0 63 9 
Phosphatidylserine 16:0/16:0 55 9 
Phosphatidylglycerol 16:0/16:0 41 9 
Phosphatidic Acid 16:0/16:0 67 5 
 
From Table 1.1, it can be seen that the transition temperature of lipids is head group, acyl 
tail length, and degree of unsaturation sensitive (Cullis, Fenske et al. 1996). For 
phosphatidylcholine (PC) lipids for example, the transition temperature increases for every two-
carbon atoms added and decreases as degree of unsaturation increases (Cullis, Fenske et al. 1996). 
Stability of lipid bilayers can be increased through the addition of cholesterol, which increases the 
membrane packing order of a lipid bilayer or through the addition of poly-ethylene glycol (PEG), 
which increases the steric stability of liposomes it is incorporated into. Prevention of liposome 
aggregation is also a result of increased steric stability. 
The addition of cholesterol and PEG also enable a prolonged circulation time of liposomes 
in vivo by preventing proteins such as apolipoproteins and opsonins from incorporating into the 
lipid bilayer of the liposome (Guo, Hamilton et al. 1980, Harashima, Sakata et al. 1994). 
Cholesterol incorporates itself into a lipid bilayer by filling the spaces between the acyl chains of 
lipids (Mouritsen and Jorgensen 1994). Cholesterol is capable of increasing the lipid acyl chain 
order and degree of orientation order of a membrane regardless of lipid headgroup and the nature of 
its acyl chain. (Yeagle 1985, Bhattacharya and Haldar 2000). This results in an increase in 
membrane packing density thereby increasing the mechanical strength and decreasing permeability 
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of the membrane (Yeagle 1985, Needham and Nunn 1990, Smaby, Brockman et al. 1994). This 
increase in membrane packing reduces the binding of proteins that either compromise the integrity 
of the liposome’s lipid bilayer (apolipoproteins) or mark the liposome for removal by an immune 
system response (opsonins) (Guo, Hamilton et al. 1980, Harashima, Sakata et al. 1994). The 
addition of cholesterol inhibits the crystallization of saturated lipids thereby maintaining its gel 
state, and liposomes composed of gel state lipids and cholesterol are preferred for in vivo 
applications as leakage and protein binding from blood serum are reduced (Maurer, Fenske et al. 
2001). The prevention of protein binding to the lipid bilayer of a liposome can also be achieved 
through the coating of the liposome’s surface with a polymer layer usually accomplished through 
the use of lipid conjugated PEG (Papahadjopoulos, Allen et al. 1991, Senior, Delgado et al. 1991, 
Torchilin 2005). PEG hinders the ability of proteins to mark or compromise the structural integrity 
of the liposome by inhibiting their approach to get in range of the liposome. 
1.2.3 Lipids in Liposome Production 
Therapeutic drugs can be categorized as being either highly hydrophilic, highly lipophilic, 
amphiphilic or having biphasic insolubility; and it is these characteristics that determine their 
suitability for inclusion in a liposomal carrier system (Gulati, Grover et al. 1998). Lipid 
formulations can vary to increase drug encapsulation efficiency and to optimise the required stimuli 
for triggering drug release (Kozubek, Gubernator et al. 2000, Immordino, Dosio et al. 2006) (see 
section 1.2.2). During production, the permeability of the lipid bilayer also has to be taken into 
consideration as this determines the retention efficiency of the drug cargo. Permeability varies with 
differing ions and lipids and can usually be improved by using lipids with high transition 
temperatures, or through the addition of cholesterol to maintain the lipid bilayer’s gel state (de Gier, 
Mandersloot et al. 1968, Deamer and Bramhall 1986, Cullis, Fenske et al. 1996). This minimizes 
the occurrence of defects that appear through the coexistence of the gel and liquid-crystalline states 
by increasing the membrane packing density as mentioned earlier (Maurer, Fenske et al. 2001). 
Research into the use of pH gradient loading techniques may also become a viable 
alternative in the production of liposomal drug delivery systems. This method circumvents the use 
of lipid formulations to maximize drug encapsulation of weakly acidic or basic compounds through 
the transmembrane diffusion of the neutral form of these compounds, which is membrane 
permeable (Cullis, Hope et al. 1997). As charged compounds are not membrane permeable, the use 
of dissociation equilibriums through pH changes can coax a neutral form of the compound into 
permeating the lipid bilayer (Cullis, Hope et al. 1997, Dos Santos, Cox et al. 2004). pH gradient 
loading techniques can also utilize other factors to increase membrane permeability such as 
increasing the temperature of the suspension to near transition temperatures of the lipids used or the 
addition of ethanol (Dos Santos, Cox et al. 2004).  
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1.2.4 pH Liposomes and the Role of Lipids 
pH-sensitive liposomes are currently one of the main methods for targeted drug delivery 
against tumours and after the lipids have internalised into a cell. Dioleoylphosphatidylethanolamine 
(DOPE) is the most widely used lipid in pH-sensitive liposomal drug delivery systems (Maurer, 
Fenske et al. 2001). This is due to DOPE’s ability to form the inverted hexagonal (HII) phase 
(inverted micelle) (see Figure 1.1) and its ability to form liposomes when coupled with a stabiliser 
such as the ionisable lipids diharmonolipid, oleic acid and cholesteryl hemisuccinate (Collins, 
Connor et al. 1990, Litzinger and Huang 1992, Sanchez, Aranda et al. 2011). These stabiliser lipids 
are ionised at physiological pH (7.0 – 7.5) and provide complementary molecular shapes that allow 
DOPE to form bilayers (Cullis and de Kruijff 1979). Their negative charged headgroups provide an 
electrostatic repulsion that prevents DOPE from forming the HII phase. Upon exposure to reduced 
pH environments, such as those found in the extracellular environment of tumours and lysosomes of 
cells, the headgroups are protonated, destabilising the system by promoting the formation of the HII 
phase (Sanchez, Aranda et al. 2011). Research into pH liposomes is still actively being pursued 
using new lipid formulations (Obata, Tajima et al. 2010, Sanchez, Aranda et al. 2011, Yuba, Harada 
et al. 2011). Examples of current uses of pH-sensitive liposomes are in cancer therapy and DNA 
transfection into mammalian cell lines (Legendre and Szoka 1992, Hong, Lim et al. 2002, Patil, 
Rhodes et al. 2004, Ishida, Okada et al. 2006, Chan, Majzoub et al. 2012). 
1.3 Liposomes in vivo 
The use of liposomes in modern medicine continues to expand and since its use as a drug 
delivery system, a large amount of information about the behaviour of liposomes in vivo has been 
obtained. Here, methods of drug delivery to site-specific areas, uptake of encapsulated drugs into 
cells and the complexities that arise from immune system responses to foreign objects are 
discussed. 
1.3.1 Liposomal Mechanism of Action 
In Figure 1.2, a summary of the interactions of liposomes with a target cell is presented. 
These interactions can occur specifically or non-specifically. Specific interactions occur through the 
use of antibody targeting or ligand specific binding and are mostly used in the area of cancer 
therapy (Park, Kirpotin et al. 2001, Sapra and Allen 2002, Sofou and Sgouros 2008). A specific or 
non-specific liposomal interaction can lead to fusion of the liposomes with the membrane of the 
target cell or endosome, and is a method used in vaccinations and DNA therapy (Bailey and Cullis 
1997, Bungener, Huckriede et al. 2002, Reddy, Abburi et al. 2002). The release of encapsulated 
drug cargo can also occur in the low pH environments of the lysosome or within the extracellular 
environments of tumours (Betageri, Jenkins et al. 1993, Stubbs, McSheehy et al. 2000). This 
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method of release utilizes the pH-sensitive liposomes mentioned earlier (Section 1.2.4 pH 
Liposomes and the Role of Lipids). Drug cargo released within the extracellular environment can be 
adsorbed through micropinocytosis, which is a regulated, non-selective form of endocytosis for the 
uptake of solutes, nutrients and antigens (Campbell, Reece et al. 1999, Torchilin 2005). 
 
Figure 1.2. Interactions of liposomes with a cell. Drug-encapsulated liposomes adsorb onto 
the cell surface specifically (a) or nonspecifically (b). Liposomes may fuse with cell 
membranes (c), to directly release their contents into the cytoplasm, or become destabilized by 
certain cell membrane components when adsorbed (d). The released drug then can enter cell 
via micropinocytosis. Liposomes can undergo direct or transfer-protein-mediated (ligand 
binding) exchange of lipid components with the plasma membrane (e) or be internalized by 
specific or nonspecific endocytosis (f). In the case of endocytosis, a liposome can be delivered 
by the endosome to the lysosome (g) or, en route to the lysosome, the liposome can 
destabilize the endosome (h), resulting in drug release into the cell cytoplasm. Image and text 
adapted from (Torchilin 2005) with permission from Nature Publishing Group. 
 
Endocytic uptake by target cells is the most common means of liposome-mediated drug-
delivery (Betageri, Jenkins et al. 1993, Schwendener 2007, Khalil, Kogure et al. 2008). This mode 
of interaction exposes the liposome to the low pH of the lumen of endo-lysosomal compartments 
(~pH 4.8) and/or the degradative enzymes of the lysosome, which degrade the liposome bilayer. 
Unfortunately however, as well as release of the drug cargo, these events expose the drug(s) to the 
degradative environment of these subcellular compartments, which can limit the drug’s desired 
activity (Betageri, Jenkins et al. 1993, Elouahabi and Ruysschaert 2005, Khalil, Kogure et al. 2006, 
Khalil, Kogure et al. 2008). This has led to the development of pH-sensitive liposomes specifically 
designed to deliver drugs into the relatively low pH (~pH 6.3), extracellular environment of tumour 
targets, where released chemotherapeutic drugs can be taken up via non-degradative means (Stubbs, 
McSheehy et al. 2000). Research into the use of positively charged liposomes (cationic liposomes) 
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for DNA transfection have shown that when exposed to the endosomal pH conditions of a cell, the 
liposome fuses with the endosome membrane thus releasing its cargo into the cell cytoplasm 
(Bailey and Cullis 1997, Torchilin 2005). 
1.3.2 Liposome Clearance 
Liposomes are vulnerable to clearance by the immune system, which can recognize them as 
foreign particulates. Elimination of liposomes typically occurs through the binding of serum 
proteins called opsonins to the surface of the liposome (i.e. ‘opsonization’) followed by recognition 
by the mononuclear phagocyte system (MPS), which leads to phagocytosis of the opsonised 
liposomes by the MPS (Harashima, Sakata et al. 1994). Liposomes that are >200 nm in diameter are 
more rapidly eliminated than those that are <200 nm in diameter (Senior and Gregoriadis 1982) and 
it has been suggested that the MPS is capable of distinguishing the sizes of foreign particles 
(Immordino, Dosio et al. 2006). 
The rate of clearance of liposomes is also dependent on the degree of opsonization. This 
may also explain why larger liposomes are cleared more rapidly than smaller ones as association of 
opsonins are hindered by the packing of phospholipids in the bilayer of smaller vesicles, which has 
fewer defects (Harashima, Sakata et al. 1994, Fischer, Oberholzer et al. 2000). The liposomal rate 
of clearance can also be lowered by increasing the steric stability and membrane packing order of 
the liposome’s lipid bilayer, which hinders the binding of serum proteins that aid in degradation and 
elimination of liposomes (see section 1.2.2 Lipid Considerations for Liposome Application in 
Medicine). However, as mentioned earlier, other physiochemical properties such as methods of 
drug release also need to be considered. 
1.3.3 Liposome Localization 
The bioavailability of a liposome-encapsulated drug at diseased sites in vivo is affected by 
the liposome clearance and its site of accumulation. Liposomes that are not cleared or compromised 
by phagocytic cells or proteins are readily taken up and cleared by the liver and spleen as these 
organs are rich in phagocytic cells and form part of the MPS. Lipoplexes have also been found 
trapped at high levels in lung capillaries after administration (Maurer, Fenske et al. 2001). 
Liposomes that are <200 nm in diameter and have long circulation times are capable of 
accumulating at disease sites such as tumours, infections or inflammation (Morgan, Williams et al. 
1985, Papahadjopoulos, Allen et al. 1991, Yuan, Leunig et al. 1994). This is a result of the vascular 
structure at these sites, which have increased permeability (Maeda 2012). Figure 1.3 provides a 
summary of this interaction. 
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Figure 1.3. Mononuclear Phagocyte System (MPS) and liposome localization. 
A) After administration of liposomes into the bloodstream, the liposomes are 
removed or marked for removal by the MPS and can localise in the liver and 
spleen with some lipoplexes known to be found in lung capillaries. B) Liposomes 
that evade clearance, and that have a prolonged half-life, can locate at disease 
sites, in this case a tumour mass. C) Accumulation of liposomes within tumor 
mass regions is a consequence of the vasculature, which have large openings and 
allow the passage of liposomes into the interstitial space between tumour cells. 
Image and text adapted from (Maurer, Fenske et al. 2001) with permission from 
Dr. Norbert Maurer. 
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1.3.4 Reactions to Lipid Compositions 
The uptake of liposomes into a cell is a factor that has to be addressed when developing a 
liposomal drug carrier. This can be improved through the use of surface charged liposomes. It has 
been reported that the use of positively charged liposomes (cationic liposomes) has the highest 
overall uptake into cancer cells and due to its charge has a lower degree of opsonization as 
compared to their negatively charged and neutral counterparts (Miller, Bondurant et al. 1998, 
Ishida, Harashima et al. 2002, Krasnici, Werner et al. 2003). However, these liposomes have also 
been observed as being toxic as they cause an increase in reactive oxygen intermediates, which 
damages the pulmonary system (Gossart, Cambon et al. 1996, Scheule, St George et al. 1997, 
Dokka, Toledo et al. 2000). Generally, charged liposomes have a shorter half-life in vivo compared 
to neutral liposomes (Parnham and Wetzig 1993, Harrington, Lewanski et al. 2001, Cui, Li et al. 
2007, Pollock, Antrobus et al. 2010) as negatively charged liposomes are readily targeted by 
opsonins. 
Interestingly, research into lipid composition has shown that liposomes comprised of 
phospholipids similar to those found in the membranes of endoplasmic reticula (which are 
composed of Phosphoethanolamine (PE) : Phosphocholine (PC) : Phosphatidylinositol (PI) : 
Phosphatidylserine (PS)) will readily co-localise and fuse to the endoplasmic reticulum of a cell 
after uptake instead of residing in the cytoplasm (Pollock, Antrobus et al. 2010). 
1.4 Drug Delivery 
Research into targeting disease sites and evading the immune system has yielded several 
advances in liposomal drug delivery systems that are in use today. Among them are the pH-
sensitive liposomes, (as detailed in section 1.2.4 pH Liposomes and the Role of Lipids) and the 
stealth liposomes. These liposomes are designed to function as an immediate release mechanism 
and to evade an immune system response respectively and are detailed further in this section. 
1.4.1 Stealth Liposomes 
As has been previously discussed, liposomes are vulnerable to removal by the MPS (Refer 
to Section 1.3, Liposomes in vivo). Stealth liposome formulations utilize the incorporation of 
polyethylene glycol (PEG); and have shown the greatest improvement in terms of prolonged 
liposome blood-circulation time. PEG works by increasing the steric stability of liposomes and thus 
slows opsonization and recognition of liposomes by the MPS via steric hindrance (Yockman, 
Maheshwari et al. 2003, Begum, Abbulu et al. 2012) as mentioned in section 1.2.2, pH Liposomes 
and the Role of Lipids. PEG also improves liposome colloidal stability by avoiding liposome 
aggregation via steric hindrance (Immordino, Dosio et al. 2006, Begum, Abbulu et al. 2012). The 
reduction of MPS uptake of stealth liposomes allows for a prolonged circulation time in which a 
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passive accumulation of the stealth liposomes at sites of interest such as tumours can be achieved 
(Immordino, Dosio et al. 2006, Begum, Abbulu et al. 2012). Figure 1.4 C and D show a schematic 
of a stealth liposome and a stealth immunoliposome respectively. 
1.4.2 Immunoliposomes 
Immunoliposomes target specific cells for drug delivery by attaching functionalized 
antibodies or antibody fragments to the outer surface of the liposome to improve the therapeutic 
efficacy of the liposomal drug carrier (Peer, Karp et al. 2007, Schwendener 2007). Most of the 
research to date into the use of ligands to specifically target drug delivery to certain cells has 
focused on cancer treatment regimens utilizing a variety of antibodies, specific for cell surface 
markers expressed on tumour cells (Mamot, Drummond et al. 2005, Torchilin 2005, Kirpotin, 
Drummond et al. 2006, Boghaert, Khandke et al. 2008, Mamot, Ritschard et al. 2012, Shahin, 
Soudy et al. 2013). By combining the use of both PEG and antibodies, long-circulating 
immunoliposomes can be created whereby antibodies are attached at the end of the PEG via a 
spacer arm (Torchilin 2005, Shahin, Soudy et al. 2013). See Figure 1.4 [B] and [D]. 
 
 
Figure 1.4. Drug encapsulation, target specific liposome and long circulating 
liposome. [A] Liposomes with water-soluble drug (a) in the aqueous interior, and 
water-insoluble drug (b) incorporated into the membrane. [B] Antibody-targeted 
immunoliposome with antibody covalently coupled (c) to reactive phospholipids in 
the membrane, or hydrophobically anchored (d) to the liposomal membrane. [C] 
Long-circulating liposome grafted with a protective polymer, PEG (e), which shields 
the liposome surface from interaction with opsonizing proteins (f). [D] Long-
circulating immunoliposome simultaneously bearing both protective polymer and 
antibody, which can be attached to the liposome surface (g) or, to the distal end of 
the grafted polymeric chain (h). Images and text adapted from (Torchilin 2005) with 
permission from Nature Publishing Group. 
 
1.4.3 Improving the Efficacy of Liposomal Drug Delivery Systems 
Drug release at specific locations in vivo is a major factor affecting the efficacy of liposomal 
drug delivery systems. Enabling site-specific release of a liposomal encapsulated drug continues to 
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be a competitive area of research with varying ideas and methods being trialled. Methods of site-
specific triggered release trialled include: 
 
1. Magnetosomes - which can be directed to a specific site via magnetic fields and release of 
encapsulated cargo occurs as the lipid bilayer degrades (Morgan, Williams et al. 1985, 
Nawroth, Rusp et al. 2004, Pradhan, Banerjee et al. 2010). 
 
Figure 1.5. Magnetic liposomes with entrapped cargo (T). Magnetic 
material is shown as: a) bound to the lipid bilayer; b) entrapped in the 
liposome; c) as a magnetic shell within the liposome. Image taken from 
(Nawroth, Rusp et al. 2004). 
 
2. Light activated nanovalves – allow a mechanosensitive channel, normally found in E.coli, to 
open/activate upon the addition of UV light (Koçer 2007). Further discussion on nanovalves 
given in Section 1.5. 
 
Figure 1.6. Light activated MscL. Image taken from (Koçer 2007) with 
permission from A/Prof. Koçer. 
 
3. Partially Polymerised Liposomes – utilize specific synthesized lipids to reduce the leakage 
of liposomal encapsulated cargo and tethered gold nanoparticles allow for release of up to 
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70% of the encapsulated cargo when excited with six 10 ns laser pulses at 532 nm (Qin, Li 
et al. 2011). The energy exerted on the gold nanoparticle induces a microbubble cavitation 
which functions as a “nano-sonicator”, resulting in an increased membrane permeabilization 
(Wu, Mikhailovsky et al. 2008). 
 
 
Figure 1.7. Partially Polymerised Liposome. A) schematic of a partially 
polymerised liposome where the attachment of a gold nanoparticle and laser 
excitation causes liposome rupture. B) a cryo-electron microscopy (EM) 
micrograph of the partially polymerised liposome with gold nanoparticle 
attached. C) cryo-EM micrograph of the partially polymerised liposome 
with attached gold nanoparticle post laser irradiation. Scale bar = 50 nm and 
is applicable to both micrographs. Image taken from (Qin, Li et al. 2011) 
and reproduced with permission from IOP Publishing Limited. 
 
1.5 The Need for Nanovalves 
Despite improving the therapeutic indices of the encapsulated drug(s), liposomes suffer 
from a number of drawbacks, especially with regards to drug release and targeting. Where, delivery 
is often non-specific and relies on the size of the liposome for passive accumulation at the intended 
target site. Other factors related to drug encapsulation, stability, release and blood-circulation time 
can only currently be addressed by modifying the lipid composition of the liposome carriers. Not 
surprisingly, liposome size and lipid composition have been identified as major issues in clinical 
studies where, due to the lack of a universal release system, variations in the toxicity and efficacy of 
similar encapsulated drugs using different lipid formulations or liposome sizes are the subject of 
ongoing investigations (Waterhouse, Tardi et al. 2001, Li, Ten Hagen et al. 2013, Serpe, Canaparo 
et al. 2013). 
A 
B C 
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It has been suggested that liposomal systems are more complicated than conventional drug 
delivery systems due to the need to optimize dosage and scheduling for each liposome formulation 
through clinical trials in order to improve bioavailability (Waterhouse, Tardi et al. 2001, Cui, Li et 
al. 2007, Yang, Ma et al. 2013). An increase in liposome accumulation at a disease site does not 
necessarily equate to improved efficacy if the encapsulated drug cargo is not released from the 
liposomes at a sufficient rate to affect the drug’s therapeutic activity at a target site (Boman, Masin 
et al. 1994, Maurer, Fenske et al. 2001, Zhao, Alakhova et al. 2013). The release rate of an 
encapsulated drug cargo highlights the need for a universal release system in liposomes, where the 
rate of drug release from liposomes and an improvement of drug encapsulation can be affected by 
lipid formulations (Kozubek, Gubernator et al. 2000, Maurer, Fenske et al. 2001, Immordino, Dosio 
et al. 2006, Schroeder, Honen et al. 2009, Hagtvet, Evjen et al. 2011). 
1.6 Mechanosensitive (MS) Channels 
Mechanosensitive (MS) channel proteins transduce changes in the transbilayer pressure 
profile of eukaryotic and prokaryotic cell membranes into electrical and/or chemical signals. MS 
channels occur in a variety of cells and have been linked to sensory perception and osmoregulation 
(Moe, Levin et al. 2000). There are two different families of MS channels in Escherichia coli, MscS 
and MscL, which are classified by their primary structures (Martinac, Nomura et al. 2013).   
 These MS channels play an essential role in osmoregulation where they act as redundant 
“emergency relief valves” (Blount, Schroeder et al. 1997, Ajouz, Berrier et al. 1998, Levina, 
Totemeyer et al. 1999). This redundancy was observed in E. coli mutants lacking both MscL and 
MscS, which had a very low survival rate after hypo-osmotic shock (Levina, Totemeyer et al. 1999) 
whereas no significant growth or survival effects were observed in mutants that lacked MscL alone 
(Sukharev, Blount et al. 1994). We have selected the MS channel of large (MscL) conductance 
from E. coli as the nanovalve of choice for our studies. 
1.6.1 E. coli MscL 
E. coli MscL is one of the most studied MS channels to date. The channel activates in 
response to changes in membrane tension (Moe and Blount 2005) and the trigger is believed to be a 
tension-activated change in the physical properties of the lipid bilayer adjacent to the channel 
(Markin and Martinac 1991, Perozo, Kloda et al. 2002).  
MscL is an 80-kDa homo-pentameric channel protein consisting of 136 amino acids. The 
15-kDa subunits of the channel contain two highly hydrophobic regions that reside in the inner-cell 
membrane (Sukharev, Blount et al. 1997). Current, X-ray crystallography structures at 3.5 Å 
resolution have revealed the closed pentameric structure of Mycobacterium tuberculosis MscL 
which shares a 37% overall similarity to E. coli MscL (Chang, Spencer et al. 1998) but requires 
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twice as much pressure to activate in liposomes compared to other orthologues (Moe, Blount et al. 
1998, Moe, Levin et al. 2000). 
MscL in its open form has not been crystallized, however, open channel models based on 
electron paramagnetic resonance (EPR) spectroscopy (Perozo, Cortes et al. 2002), fluorescence 
resonance energy transfer (FRET) spectroscopy (Corry, Rigby et al. 2005, Corry, Hurst et al. 2010) 
and computational modelling (Gullingsrud, Kosztin et al. 2001, Betanzos, Chiang et al. 2002) have 
been proposed. The open channel models obtained through EPR and FRET spectroscopy utilised an 
amphipathic conical lipid known as L-!-lysophosphatidylcholine (LPC) to activate the channel (see 
Section 1.7 Activation of MscL).  
 
Figure 1.8. Structure of the homopentameric MscL of M. tuberculosis along with 
measured dimensions. Each of the five subunits consists of two transmembrane (TM) 
!-helices, TM1 and TM2; and a cytoplasmic !-helix. Image taken from (Chang, 
Spencer et al. 1998) with permission from Science. 
 
Each subunit of the channel consists of two !-helical transmembrane (TM) domains, which 
span the membrane twice, with the N- and C- terminii located in the cytoplasm. The two TM 
domains are connected via a periplasmic loop, which is thought to act as a spring that resists 
channel opening (Ajouz, Berrier et al. 2000, Tsai, Liu et al. 2005). As can be seen in Figure 1.8, the 
channel pore is lined by five TM1 helices, while TM2 interacts with the lipid bilayer. The 
periplasmic loop at the end of the TM1 helix partly interacts with the membrane (Yoshimura, 
Nomura et al. 2004, Tsai, Liu et al. 2005). 
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The pentameric structure of MscL has been confirmed via EPR spectroscopy; however 
discrepancies at the COOH-terminal end of the TM 2 !-helix are apparent (Perozo, Kloda et al. 
2001). These discrepancies are likely to be the result of the different conditions that each method 
requires for study, such as the use of detergent micelles for X-ray crystallography versus the use of 
liposomes for EPR spectroscopy. Nevertheless, based on the sequence similarity between each type 
of MscL, the structure determination provides some useful insights into the domains believed to be 
responsible for channel function. Of particular interest is that detergents have been reported as 
having an impact on the structure of MscL by rearrangement of its monomers resulting in the 
formation of tetramers (Dorwart, Wray et al. 2010). 
1.6.2 The Open Pore of E.coli MscL 
MscL produces a pore that is non-selective with a size of approximately 3 nm in diameter 
when activated (Cruickshank, Minchin et al. 1997, Corry, Rigby et al. 2005). It has been shown that 
protein complexes of up to 6.5 kDa are able to pass through the open MscL pore unhindered 
(Ajouz, Berrier et al. 1998, Berrier, Garrigues et al. 2000, van den Bogaart, Krasnikov et al. 2007). 
As aforementioned, the channel activates in response to changes in membrane tension and also 
retains its gating functionality after purification and reconstitution into lipid vesicles (Häse, Le Dain 
et al. 1995). Reconstitution of MscL can be achieved using a variety of different lipids (Grage, 
Keleshian et al. 2011) and the channel can be readily engineered (Koçer, Walko et al. 2007) with 
the inclusion of gain and loss of function mutants (Koçer, Walko et al. 2007). These characteristics 
make it an ideal candidate for use as a nanovalve in liposomal drug delivery system (LDDS). 
 
Figure 1.9. MscL in a closed and open state as seen in FRET 
spectroscopy. Image taken from (Corry, Rigby et al. 2005) with 
permission from Elsevier. 
 
1.6.3 MscL Mechanosensitivity 
MscL is encoded by the mscl gene and mutational studies on the Glycine-22 residue in TM1 
have shown that as the hydrophilicity at this residue increases, the gating threshold to activate MscL 
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decreases (Ou, Blount et al. 1998, Yoshimura, Batiza et al. 1999, Yoshimura, Batiza et al. 2001). 
Based on these results, it has been proposed that a hydrophobic interaction at TM1 maintains MscL 
in its closed state and that this interaction must be overcome in order for the channel to open (Ou, 
Blount et al. 1998, Blount and Moe 1999, Yoshimura, Batiza et al. 1999, Moe, Levin et al. 2000, 
Yoshimura, Batiza et al. 2001). It has been shown that replacement of a hydrophobic residue with a 
hydrophilic one at this location causes a destabilization in the hydrophobic interaction, resulting in 
an ability of MscL to open in response to relatively weaker mechanical stimuli (Yoshimura, 
Nomura et al. 2004).  
Further mutational analysis of MscL has identified a band of residues between the 
membrane lipid and the periplasmic loop on TM1 and TM2 that aid in the mechanosensitivity of the 
channel (Yoshimura, Nomura et al. 2004). When these hydrophobic residues are replaced with the 
hydrophilic, and neutral, asparagine, MscL function is lost (Yoshimura, Nomura et al. 2004). These 
bands of residues are summarised in Figure 1.10. 
 
Figure 1.10. The location of residues that affect MscL mechanosensitivity. A) 
Replacement of amino acids highlighted in red had the highest effect on 
mechanosensitivity with yellow and blue amino acids having moderate and no 
effect respectively. B) High impact amino acids shown on the structure of MscL, 
red residues are located at the end of TM1 and blue residues are located on TM2. 
Images from (Yoshimura, Nomura et al. 2004) reproduced with permission from 
Elsevier. 
 
Removal of the periplasmic loop also causes MscL to have a lower gating threshold (Ajouz, 
Berrier et al. 2000) and is believed to also contribute to maintaining MscL in a closed state. 
Molecular dynamics (MD) simulations and mutational studies show that glutamine 65 in the 
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periplasmic loop exhibits an important role in the interaction between MscL and the lipid bilayer 
(Tsai, Liu et al. 2005, Meyer, Gullingsrud et al. 2006). 
1.6.4 Elucidating the Conformational Changes of MscL 
EPR, FRET spectroscopy and molecular dynamics (MD) studies have provided some insight 
into the structural changes that occur as the channel opens. During channel activation, in silico 
studies of MscL have suggested that the periplasmic loop of the channel could be the first to 
undergo structural rearrangement during channel opening (Meyer, Gullingsrud et al. 2006). The 
transmembrane !-helices expand and tilt to form an open pore of ~30 Å in diameter (Häse, Le Dain 
et al. 1995, Cruickshank, Minchin et al. 1997, Betanzos, Chiang et al. 2002, Perozo, Cortes et al. 
2002, Perozo, Kloda et al. 2002). The N-terminus is thought to function as an anchor that maintains 
the lipid-protein interaction of MscL (Corry, Hurst et al. 2010). This interaction may also function 
as a sensor for membrane tension due to its connection to the pore-lining TM1 domain that may 
induce a larger tilt in the domain (Iscla, Wray et al. 2008, Corry, Hurst et al. 2010). This is 
reinforced by reports that N-terminal deletion mutants require increased pressure to open the 
channel (Häse, Le Dain et al. 1995, Blount, Sukharev et al. 1996). 
Studies have also suggested that the C-terminal region of MscL participates in channel 
opening. The C-terminal !-helix in a closed channel protrudes into the cytoplasm of the membrane. 
Mutational and scanning electron microscopy studies have shown that as the channel opens, the C-
terminal migrates into the pore to form part of the open channel (Figure 1.11) (Yoshimura, Usukura 
et al. 2008). It has further been observed in FRET studies that there is a large variation in the 
conformation of this domain as the channel opens (Corry, Hurst et al. 2010). MD simulations have 
suggested the existence of a filter that prevents large solutes from entering the cell when MscL 
opens (Anishkin, Gendel et al. 2003, Corry, Hurst et al. 2010). This filter formation occurs as the !-
helices at the top of the C-terminal region of MscL forms part of the large open pore whilst 
maintaining a narrowing structure at the end of the terminal region (Anishkin, Gendel et al. 2003, 
Corry, Hurst et al. 2010). Another observation was made on the charged residues in this region, 
which suggests that the C-terminus may also act as a pH sensor (Kloda, Ghazi et al. 2006). This 
ensures that the channel remains closed when the extracellular pH conditions are below the 
bacteria’s optimal range, as MscL can form a pathway for the influx of protons (Buurman, 
McLaggan et al. 2004, Kloda, Ghazi et al. 2006). 
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Figure 1.11. Elucidated MscL open and closed states. A) reconstructed 3D 
tomography images obtained by SEM and diagram of closed WT MscL with the red 
arrow indicating the C-terminal protrusion. B) reconstructed 3D tomography images 
obtained by SEM, and diagram of the spontaneously opened G22N mutant MscL, with 
the C-terminal protrusion, not visible in the open channel, marked by the red arrow. C) 
MD modelling of the closed MscL channel at the cytoplasmic (left) and side (right) 
view. D) MD modelling of the open MscL channel at the cytoplasmic (left) and side 
(right) view. Image and text adapted from (Yoshimura, Usukura et al. 2008). 
 
1.7 Activation of MscL 
MscL is capable of sensing membrane tension directly without the aid of additional proteins 
(Sukharev, Blount et al. 1994, Häse, Le Dain et al. 1995). It has been determined that tension across 
the membrane is the primary stimulus that leads to channel gating (Sukharev, Sigurdson et al. 1999, 
Moe and Blount 2005). Experimental and MD simulations have shown that the initial response of 
MscL to membrane tension is an expansion of the channel via TM tilting. 
 
 
Figure 1.12. Schematic of a patch clamp setup. 
Stretching of the lipid bilayer (green) is attained through 
suction. A graph of channel opening against negative 
pressure is produced. Image obtained from (Martinac 
2011) with permission from Prof. Boris Martinac 
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In electrophysiology studies using patch-clamp experiments (Figure 1.12), MscL is activated 
via membrane stretching by applying suction. As bacterial cells are too small for direct applications 
of the patch-clamp, the technique is used on liposomes with reconstituted purified channels, or on 
giant spheroplasts where the addition of penicillin and lysozymes can cause the ballooning of 
bacterial cells into large unilamellar spheres (Felle, Porter et al. 1980, Ruthe and Adler 1985). 
In site directed spin labelling studies using EPR, it was shown that the addition of 
amphiphatic compounds such as the conical lipid lysophosphatidylcholine (LPC) is also capable of 
activating MscL (Perozo, Kloda et al. 2001). The mechanism of how this process occurs is not 
known but it is believed that the asymmetric addition of the conical lipid to the outer leaflet of the 
lipid bilayer induces local membrane curvature (Figure 1.13 B) (Perozo, Kloda et al. 2002). 
 
 
Figure 1.13. A) MscL activation via two proposed mechanisms; hydrophobic 
mismatch and bilayer curvature. B) Asymmetric addition of lysophosphatidylcholine 
(LPC) to one side of the monolayer of a lipid bilayer is postulated to cause membrane 
curvature. Image and text adapted from (Martinac 2009) with permission from Springer. 
 
As the membrane curves, the bilayer stretches, and it is suspected that the driving force of 
MscL opening is caused by the exposure of its hydrophobic TM !-helices to water during this 
bilayer stretching. This exposure is minimized by an expansion of the protein to maintain contact 
with the lipid bilayer, resulting in an open pore (Powl and Lee 2007). The open confirmation of 
MscL has a total open area that is larger than that of its closed confirmation with an in-plane protein 
expansion of 18-20 nm2 upon opening (Corry, Hurst et al. 2010).  
1.7.1 Activation by Hydrophobic Mismatch 
The expression and purification of transmembrane proteins, such as MscL, requires annular 
lipids to maintain a hydrophobic area around the transmembrane region of the protein whilst 
suspended in detergent. As the protein reconstitutes into the more energetically favourable setting of 
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a lipid bilayer, the annular lipids exchange themselves rapidly with the bulk lipid of the bilayer. As 
exposure of hydrophobic regions of the protein and lipid to the aqueous solution is energetically 
unfavourable the thickness of the lipid bilayer surrounding the protein has to be considered (Figure 
1.13 A). 
Compression of the lipids can occur when the hydrophobic thickness of the lipid bilayer is 
greater than the hydrophobic thickness of the protein. Likewise, stretching can occur if the 
hydrophobic thickness of the lipid bilayer is thinner than the hydrophobic thickness of the protein 
(Figure 1.14 A). These events take place to minimize exposure of the hydrophobic regions to the 
solvent. Distortion of the protein may also take place when it becomes energetically unfavourable 
for the membrane bilayer to adjust its thickness (Figure 1.14 B) (Powl and Lee 2007). Likewise, 
both distortions of the lipid bilayer and protein can occur. In the case of MscL, the distortion of the 
protein more readily occurs in shorter acyl chain length lipids, resulting in decreased activation 
energy of the channel (Perozo, Cortes et al. 2002, Elmore and Dougherty 2003, Powl, East et al. 
2003, Nomura, Cranfield et al. 2012). 
 
 
Figure 1.14. Possible hydrophobic mismatch interaction between 
the lipid bilayer and a membrane protein. A) Distortion of the lipid 
bilayer. B) Distortion of the protein. Image obtained from (Powl and 
Lee 2007) with permission from Elsevier. 
 
1.7.2 MscL Subconducting States 
As mentioned previously, MscL may adopt a state that requires decreased activation energy 
when certain conditions are met. These are known as sub-conducting states. Patch clamp studies 
have provided evidence that MscL passes through several transient sub-conducting states before 
finally progressing to the fully open state after the application of increased membrane tension 
(Sukharev, Blount et al. 1994, Yoshimura, Batiza et al. 1999). Details regarding putative structural 
changes believed to occur during channel gating have been derived from molecular dynamics (MD) 
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simulations. These in silico studies have provided useful insights into structural changes of MscL 
during the initial stages of gating but are unable to follow the gating process entirely (Corry and 
Martinac 2008). Nevertheless, information obtained from these studies coupled with EPR 
spectroscopy have recorded interactions between the lipid membrane bilayer thickness and intrinsic 
curvature and these MS conformational states (Betanzos, Chiang et al. 2002, Perozo, Cortes et al. 
2002, Perozo, Kloda et al. 2002). 
1.7.3 Effects of Lipids on MscL 
The interactions between lipids and MscL are still being debated. Specific interactions 
between lipids and MscL at the lipid-water interface have been known to initiate structural 
rearrangements of the channel. While it has been suggested that lipid effects alter MscL tension 
thresholds by altering the biophysical properties of the membrane rather than affecting MscL 
directly (Moe and Blount 2005, Nomura, Cranfield et al. 2012), MD simulations have suggested 
that lipid headgroups do interact with MscL (Elmore and Dougherty 2003). 
MD simulations using MscL and phophatidylcholine (PC) or phosphatidylethanolamine 
(PE) shows that different patterns of hydrogen bonding exist between these lipids’ headgroups with 
the C- terminal and periplasmic loop of MscL, which leads to differences in the protein structure 
(Elmore and Dougherty 2003) and may result in an increase of membrane tension required to 
activate the channel (Powl and Lee 2007). Elmore and Dougherty, using MD simulations on MscL 
with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) reported that there is a higher number of hydrogen bonding 
interactions between MscL and POPE compared to POPC (Elmore and Dougherty 2003). The 
difference in hydrogen bonding was related to the different headgroups of the lipids (Elmore and 
Dougherty 2003) and may explain an observation that dioleoylphosphatidylethanolamine (DOPE) 
increases MscL incorporation into a lipid bilayer when compared to bilayers of pure 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) with bilayers of DOPE/DOPC mix (Grage, Keleshian et al. 
2011). 
The presence of PE in the lipid bilayer has been reported to cause an increase in tension 
required to open MscL and it has been argued that PE lipid headgroups induces changes in the 
biophysical properties of the lipid bilayer via an increase in the membrane thickness and lateral 
pressure (Moe and Blount 2005, Nomura, Cranfield et al. 2012), which decreases channel activity 
(Perozo, Kloda et al. 2002). However, it has also been suggested that the direct interaction of the 
immediate surrounding lipid with the MscL transmembrane domains buffers any changes 
experienced by the bulk lipid on the protein (Powl, East et al. 2007) and reinforces the opinion that 
the hydrogen bonds between PE and MscL may have an effect on the channel function and 
incorporation. 
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Recent patch-clamp studies have demonstrated that lipid bilayer stiffness, thickness 
(hydrophobic mismatch) and changes in its pressure profile affect the structural dynamics of MscL 
(Nomura, Cranfield et al. 2012). This is reinforced by a recent MD study suggesting that lipid-lipid 
interaction is stronger than that of protein-lipid interaction and as tension is applied, contact 
between lipid and protein is slowly lost, resulting in a change of MscL conformation in order to 
maintain its hydrophobic environment (Rui, Kumar et al. 2011). These simulations performed on M. 
tuberculosis MscL imply that as TM-2 tilts and expands, it facilitates the tilting of TM-1 via 
interactions between hydrophobic residues between the domains (Rui, Kumar et al. 2011). This 
overcomes and weakens the hydrophobic forces within the pore allowing MscL to fully open (Rui, 
Kumar et al. 2011). 
1.8 MscL Clustering 
E. coli MscL has been suggested to cluster at the poles of the bacteria (Norman, Liu et al. 
2005). This phenomenon was also observed recently in reconstituted MscL using a variety of 
methods such as small-angle neutron scattering, atomic force microscopy, neutron scattering, 
fluorescence spectroscopy and patch-clamp analysis (Grage, Keleshian et al. 2011, Nomura, 
Cranfield et al. 2012). Variation in the types of lipids used and methods of MscL reconstitution also 
showed the clustering effect (Grage, Keleshian et al. 2011). This led to the postulation that MscL 
clustering modulates channel activity through a membrane-mediated protein-protein interaction, 
where a thickness deformation of the lipid bilayer is the driving force of clustering (Grage, 
Keleshian et al. 2011). In this study it was determined that MscL maintains its mechanosensitivity 
while in the clusters, however the close proximity of the channels to each other also affect their 
open probability upon stimulation (Grage, Keleshian et al. 2011, Nomura, Cranfield et al. 2012). 
As membrane tension is added to the lipid bilayer containing the MscL cluster, it was 
observed that not all of the channels activate (Grage, Keleshian et al. 2011). It was postulated that 
there is a segregation of closed and open channels to favour a more energetically favourable setting 
due to a thickness deformation of the lipid bilayer (Grage, Keleshian et al. 2011) and it is assumed 
that hydrophobic mismatch between the open and closed channels over a short distance (7 nm) 
induces them to repel each other (Grage, Keleshian et al. 2011). This is coupled with the elastic 
membrane deformation properties of the lipid bilayer, which causes the segregation of the channels 
to a more energetically favourable setting (Ursell, Huang et al. 2007, Grage, Keleshian et al. 2011) 
and has led to the assumption that the probability of gating MscL channels is reduced due to 
repulsive forces exerted from neighbouring open channels (Grage, Keleshian et al. 2011). 
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1.9 MscL as Nanovalves 
Studies on MscL have shown that it can putatively be used as a nanovalve in liposomal drug 
delivery systems. To this end, MD simulations have been carried out to fine-tune a potential MscL-
liposomal drug delivery system (Louhivuori, Risselada et al. 2010) and other work has 
demonstrated that MscL mutants can be light- and pH-activated (Koçer, Walko et al. 2005, Koçer 
2007, Koçer, Walko et al. 2007), with both mutants patented under US 7,393,828 and 
WO/2005/051902. 
1.10 Aims 
The first aim of this thesis was to determine the effects of different degrees of lipid bilayer 
curvature on MscL activation within liposomes. This is done through the application of various 
chain length L-!-lysophosphatidylcholine (LPC) to the MscL-liposomes. The studies will show that 
membrane deformation can activate wild type (WT) MscL channels incorporated into liposomes, 
thus allowing the efflux of an encapsulated cargo through the resulting open channel pore. As soy 
azolectin is the most widely used lipid in MscL functionality studies, further investigations into 
varying batches of soy azolectin showed that lipid constituents that make up the lipid bilayer have 
an effect on MscL activity. A majority of the publications on MscL efflux have mostly been 
focused on an MscL mutant known as G22C and its ability to be chemically activated through the 
attachment of positively charged or negatively charged compounds to the introduced cysteine 
residue (Yoshimura, Batiza et al. 2001, Koçer 2007, van den Bogaart, Krasnikov et al. 2007, Powl, 
East et al. 2008, Birkner, Poolman et al. 2012). The characterization of lipid bilayer curvature on 
MscL activation within liposomes and the background to G22C MscL mutants is discussed in 
Chapter 3. 
Studies aimed at understanding the effects of lipid constituents along with ionic effects on 
liposome size and structure were undertaken such that in turn, they will facilitate future structural 
studies on the development of a nanovalve drug delivery system in their near native states. As part 
of this aim, it was considered important to investigate MscL incorporation efficiency and channel 
orientation since these factors will likely have ramifications for the future development of an MscL-
based drug release mechanism. There are also reported benefits of liposomes that are <200 nm in 
diameter having prolonged half-lives and increased accumulation at disease sites (Morgan, 
Williams et al. 1985, Papahadjopoulos, Allen et al. 1991, Yuan, Leunig et al. 1994, Maeda 2012) 
and so an additional aim was to develop a methodology enabling the production of uniformly-sized 
liposomes that satisfy this size requirement. These aims are addressed in Chapters 4 and 5. 
Furthermore, as WT MscL is activated by changes in the transbilayer pressure profile, which is 
induced by changes in the degree of curvature of the lipid bilayer MscL is incorporated into, it has 
been speculated that decreasing MscL-liposome diameter can lower the activation energy of MscL 
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as smaller sized MscL-liposomes have an increasing degree of curvature. This view is strongly 
supported by a recent study on the transmembrane !-hemolysin protein, suggesting that membrane 
curvature could likely regulate allosterically the structure and function of transmembrane proteins 
(Tonnesen, Christensen et al. 2014). 
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2.1 MscL Expression and Purification 
MscL was expressed in E. coli strain AW737-KO (MscL knockout strain) from a pQE30 
plasmid encoding full-length MscL fused to an N-terminal 6xHis-tag. 1 L of lysogeny broth (LB; 
10 g tryptone, 5 g yeast extract, 5 g NaCl /L) was prepared and sterilised in two 2 L conical flasks 
(500 mL each). Stock solutions of ampicillin (50 mg/mL; 1000x) and chloramphenicol (40 mg/mL 
in 50% EtOH; 2000x) were prepared and filtered using a 0.22 µm filter. 10 mL of LB broth 
containing antibiotics (50 mg/mL ampicillin and 20 mg/mL chloramphenicol) was inoculated with 
100 mL of glycerol stock and grown overnight at 37 °C with shaking. 
Two times 500 mL of LB broth (containing 50 mg/mL ampicillin and 20 mg/mL 
chloramphenicol) was inoculated with the starter culture (1/100 vol) and grown at 37 °C with 
shaking to OD = 0.8-0.9. Isopropyl !-D-1-thiogalactopyranoside (IPTG) was added to the two LB 
cultures at a final concentration of 1 mM. Incubation was continued at 37 °C for 4 hours. The 
culture was split into two 500 mL centrifuge tubes and spun down at 6,000 rpm (RCFavg = 4,435 g) 
for 15 minutes. The supernatant was discarded and the cell pellets were then resuspended in 20 mL 
of "breaking" buffer (50 mM Na2PO4, pH 8.0, 2 mM MgSO4, 5% sucrose, 10 mM NaCl). 2 mL of 
benzonase and a 1 mM final concentration of phenylmethanesulfonylfluoride (PMSF) were added 
to each resuspended cell pellet, which was ruptured by French pressing twice at 16,000 psi. Cell 
debris was then spun down at 10,000 rpm (RCFavg = 8,204 g) for 15 minutes at 4 °C and the 
supernatant was spun down at 50,000 rpm (RCFavg = 180,000 g) for 90 minutes at 4 °C resulting in 
a cell membrane pellet. This cell membrane pellet was resuspend in 3mL of phosphate buffered 
saline (PBS) with 8 mM dodecyl !-D-maltopyranoside (DDM) buffer, pH 7.2 (280 mg of 
membrane / mL of buffer). The suspension was solubilised at 23 °C for 2 hours followed by 4 °C 
overnight. The 6xHis-tagged MscL was then purified on TALON resin (BD Biosciences Clontech). 
MscL was eluted by on-resin cleavage with bovine thrombin (GE Healthcare) for 4 hours at 23 °C 
using 20 U of enzyme per g of initial membrane yield in PBS with 1 mM DDM. Protein purity was 
assessed by standard 12% SDS-polyacrylamide gel electrophoresis. Note: His-MscL is used in 
Nanogold® tagging see Section 2.9.3 Nanogold Tagging. 
2.2 MscL Activity Analysis 
2.2.1 Liposome Preparation for Patch Clamp 
Soybean azolectin was purchased from Sigma-Aldrich (St Louis, MO) and was used without 
further purification. The method followed an adaptation of that described by Häse and colleagues 
(Häse, Le Dain et al. 1995). Briefly, 10 mg of lipid was dissolved in chloroform (CHCl3) and then 
air dried under a stream of N2 gas. To this 1 mL of carboxyfluorescein buffer containing 50 mM 
5,6-carboxyfluorescein, 100 mM KCl and 5 mM HEPES (pH adjusted to 7.2 using KOH) was 
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added. The resulting suspension was sonicated for 20 minutes. 200 µL (2 mg lipid total) was taken 
from this solution and placed in a 10 mL Falcon tube and the appropriate volume of MscL was 
added to make a protein:lipid ratio of 1:1000 w/w. The volume was increased to 3 mL using the 
bulk solution above and the tube placed on a rotary wheel for 1 hour. Biobeads SM-2 (BioRad, 
Richmond, CA) were then added and the solution further rotated for another 3 hours. After this 
time, the solution was centrifuged at 40,000 rpm (RCFavg = 117,734 g) for 30 minutes. The pellet 
was collected, spotted onto a microscope slide and dehydrated under vacuum overnight at 4 °C. The 
bright orange spot was then rehydrated using a solution containing 200 mM KCl and 5 mM HEPES 
(pH adjusted to 7.2 using KOH) at 4 °C for 24 hours.  
2.2.2 Patch Clamp Analysis 
An aliquot (2–4 µL) was taken from the rehydrated liposomes and added to the recording 
bath. MscL channel activity was examined using the patch clamp method with the “inside-out” 
configuration on liposomes that settled on the bottom of the recording chamber and formed 
unilamellar blisters (Delcour, Martinac et al. 1989). Negative pressure (recorded in mm Hg) was 
applied to patch pipettes by using a 1 mL syringe and was monitored using a piezoelectric pressure 
transducer (Omega Engineering, Stamford, USA). Borosilicate glass pipettes (Drummond Scientific 
Co., Broomall, PA) were pulled using a Flaming/Brown pipette puller (P-87, Sutter Instrument Co., 
Novato, CA) to a diameter that corresponded to a pipette resistance in the range of 3.0–6.0 M". Ion 
currents arising from activation of MscL were recorded using an Axon 1D patch-clamp amplifier 
(Axon Instruments), filtered at 2 kHz and digitized at 5 kHz. Single channel analysis was carried 
out using pCLAMP10 software (Axon Instruments). Bath and pipette solutions were symmetrical 
and consisted of 200 mM KCl, 40 mM MgCl2, 5 mM HEPES (MscL, solution adjusted to pH 7.2 
using KOH) either with or without 50 mM 5,6-carboxyfluorescein. 
2.3 Lipid Storage 
Azolectin granules* / lipid powders** were dissolved in chloroform (CHCl3) as a stock 
solution of 20 mg/mL and stored as 1 mL aliquots in high-performance liquid chromatography 
(HPLC) glass vials at -80 °C. This serves as a means for long-term lipid storage, which slows the 
oxidation and degradation of lipids. When ready for use, a glass syringe with a metallic needle is 
used to puncture the rubber top of the HPLC glass vial and the desired amount of lipid-chloroform 
solution aspirated. 
 
* Azolectin used in these studies:-  
1. Soy 11-23% PC  [Sigma-Aldrich® cat # P5638] 
2. Egg yolk   [Sigma-Aldrich® cat # P5394] 
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3. Soy 20% PC   [Avanti Polar Lipids® cat # 541601G] 
4. Soy 40% PC  [Avanti Polar Lipids® cat # 341602G] 
**Lipid powders used:- 
1. 1,2-dioleoyl-sn-glycero-3-phosphocholine, DOPC (18:1; #9-Cis) [Avanti Polar Lipids® cat 
# 850375P] 
2. 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(ammonium salt) (18:1 Liss Rhod PE) [Avanti Polar Lipids® cat # 810150P] 
3. Cholesterol (5-Cholesten-3!-ol) [Sigma-Aldrich® cat # C8667] 
2.4 Liposome and MscL-liposome Production 
The method used for liposome production was modified from a protocol by Koçer et al. 
(Koçer, Walko et al. 2005). Dissolved azolectin / lipid* was aspirated from a previously prepared 
stock solution and placed into a glass test tube. The CHCl3 was evaporated using a stream of 
nitrogen (N2) gas whilst a continuous circulating motion along the longitudinal axis of the glass test 
tube was applied, resulting in a thin lipid film along the sides of the glass test tube. The lipid film 
was then further flushed with N2 gas for 20 minutes, or was stored under vacuum overnight at 23 °C 
until required. 
A desired volume of buffer** was aspirated onto the lipid film (final concentration of 
intended liposomes is 20 mg/mL). The lipid film with buffer was vortexed and sonicated using an 
ice chilled water bath sonicator (Unisonics Australia Pty. Ltd., Brookvale, Australia). The liposome 
suspension was then extruded using the LiposoFast-Basic system (Avestin Inc., Ontario, Canada) 
by using a 400 nm Nucleopore track-etched polycarbonate membrane followed by a second 
extrusion through either a 100 nm or a 100 nm and then 50 nm membrane (Whatman Inc., Florham 
Park, NJ) depending on the desired liposome size. Liposomes were extruded through each 
membrane 11 times. 
MscL in PBS containing 1 mM DDM was added to the liposomes at a protein:lipid w/w 
ratio of 1:4000, 1:3000, 1:2000 or 1:500. Incorporation of MscL was achieved by incubation of the 
MscL-liposome mixture for 1 hour at 23 ºC on a rocker. This was followed by detergent removal 
using pre-hydrated BioBeads SM-2 (approximately a spatula full; BioRad, Richmond, CA) and the 
incubation continued for a further 4 hours at 23 °C, or overnight at 4 °C. Control liposomes were 
also prepared without MscL. Note; production of liposomes through extrusion causes a loss of 
approximately 44% of starting lipid due to residues adhering on filters and on the internal extruder 
components. 
 
*  Desired amount of azolectin / lipid varies depending on the study conducted. For fluorescence 
assays using azolectin, 20 mg of azolectin was used to prepare both MscL-liposomes and its 
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control. For continuous sucrose gradients, 10 mg of azolectin / lipid was used as only MscL-
liposomes were required. 
**Buffer used in fluorescence assays and continuous sucrose gradients was carboxyfluorescein 
buffer (50 mM 5,6-carboxyfluorescein, 100 mM KCl, 5 mM HEPES pH7.2). Note 100 mM KCl 
can be replaced with different concentrations (1 mM, 10 mM, 50 mM and 100 mM) and salts 
(KCl, K2SO4, MgCl2 and MgSO4). In confocal microscopy experiments, water was used to 
generate liposomes followed by titration with salts of interest. 
 
 
Figure 2.1. A summary of MscL-liposome production via extrusion process. A photograph of  
"Liposofast ", a syringe-based membrane extruder from Avestin, Inc. (Ottawa, Ontario, Canada). 
  
2.5 Fluorescence Assay 
Non-encapsulated carboxyfluorescein was separated from the liposomes by Sephadex G-50 
size exclusion chromatography using a running buffer of 100 mM KCl, 5 mM HEPES, pH 7.2 (SEC 
buffer) under gravity flow. L-$-lysophosphatidylcholine (LPC) was used to induce membrane stress 
and trigger opening of MscL channels. 145.7 µL of liposomes post size exclusion (approximately 
1 mg/mL) were mixed with LPC (pre-dissolved in methanol) to produce a final concentration of 0, 
0.05, 0.1, 0.5, 1, 1.5 or 2.79 mM. The volume of methanol added to all samples was constant. 
Following LPC addition, samples were incubated for 30 minutes at 23 ºC. 2 µL of the LPC-treated 
liposomes were then diluted at a 1:28,125 dilution factor into the SEC buffer and assayed in 
replicates (8 wells per experiment) for carboxyfluorescein release, in a 96 well plate format using a 
POLARstar Omega fluorescence polarization reader (BMG Labtech GmbH, Offenburg, Germany) 
with an excitation and emission wavelength of 485 nm and 535 nm respectively. A fluorescence 
reading for 100% carboxyfluorescein release was obtained by incubating with 0.05% Triton X-100 
in place of LPC. 
2.6 Continuous Sucrose Gradient Size Separation 
MscL-liposomes were produced at a 1:2000 protein:lipid w/w ratio (according to Section 2.4 
Liposome and MscL-liposome Production) using carboxyfluorescein buffers* of interest. Size 
separation of MscL-liposomes was conducted using a continuous sucrose gradient of 400 mM 
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sucrose, salt of interest**, 5mM HEPES pH7.2 in a thin wall Ultra-ClearTM ultracentrifuge tube 
(Beckman Coulter, Inc.). Sucrose solutions were frozen in ultracentrifuge tubes at -80 °C and 
thawed for 3 hours prior to use at 4 °C, creating the continuous sucrose gradient. MscL-liposomes 
were loaded onto the continuous sucrose gradient and were centrifuged at 30,000 rpm (RCFavg = 
113,652 g) at 4 °C for 14 hours. Visible broad regions and bands are extracted from ultracentrifuge 
tubes using syringes to puncture the tube walls and aspirate the samples. 
 
*  Carboxyfluorescein buffers used contained 50 mM 5,6-carboxyfluorescein, salt, 5 mM HEPES 
pH7.2. Salt used in these studies are: 
1. 1 mM, 10 mM, 50 mM, 100 mM KCl 
2. 1 mM, 10 mM, 50 mM, 100 mM K2SO4 
3. 1 mM, 10 mM, 50 mM, 100 mM MgCl2 
4. 1 mM, 10 mM, 50 mM, 100 mM MgSO4 
** Salt of interest used in the continuous sucrose gradients matched the salt content and 
concentration used in the carboxyfluorescein buffers. 
2.7 Counterion Titration 
100 nm liposomes of soy 11-23% PC, egg yolk, soy 20% PC and soy 40% PC were 
produced as in Section 2.4 Liposome and MscL-liposome Production. 0.1% 18:1 Liss Rhod PE 
(w/w) was added to the azolectins in CHCl3. After CHCl3 evaporation, dH2O was added as the 
buffer. No MscL was added to the extruded liposomes. The liposomes were aliquoted into seven 
separate eppendorf tubes and were titrated with KCl and MgCl2 to a final concentration of 1 mM, 
10 mM, 20 mM, 30 mM, 40 mM, 50 mM and 100 mM respectively. 
2.8 Confocal Microscopy 
5 %L of liposomes (generated with an azolectin and mixed with 0.1% 18:1 Liss Rhod PE, 
w/w) titrated with KCl and MgCl2 was pipetted onto a glass slide and covered with a glass cover 
slip. KCl titration produced no visible change. The liposomes were analysed using a LSM 510 Meta 
UV confocal microscope (Carl Zeiss Group, Oberkochen, Germany), with a Plan Apochromat 63x / 
1.4 Oil immersion objective. Images and time-based recordings were analysed using Zen 2008 
software (Carl Zeiss Group, Oberkochen, Germany). 
2.9 Electron Microscopy 
2.9.1 Negative Staining 
Liposomes at a 1:10 dilution factor were analysed initially by negative stain EM. Samples 
were applied to glow discharged carbon-coated mesh grids covered with 1.5% (w/v) Formvar 
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(ProSciTech, Thuringowa, Australia) and stained with 1 % uranyl acetate. Samples were analysed 
in a JEOL 1011 transmission electron microscope (TEM) (JEOL Ltd., Tokyo, Japan) operating at a 
high-tension voltage of 80 keV (magnification = 80,000x), and images were recorded on a SiS 
Morada charge coupled device (CCD) imaging system (Olympus Soft Imaging Solutions GmbH, 
Münster, Germany). 
2.9.2 Preparation of Sucrose Gradient Extracted Liposomes for Cryo-preservation 
Liposomes and MscL-liposomes extracted from continuous sucrose gradients were prepared 
for cyro-preservation via dialysis in a buffer corresponding to the salts used to generate the 
liposomes with the exception of 5,6-carboxyfluorescein and sucrose. Dialysis was performed at a 
1:5000 dilution factor with a 10,000 molecular weight cutoff Snakeskin® dialysis membrane 
(Thermo Fisher Scientific, Inc.) and dialysis buttons (Hampton Research Corp., California, United 
States). Dialysis was performed overnight at 4 ºC with constant stirring using magnetic bars. 
2.9.3 Nanogold Tagging 
A final concentration of 1 mM DDM was added to the 5 nm Ni-NTA-nanogold® 
(Nanoprobes, Inc., New York, United States) solution. This was immeadiately added to His-MscL 
in PBS with 1 mM DDM. The mixture was placed on a rotary wheel and incubated for 1 hour at 
23 ºC followed by overnight incubation at 4 ºC. Nanogold-His-MscL was added to extruded 
liposomes as stated in Section 2.4 Liposomes and MscL-liposomes Production. Buffer used was 
100 mM KCl, 5 mM HEPES, pH 7.2. MscL reconstitution was performed at a 1:1000 protein:lipid 
w/w ratio. Excess gold was removed through Sephadex G-50 size exclusion chromatography using 
a running buffer of 100 mM KCl, 5 mM HEPES, pH 7.2 (SEC buffer). 
2.9.4 Cryo-Electron Microscopy 
Electron cryomicroscopy and cryotomography was performed on a Tecnai T12 TEM (FEI 
Company, Eindhoven, The Netherlands) at a high tension voltage of 120 keV (magnification = 
67,000x, typical defocus = 0.5–1.5 µm) operating at liquid N2 temperatures (~-176 ºC) and imaged 
under low dose conditions (~10 e-.Å2) using a FEI Eagle 4Kx4K CCD imaging system (FEI 
Company). Samples containing sucrose were first dialysed overnight against sucrose-free buffer. 
Liposomes were then applied to 1.2/1.3 or 2/4 Quantifoil grids (Quantifoil Micro Tools GmbH, 
Jena, Germany) prior to vitrification using an FEI Vitrobot system (50 ºC, 100% humidity, 1 second 
blot time (Frederik and Hubert 2005)). Grids were prepared for sample application and vitrification 
by soaking in 100% CHCl3 (30 minutes) followed by either glow discharge or plasma cleaning (gas 
mixture = 4:1 H2/O2) with no noticeable difference in the liposome populations. 
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2.9.5 Liposome Size Measurements 
Liposome diameters were measured using iTEM (Olympus Soft Imaging Solutions GmbH, 
Münster, Germany).
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Chapter 3: Efflux of Carboxyfluorescein from Liposomes 
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3.1 Abstract 
Bacterial mechanosensitive channels act as osmotically activated nanovalves allowing 
bacteria to respond to hypo-osmotic stress by opening nanometer-size channel pores. The 
underlying mechanism of the channel activation and opening by membrane tension has been 
particularly well studied for the mechanosensitive channel of large conductance (MscL) 
reconstituted into artificial liposomes, by using patch clamp, electron paramagnetic resonance and 
fluorescence spectroscopy techniques combined with computational modelling of the channel 
dynamics during channel opening. Liposomes present one of the major forms of particulate drug 
carriers, providing an excellent method of encapsulation of highly toxic drugs; and MscL has 
recently been identified as a candidate for incorporation into liposomes to function as a nanovalve, 
enabling controlled release of particulates from the liposomes. In this chapter, a method to analyze 
the release of an encapsulated cargo, in this case 5,6-carboxyfluorescein (carboxyfluorescein), from 
MscL-liposomes is described. The effect of different size extruded liposomes, lipids and acyl length 
LPCs on the release of carboxyfluorescein from MscL-liposomes is also compared. 
3.2 Introduction 
Liposomes are one of the most studied and advanced forms of drug delivery used in modern 
medicine. The system however is limited by the release efficiency of its encapsulated compounds 
and the development of a more efficient means of cargo release is actively being pursued. This 
chapter focuses on the use of a bacterial mechanosensitive (MS) channel, found in E. coli, as a 
nanovalve candidate for the release of a liposome encapsulated cargo. 
3.2.1 Monitoring the Efflux of Molecules from Liposomes via MscL 
There have been several methods used to induce an open channel structure of reconstituted 
MscL. A majority of these are based on patch-clamp studies that apply tension to MscL via 
increasing local membrane curvature, which is achieved through the application of negative 
pressure (suction) to excised membrane patches. Such patch-clamp studies have allowed for the 
investigation of several factors that affect MscL activation such as lipid headgroups, acyl chain 
lengths, and MscL mutations that allow for the determination of MscL structure and the functional 
significance of particular amino acids. 
As interest in the use of MscL as a nanovalve has grown, there have been an increasing 
number of studies reporting on the efflux of compounds from MscL-liposomes (Koçer 2007, van 
den Bogaart, Krasnikov et al. 2007, Powl, East et al. 2008, Rui, Kumar et al. 2011, Birkner, 
Poolman et al. 2012). A majority of the investigations into the efflux of particulates from liposomes 
via reconstituted MscL utilize a mutant form of E. coli MscL where the glycine residue at position 
22 is replaced with cysteine (G22C mutants) (Yoshimura, Batiza et al. 1999, Yoshimura, Batiza et 
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al. 2001). Gly22 moves from a hydrophobic to a hydrophilic environment when transitioning from a 
closed to open state and substitutions of Gly22 with hydrophobic or hydrophilic residues increases 
or decreases the threshold pressure required to open MscL respectively (Yoshimura, Batiza et al. 
1999). The mutational analysis of Gly22 by Yoshimura and colleagues led to the discovery of the 
G22C MscL mutant (Yoshimura, Batiza et al. 1999, Yoshimura, Batiza et al. 2001), which has been 
employed in several efflux studies (Koçer, Walko et al. 2007, van den Bogaart, Krasnikov et al. 
2007, Powl, East et al. 2008, Birkner, Poolman et al. 2012). 
G22C MscL normally requires a higher application of pressure to activate (Yoshimura, 
Batiza et al. 2001), however the attachment of positively or negatively charged 
methanethiosulfonate (MTS) reagents, such as 2-(trimethylammonium)ethyl methanethiosulfonate 
(MTSET) and sodium 2-sulfonatoethyl methanethiosulfonate (MTSES), to the cysteine residue of 
G22C MscL leads to spontaneous activation of the channel (Yoshimura, Batiza et al. 2001). Among 
the MTS reagents, MTSET is the most widely used in the activation of G22C MscL reconstituted 
liposomes (G22C MscL-liposomes) and among the compounds whose efflux from G22C MscL-
liposomes has been monitored are fluorescently labelled insulin and 5,6-carboxyfluorescein (Koçer 
2007, van den Bogaart, Krasnikov et al. 2007, Powl, East et al. 2008, Birkner, Poolman et al. 2012). 
MTSET deposits five positive charges at the pore constriction of G22C MscL, forcing the channel 
to open, thus allowing spontaneous activation without the requirement for direct application of 
pressure (Yoshimura, Batiza et al. 2001). G22C MscL has been used to investigate the efflux of 
compounds from MscL-liposomes (Koçer, Walko et al. 2007, van den Bogaart, Krasnikov et al. 
2007, Powl, East et al. 2008, Birkner, Poolman et al. 2012), as it can be expressed in E. coli with 
relative ease, compared to other constitutively active or more easily gated MscL mutants which may 
have adverse effects on cell growth (Yoshimura, Batiza et al. 1999, Yoshimura, Batiza et al. 2001).  
L-!-lysophosphatidylcholine (LPC) has been shown to induce spontaneous MscL channel 
activity in MscL-liposomes (Perozo, Kloda et al. 2002, Corry, Rigby et al. 2005, Corry, Hurst et al. 
2010, Birkner, Poolman et al. 2012) through the postulated asymmetric incorporation of this 
amphipath into one of the leaflets of the lipid bilayer (Perozo, Kloda et al. 2002). This asymmetric 
addition curves the membrane thereby exerting membrane tension on MscL (Martinac 2009). 
Activation of MscL using LPC allows for the use of wild-type (WT) E.coli MscL in efflux studies 
on MscL-liposomes. 
 
In order to determine the effect of lipid bilayer composition and increased lipid bilayer 
curvature on liposomal MscL activity, soy azolectins of varying lipid compositions were tested with 
exposure to LPCs of varying chain lengths. As mentioned earlier, LPCs of varying chain lengths are 
capable of applying varying degrees of curvature on lipid bilayers. Soy azolectin has been widely 
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used in biophysical studies of MscL and served as an initial proof-of-concept material for these 
studies. 
3.3 Results 
The initial aim of this work was to develop a system whereby the release of a small, drug-
sized molecule from liposomes via a wild type MscL channel could be monitored. In this study, the 
self-quenching fluorophore, 5,6-carboxyfluorescein (carboxyfluorescein) was chosen as a reporter 
molecule and channels were activated through membrane deformation using L-!-
lysophosphatidylcholine (LPC). The amount of carboxyfluorescein released from MscL-liposomes 
was determined from the observed increase in fluorescence when it becomes more diluted upon 
release into the extra-liposomal environment. Relative fluorescence release was calculated by 
comparison with 100% release when liposomes were lysed with Triton-X 100. 
3.3.1 Release of Carboxyfluorescein from MscL-liposomes 
In order to test the effect of membrane tension change on MscL-liposomes that are too small 
to be studied by patch-clamp analysis, LPC was added to MscL-liposomes and zero protein 
controls. These tests were combined with analyses on the effect of increasing the number of 
incorporated MscL channels on carboxyfluorescein efflux, in order to demonstrate that release was 
MscL-dependent. The result displayed in Figure 3.1 shows a chart of relative fluorescence of 
carboxyfluorescein release when MscL-liposomes (generated using Sigma 14-23% PC soy 
azolectin) with increasing protein : lipid ratios (w/w), and its zero protein control, are subjected to 
increasing concentrations of LPC with a mixture of acyl chain lengths (Sigma). The experiments in 
this chapter were conducted in eight replicates and the variances between the measurements were 
routinely low. A greater source of variability exists between the different liposome preparations and 
therefore the numbers of experiments recorded in this chapter are of independent liposome 
preparations, n, and the statistics tests reflect the variance between each preparation. An example of 
this will be detailed later in Figure 3.7. 
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Figure 3.1. Release of 5,6-carboxyfluorescein from 
MscL-liposomes measured as relative fluorescence 
released with increasing LPC concentration. LPC 
used consists of a mixture of chain lengths. Blue = 
MscL-liposomes. Orange = zero protein control. Error 
bars are standard error of the mean across 7 indepent 
liposome preparations (n = 7).  
 
As can be seen in Figure 3.1, with increasing concentrations of LPC, release of 
carboxyfluorescein was detected in both the MscL-liposomes (blue) and the control (orange). 
MscL-liposomes released a higher amount of carboxyfluorescein compared to its control, and this 
release was directly related to the protein : lipid ratios used, where the release of carboxyfluorescein 
increases with increasing concentrations of MscL. The release trend of the MscL-liposomes at 
1:2000 protein : lipid ratio (blue squares) was approximately double the release of 1:3000 (blue 
diamonds) and 1:4000 (blue triangles) protein : lipid ratios. Carboxyfluorescein release was also 
recorded in control liposomes, which do not have MscL incorporated into them. Release of 
carboxyfluorescein here increases with increasing concentrations of LPC and plateaus at 1 mM 
LPC. 
3.3.2 Effect of Liposome Size on Carboxyfluorescein Release 
 As noted above, batch to batch variation of liposome preparations was a significant 
contributor to the observed variance in LPC-triggered release. It was hypothesised that intrinsic 
membrane curvature and thus liposome size may be a contributing factor to this variance. In order 
to determine whether the size of liposomes has an effect on carboxyfluorescein efflux, zero protein 
control liposomes and MscL-liposomes of a different size were exposed to LPC and fluorescence 
release monitored. The protein : lipid ratio (w/w) used here was 1:2000 following the higher trend 
of carboxyfluorescein release observed in Figure 3.1. Liposomes prepared for MscL incorporation, 
and as controls, were extruded using either a 100 nm polycarbonate filter – designed to reform most 
liposomes to 100 nm in diameter (the homogeneity of these preps is addressed further in Chapter 4) 
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or a twice extruded liposome preparation first passed through a 100 nm filter and then passed 
through a 50 nm filter. The comparative fluorescence release between the 50 nm and 100 nm 
extruded liposomes generated using Sigma 14-23% PC soy azolectin, is shown in Figure 3.2.  
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Figure 3.2. Relative fluorescence percentage due to carboxyfluorescein release from 
A) 50 nm and B) 100 nm size extruded liposomes (orange) and MscL-liposomes 
(blue) encapsulating carboxyfluorescein and stressed with LPC. Relative fluorescence 
attained through comparison with 100% release when liposomes and MscL-liposomes are 
lysed with Triton-X 100. A T-test comparison between the differently sized extruded 
MscL-liposomes ranges between 0.2 and 0.8 for the increasing LPC concentrations 
indicating that there is no significant difference in fluorescence release between the two 
differently sized MscL-liposomes. n = 5.  Errors bars are the standard error of the mean. 
 
The larger, 100 nm diameter extruded liposomes seemed to exhibit a greater relative 
carboxyfluorescein release in the zero protein control liposome samples in response to LPC than the 
50 nm diameter extruded liposomes. As can be seen in Figure 3.2, the leakage of 
carboxyfluorescein from 100 nm liposomes is approximately 3 - 4 times higher than 50 nm 
liposomes when stressed with 0.1 - 2.79 mM LPC. Release of carboxyfluorescein from the MscL-
liposomes of different sizes showed no noticeable difference at 0.1 mM and 0.5 mM LPC. 
However, 100 nm extruded MscL-liposomes had a 5% higher relative fluorescence difference 
compared to its 50 nm counterpart at 1 mM and 2.79 mM LPC. At these LPC concentrations, 
MscL-liposomes produced through 50 nm extrusion released on average 6.5 times more 
carboxyfluorescein compared to their control, and an average 2.3 fold difference was observed 
between 100 nm extruded MscL-liposomes and their control. Comparison of the different sized 
MscL-liposomes suggests that while the size of the MscL-liposomes does not have a major effect 
on the net carboxyfluorescein release following LPC addition, there is a lower occurrence of 
leakage from the smaller size extruded zero protein liposomes stressed with LPC. 
It can also be seen that at 0.05 mM LPC, the leakage of carboxyfluorescein from liposomes 
is larger than that from MscL-liposomes under both size extrusions. This may indicate that the 
A  50 nm extrusion B  100 nm extrusion 
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MscL-liposomes are not activated at this concentration, but it is worth noting that the LPC used in 
these experiments consisted of a mixture of different acyl chain lengths, and this effect was not 
observed in further studies using specific acyl chain length LPCs (detailed in section 3.3.3). 
It should also be noted that extrusion of 50 nm liposomes is markedly more difficult than 
100 nm extrusions. This is probably due to the pore size of the filters and the transition temperature 
of the azolectin used, with frequent clogging and rupturing of the 50 nm diameter pore 
polycarbonate filter observed. A method of isolating variously sized MscL-liposomes through the 
use of continuous sucrose gradients, which will be detailed in Chapter 4, was therefore pursued in 
parallel with the experiments that follow. 
3.3.3 Effect of Specific Acyl Chain Length LPCs on Fluorescence Release 
MscL channels respond to changes in the trans-bilayer pressure profile, which is affected by 
different degrees of induced curvature on the lipid bilayer MscL is incorporated into (Martinac, 
Adler et al. 1990, Perozo, Kloda et al. 2002). Different degrees of curvature can be induced on 
MscL-liposomes by varying the degree of unsaturation and acyl chain length of LPCs being added 
(Genc, Ortiz et al. 2009). To investigate this responsiveness, a preliminary assay using varying 
LPCs of these natures was performed to determine the effects on the release of carboxyfluorescein 
from 100 nm extruded azolectin zero protein control liposomes and MscL-liposomes. A secondary 
motivation for these experiments was to determine which type of LPC best triggered fluorescence 
release and would thus be best implemented as a trigger in experiments that followed. 
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Figure 3.3. Relative fluorescence from the release of 
carboxyfluorescein from MscL-liposomes (blue line) and its 
zero protein control (orange line) after LPC 18:1 
incorporation into the liposome membrane. Errors bars are the 
standard error of the mean across a single liposome preparation. 
Electron micrograph insert showing liposome structure analysed 
through negative staining. Red arrowheads indicate LPC 
concentration that affects liposome structural integrity. Scale bar 
= 50 nm. 
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Figure 3.4. Relative fluorescence release from MscL-liposomes 
(blue line) and its zero protein control (orange line) after LPC 
16:0 incorporation into liposome membrane. Errors bars are the 
standard error of the mean across a single liposome preparation. 
Electron micrograph insert showing liposome structure analysed 
through negative staining. Red arrowheads indicate LPC 
concentration that affects liposome structural integrity. Scale bar 
= 50 nm. 
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Figure 3.5. Relative fluorescence release from MscL-liposomes 
(blue line) and its zero protein control (orange line) after LPC 
12:0 incorporation into liposome membrane. Errors bars are the 
standard error of the mean across a single liposome preparation. 
Electron micrograph insert showing liposome structure analysed 
through negative staining. Red arrowheads indicate LPC 
concentration that affects liposome structural integrity. Scale bar 
= 50 nm. 
 
As expected, there was an observed difference in carboxyfluorescein release between the 
zero protein control liposomes and MscL-liposomes exposed to LPCs of various acyl chain lengths 
and degrees of unsaturation (Figures 3.3, 3.4 and 3.5). Due to the leakage seen in zero protein 
control liposomes exposed to LPCs of mixed acyl chain lengths (Figures 3.1 and 3.2), electron 
microscopy (EM) studies was also conducted on the liposomes exposed to LPC to assess structural 
integrity. 
In Figures 3.3 and 3.4, saturated and unsaturated LPCs with an acyl chain length of 18:1 and 
16:0 produced a maximum relative fluorescence percentage release of 20% from MscL-liposomes 
at 0.5 mM LPC. This is approximately two-fold above that of the zero protein control liposomes. 
Carboxyfluorescein release from MscL-liposomes exposed to LPC 12:0 (Figure 3.5) did not reach 
similar fluorescence levels as that seen with LPC 18:1 and 16:0. A maximum relative fluorescence 
observed from MscL-liposomes compared with minimal leakage from zero protein control 
liposomes is approximately 5% at 1 mM LPC 12:0 concentration. 
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The increase of carboxyfluorescein release from the control liposomes suggested that the 
membrane bilayer became compromised with increasing LPC concentration. This was observed at a 
1 mM LPC concentration for both LPC 18:1 and 16:0 and at 1.5 mM concentration for LPC 12:0. 
Electron microscopy analysis on the effects of LPC on the integrity of the liposomes indicated that 
liposome integrity had become compromised at LPC concentrations higher than 0.5 mM for LPC 
18:1 and 16:0 (highlighted by red arrowheads in Figures 3.3 and 3.4) while compromised liposomes 
were seen at concentrations higher than 1 mM LPC 12:0 (highlighted by red arrowheads in Figure 
3.5). 
This assessment of compromised liposomal structure at high concentrations of LPC seen in 
the electron micrographs agreed with the fluorescence data to some extent, although the fact that 
release was not on par with Triton X-100 treated liposomes could not be explained. Regardless, the 
observations here indicate that a difference in carboxyfluorescein release trends occur when 
different LPCs are used. Furthermore, release trends were observed to vary when using different 
batches of Sigma (14-23% PC) soy azolectin (full data set is not shown here). This led to an 
investigation of the effect of lipid bilayer composition on the release of carboxyfluorescein through 
the use of different azolectin batches, as well as azolectin sourced from different suppliers (Sigma 
and Avanti Polar Lipids, Inc.). 
To determine the effect of MscL-liposome lipid constituents on cargo efflux, preliminary 
assay experiments comparing MscL-liposomes generated using three different soy azolectins 
(Sigma and Avanti) were trialled using LPC 12:0 as the lipid bilayer stressor, which was tolerated 
by the liposomes at a higher concentration compared to LPCs 16:0 and 18:1, before they became 
compromised. The preliminary results indicated that there was a lipid effect on the release of 
carboxyfluorescein from MscL. As seen in Figure 3.6, the release of carboxyfluorescein from 
MscL-liposomes varied with the different soy azolectins used. MscL-liposomes generated using 
Sigma (14-23% PC) soy azolectin had a relative fluorescence release of 2% at 0.5 mM LPC (Figure 
3.6 A). MscL-liposomes generated using Avanti (20% PC) soy azolectin had a relative fluorescence 
release of 2% and 17.5% at 0.05 mM LPC and 0.5 mM LPC respectively (Figure 3.6 B), whereas, 
MscL-liposomes generated using Avanti (40% PC) soy azolectin had a relative fluorescence release 
of 8% and 31% at 0.05 mM LPC and 0.5 mM LPC respectively (Figure 3.6 C). 
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Figure 3.6. Preliminary results comparing the relative fluorescence release from 
liposomes (orange) and MscL-liposomes (blue) generated using A) Sigma (14-
23% PC), B) Avanti (20% PC) and C) Avanti (40% PC) soy azolectin and 
stressed with LPC 12:0 for 30 minutes. Errors bars are the standard error of the 
mean across a single liposome preparation. 
 
From this preliminary carboxyfluorescein efflux data, further investigations into the effect of 
different LPC species on carboxyfluorescein efflux was repeated using MscL-liposomes generated 
using Avanti 40% PC due to the higher observed percentage fluorescence released (Figure 3.6 C). 
As mentioned previously, the variation between measurements was routinely low with a greater 
source of variability existing between different liposome preparations. An example of this 
variability is shown in Figure 3.7 A – C, where different liposome preparations using Avanti 40 % 
PC produced varying degrees of carboxyfluorescein efflux when stressed with LPCs. This effect is 
minimal in each independent liposome preparation but is visible across different liposome batches, 
which are prepared on different days using similar materials and methods. Thus the results from 
each liposome assay was combined in order to ascertain an average efflux profile of liposomes 
A  Sigma (14-23% PC) B  Avanti 20% PC 
 
C  Avanti 40% PC 
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exposed to various acyl chain length LPCs. Figure 3.7 D shows the average of the Avanti 40% PC 
liposomes displayed in Figures 3.7 A – C stressed with LPC 12:0 for 30 minutes. 
 
 
 
Figure 3.7. Example of individual relative fluorescence percentage 
release experiments of Avanti 40% PC liposomes and MscL-liposomes 
stressed with LPC 12:0 for 30 minutes (A - C). D) Average of individual 
experiments to determine efflux profile. 
 
 From the preliminary data obtained in Figure 3.6, LPCs with A) a mixture of acyl chain 
lengths, B) 16:0, C) 18:1 and D) 12:0 were used to activate MscL channels incorporated into Avanti 
40% PC liposomes (Figure 3.8). Varying degrees of fluorescence release were observed when the 
zero protein control liposomes and MscL-liposomes were exposed to these LPCs, confirming that 
release is dependent on the type of LPC used. The lowest level of release from the MscL-liposomes 
generated using Avanti 40% PC azolectin was observed with liposomes exposed to an LPC mixture 
of varying acyl tail lengths (Figure 3.8 A). This may indicate that the effect of carboxyfluorescein 
release is not only affected by the lipid composition MscL is incorporated into, but also by the 
A  Experiment 1 
 
B  Experiment 2 
 
C  Experiment 3 
 
D Averaged Release Profile 
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stimulus exhibited by certain LPCs, which an LPC mixture may not contain in sufficient 
concentration. 
  
   
 
   
  
Figure 3.8. Comparing the relative fluorescence percentage release after 30 
minutes from liposomes (orange) and MscL-liposomes (blue) generated using 
Avanti (40% PC) soy azolectin. The samples were stressed with A) an LPC 
mixture, B) LPC 16:0, C) LPC 18:1 and D) LPC 12:0. The T-test (P & 0.05 = *) 
compares the effect of MscL incorporation on fluorescence release from liposomes 
when stressed with specific LPCs. LPC 12:0 shows that MscL incorporation 
produces a significant difference in fluorescence release from liposomes at both 
concentrations tested. n = 4. Error bars are standard error of the mean. 
 
Through comparison of the observed release of carboxyfluorescein from liposomes exposed 
to the LPCs 16:0, 18:1 and 12:0 (Figures 3.8 B, C, D respectively) with the mixture of different acyl 
chain length LPCs (Figure 3.8 A), it can be seen that the release of carboxyfluorescein from MscL-
liposomes at a concentration of 0.05 mM LPC produced a relative fluorescence of 5% with the LPC 
mixture, 8% with LPC 16:0, 13% with LPC 18:1 and 10% with LPC 12:0. The release seen from 
control liposomes is ~2% in all conditions at this LPC concentration. Furthermore, the release 
observed from MscL-liposomes at the 0.5 mM LPC concentration range displayed a relative 
fluorescence percentage release of 11% with the LPC mixture, 17% with LPC 16:0, 26% with LPC 
A         LPC mix B       LPC 16:0 
 
C         LPC 18:1 D        LPC 12:0 
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18:1 and 28% with LPC 12:0. Similar levels of fluorescence release was observed in the zero 
protein control liposomes exposed to LPC 16:0 (Figure 3.8 B), which were recorded at 15.5% 
compared to 17% from MscL-liposomes. This indicates similar concentrations of 
carboxyfluorescein released and may be due to the critical micelle concentration (CMC) of the LPC 
species. The CMC of LPC 16:0 is 4 – 8.3 %M with LPC 12:0 having a CMC of 0.4 – 0.9 mM 
according to Avanti. The CMC of LPC 18:1 is unknown but speculated to be similar with LPC 16:0 
(Smith and Jungalwala 1981). The CMC of the LPCs is discussed later in Section 3.4.3. Effect of 
LPC. 
From Figure 3.8 it can also be seen that the highest fluorescence release levels with minimal 
compromise of the lipid bilayer of the liposome, such as that recorded with liposomes treated with 
0.5 mM LPC 16:0, are obtained from MscL-liposomes stressed with LPC 18:1 and 12:0. There is an 
approximate five-fold difference between the relative fluorescence release observed between the 
control liposomes and MscL-liposomes at 0.05 mM LPC 18:1 and 12:0. There is a two and three-
fold difference between the control liposomes and MscL-liposomes at 0.5 mM LPC 18:1 and 12:0 
respectively. However, the standard error of these measurements was large, likely reflecting the 
batch to batch variability discussed earlier. Potential sources of this variability may be the inability 
to control the efficiency of channel incorporation into the lipid bilayer, or the number of active 
channels present. For example, the main method of studying membrane channel functionality is 
through patch clamp analysis, which is capable of qualitative and not quantitative analysis of MscL 
incorporation. It was also difficult to assess what percentage of the liposomes are unilamellar in any 
given preparation. Despite the wide error bars seen in Figure 3.8, the release from MscL liposomes 
was consistently higher than that of the controls in all experiments, suggesting that the release 
trends reflected real effects and were not just spurious outliers. 
The release of carboxyfluorescein was monitored after four hours of exposure to the LPCs. 
This is displayed in Figure 3.9. The leakage of carboxyfluorescein increased over time as evident 
from the relative fluorescence release. In the LPC mix and LPC 16:0 conditions, the leakage from 
the control liposomes became equivalent to that released from the MscL-liposomes over time 
(Figure 3.9 A and B). With LPC 18:1 conditions, the control liposomes exhibited a relative 
fluorescence release of 23% and 50% at 0.05 and 0.5 mM respectively, whereas MscL-liposomes 
released 42% and 75% at the same LPC concentrations (Figure 3.9 C). With LPC 12:0 the control 
liposomes had a leakage of 20.5% and 43% at 0.05 mM and 0.5 mM compared to 55% and 74% 
from MscL-liposomes at the same concentrations (Figure 3.9 D). 
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Figure 3.9. Comparing the relative fluorescence percentage release after 4 hours from 
liposomes (orange) and MscL-liposomes (blue) generated using Avanti (40% PC) soy 
azolectin. The samples were stressed with A) an LPC mixture, B) LPC 16:0, C) LPC 18:1 
and D) LPC 12:0. The T-test (P & 0.05 = *) compares the effect of MscL incorporation on 
fluorescence release from liposomes when stressed with specific LPCs. LPC 12:0 shows 
that MscL incorporation produces a significant difference in fluorescence release from 
liposomes at both concentrations tested. n = 4. Error bars are standard error of the mean. 
 
In Figures 3.10 and 3.11, the recorded release profiles of the zero protein liposomes and 
MscL-liposomes generated using Avanti (40% PC) soy azolectin are shown. The measurements 
were recorded from 0 to 240 minutes (4 hours) at both 0.05 mM (Figure 3.10) and 0.5 mM (Figure 
3.11) LPC concentrations. Figures 3.10 A and 3.11 A, shows an example of the release profiles of 
zero protein control liposomes and MscL-liposomes when exposed to LPC 12:0 at the two 
concentrations. The differences between the fluorescence release (F) of MscL-liposomes (M) 
compared to zero protein control liposomes (C) were calculated for each LPC condition and each 
time point recorded using, 
F = M – C 
 
 
 
 
A   LPC mix B         LPC 16:0 
 
C   LPC 18:1
   
 
D        LPC 12:0 
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Figure 3.10. Fluorescence release trends from 100 nm extruded zero protein control liposomes 
and MscL-liposomes (produced at 1:2000 protein : lipid (w/w) ratio) exposed to 0.05 mM of 
varying LPC over a 4 hour period. A) A representative release trend for LPC 12:0 treated 
liposomes. Charts i – iv details the difference in MscL-liposome release compared to zero protein 
control liposomes exposed to 0.05 mM LPCs of different chain lengths at similar time points. n = 4. 
Error bars are standard error of the mean. 
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Figure 3.11. Fluorescence release trends from 100 nm extruded zero protein control liposomes 
and MscL-liposomes (produced at 1:2000 protein : lipid (w/w) ratio) exposed to 0.5 mM of 
varying LPC over a 4 hour period. A) A representative release trend for LPC 12:0 treated 
liposomes. Charts i – iv details the difference in MscL-liposome release compared to zero protein 
control liposomes exposed to 0.5 mM LPCs of differing chain lengths at similar time points. n = 4. 
Error bars are standard error of the mean. 
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The observed differences in release for both LPC concentrations are shown in Figures 3.10 i 
– iv and 3.11 i – iv. The largest difference in relative fluorescence release produced from MscL-
liposomes compared to the zero protein controls was recorded for the Avanti 40% PC MscL-
liposomes exposed to 0.05 mM and 0.5 mM LPC 12:0 (Figures 3.10 iv and 3.11 iv respectively). 
The second largest release was observed in MscL-liposomes exposed to LPC 18:1 (Figures 3.10 iii 
and 3.11 iii). Lower release profiles were recorded in MscL-liposomes exposed to LPC mix and 
LPC 16:0. 
The spontaneous release of carboxyfluorescein from MscL-liposomes and its controls over 
time (Figure 3.12) was also monitored. The liposomes were generated based on the largest 
difference observed in fluorescence release between the MscL-liposomes and the controls when 
exposed to LPC 12:0 (Figure 3.6); in this case Avanti 20% PC and 40% PC. A steady rate of 
leakage of encapsulated carboxyfluorescein was seen during the first hour for both soy azolectins 
used to generate MscL-liposomes and its controls (Figure 3.12 A and B Insets). The rate of leakage 
was not constant over a period longer than the first hour post excess carboxyfluorescein dye 
separation. 
MscL-liposomes generated using Avanti 20% PC (Figure 3.12 A Inset) yielded a 
fluorescence release at a rate of 0.15% min-1 during the first hour, whereas during a four-hour time 
period this rate was 0.10% min-1. Liposome controls generated using this Avanti 20% PC had a 
leakage rate of 0.08% min-1 during the first hour and as the rate of leakage varied (Figure 3.12 A), 
the average rate of leakage over a four hour period was at 0.04% min-1. MscL-liposomes generated 
using Avanti 40% PC recorded a fluorescence release at a rate of 0.08% min-1 during the first hour 
after carboxyfluorescein dye separation (Figure 3.12 B Inset) and 0.15% min-1 over a four-hour 
period (Figure 3.12 B). The Avanti 40% PC control liposomes have a relative leakage rate of 0.07% 
min-1 for the first hour and an average of 0.09% over the four-hour period. 
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Figure 3.12. Leakage of carboxyfluorescein from liposomes (orange) and MscL-
liposomes (blue) generated using A) Avanti 20% PC (n = 3) and B) Avanti 40% PC 
(n = 6) over a time period of 4 hours. Inset focuses on leakage over one hour period 
(highlighted by a blue box). Error bars are standard error of the mean. n = 5 
 
3.4 Discussion 
It is shown here that the MscL channels incorporated into liposomes are functional as 
controllable nanovalves for the release of 5,6-carboxyfluorescein (376 Da). MscL has been reported 
to allow the unhindered passage of protein molecules up to 6.5 kDa through its open channel pore 
(van den Bogaart, Krasnikov et al. 2007) and the size of 5,6-carboxyfluorescein falls below this size 
range. 
3.4.1 MscL and Efflux 
5,6-carboxyfluorescein (carboxyfluorescein) fluoresces strongly when diluted and has been 
used as a molecule to study the efflux of particulates from MscL-liposomes (Koçer 2007, Powl, 
East et al. 2008, Birkner, Poolman et al. 2012). Patch-clamp analysis has shown that 
carboxyfluorescein does not hinder MscL activation (Figure S3.3). Further analysis of MscL-
liposomes showed that the efflux of carboxyfluorescein was related to the number of channels 
Inset 
Inset 
A      Avanti 20% PC
   
 
B      Avanti 40% PC 
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incorporated into the liposomes as shown in Figure 3.1. The MscL-liposome size determined 
through size extrusion did not increase the net release of carboxyfluorescein through MscL. 
However, the leakage of carboxyfluorescein from the zero protein control liposomes was on 
average approximately 3 times less in 50 nm extruded liposomes compared to 100 nm extruded 
liposomes. This may be due to greater lipid compaction of smaller sized liposomes, where the 
existence of protrusions and undulations in the lipid bilayer caused by the packing of lipid 
molecules may be minimized with smaller sized liposomes. A higher lipid compaction of lipid 
bilayers would impede the incorporation of LPC into the lipid bilayer of small sized liposomes or 
minimize its leakage within the time frame of these experiments. This would also explain the 
similar levels of carboxyfluorescein release seen in both sizes of MscL-liposomes. A previous study 
of membrane permeability observed higher permeability to low molecular weight molecules (such 
as fluorescein diphosphate) in electroformed 60 - 100 %m vesicles compared to extruded liposomes 
of 50 - 400 nm (Fischer, Oberholzer et al. 2000). Furthermore, the targeting by opsonins in blood 
serum to liposomes was reported to decrease with decreasing liposome size (Harashima, Sakata et 
al. 1994). Fischer and colleagues (Fischer, Oberholzer et al. 2000) speculated that the existence of 
protrusions and undulations in the lipid bilayer may be a cause of leakiness, however, it could not 
be determined if the effect was due to a difference between liposome preparations. Although this 
speculation warrants further investigation, it falls outside the scope of this project. 
The 50 nm diameter liposomes have increased intrinsic membrane curvature compared to 
100 nm diameter liposomes. It was seen here that the size of MscL-liposomes did not affect the 
total net carboxyfluorescein release from MscL as carboxyfluorescein release was similar for both 
sizes of MscL-liposomes exposed to varying concentrations of LPC. The reduced leakage from 50 
nm diameter liposomes however does indicate that a higher amount of carboxyfluorescein is 
released via incorporated MscL. However, the zero protein control liposome and MscL-liposome 
size may not be completely uniform due to the size range produced by extrusion and the effect of 
detergent on lipid bilayer when MscL is incorporated. The use of continuous sucrose gradients, 
detailed in Chapter 4, may resolve this issue. 
3.4.2 Effect of Annular Lipids 
Information regarding the composition of the azolectins used in these experiments, drawn 
from the manufacturing companies’ websites, is displayed in Tables 3.1 and 3.2.  
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Table 3.1. Breakdown of the major lipid headgroups from the different azolectins 
used. Information was sourced from supplier websites. M indicates a major component 
but where the percentage is not known. Azolectin catalogue numbers are: Sigma 11-
23% PC (#P5638), Avanti 40% PC (341602G) and Avanti 20% PC (541601G). 
Table 3.2. Fatty acid breakdown of Sigma sourced azolectin. 
Avanti fatty acid information was not available. Information 
obtained from the supplier websites. 
 
 
 
 
It can be seen from the information obtained that full details of the headgroups and acyl 
chain length composition of the soy azolectins are lacking. However, in Figure 3.6, LPC 
experiments conducted on MscL-liposomes generated with varying types of soy azolectin indicate 
that the efflux of carboxyfluorescein via MscL is dependent on the type of azolectin used to 
generate the liposomes. This observation ties in with the postulate that different types of annular 
lipids surrounding the incorporated MscL can influence the channel’s activity (Perozo, Cortes et al. 
2002, Elmore and Dougherty 2003, Moe and Blount 2005, Powl, East et al. 2007, Powl and Lee 
2007). This is further evident in the different rates of spontaneous leakage observed in Figure 3.12 
between MscL-liposomes generated with both Avanti 20% PC and 40% PC over a four-hour period. 
As leakage was also observed in the zero protein control liposomes of both azolectins, the 
spontaneous channel activity may be due to the variation in osmolarity between the encapsulated 
cargo of the liposomes and the size exclusion buffer used to separate un-encapsulated 
carboxyfluorescein via a Sephadex G-50 column. The differences in leakage rates between the two 
MscL-liposomes generated with the different Avanti soy azolectins indicate that MscL incorporated 
in the Avanti 40% PC liposomes has a higher tendency to open. This may explain the higher levels 
of fluorescence release from these MscL-liposomes compared with other soy azolectin MscL-
liposomes tested with the addition of 0.05 mM LPC 12:0 (Figures 3.8 D, 3.9 D and 3.10 iv). 
The average spontaneous leakage rates from both Avanti 20% PC and 40% PC control 
liposomes are different with 40% PC having a rate that is 2.25 times higher than that of 20% PC. 
Were and colleagues have also reported different leakage rates from liposomes with varying PC 
content (Were, Bruce et al. 2003). This may be due to the lipid packing structure of the lipid 
Lipid head 
Azolectin 
PC PE PI PA LPC Notes 
Sigma 14-23% PC 14-23% M - - - inositol phosphatides 
Avanti 40% PC 40% 16% 11% - - Unknown 33% 
Avanti 20% PC 24% 18.6% 11.5% 4.3% 4.6% Unknown 37% 
Fatty Acid 
Azolectin 
16:0 18:0 18:1 18:2 18:3 
Sigma (14-23%PC) 13% 4% 10% 64% 6% 
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bilayers in both Avanti soy azolectins. Although a full analysis of the composition in the soy 
azolectins is lacking (Table 3.1), the extrusion of Avanti 40% PC liposomes through a 100 nm 
polycarbonate filter was much harder, with the polycarbonate filter more prone to rupture, than for 
the other azolectins and also the 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) used later in 
this thesis. This may indicate that the transition temperature of the lipid constituents in Avanti 40% 
PC is much higher than room temperature, which would result in a more rigid lipid bilayer at this 
temperature. However, a full analysis of the lipid constituents would be required to confidently 
conclude this. Consistently though, it is generally understood that a rigid lipid bilayer magnifies the 
packing defects normally found in lipid bilayers, such as protrusions and undulations of the lipid 
bilayer, and this may influence leakage of the encapsulated content over time (Kirby, Clarke et al. 
1980, Maurer, Fenske et al. 2001). This behaviour would be similar to that of the less ordered and 
less tightly packed liquid crystalline state compared to the Avanti 20% PC liposomes, which, due to 
its relative ease of extrusion, appears to have a lower transition temperature than that of Avanti 40% 
PC. 
As mentioned previously, spontaneous leakage from the control liposomes may be caused 
by the difference in osmolarity inside and outside of the liposomes. The stabilization of leakage 
seen in control liposomes generated using Avanti 20% PC azolectin over the four-hour time course 
(Figure 3.12 A) may be due to an equilibrium being achieved, resulting in minimal or no leakage 
after one hour post un-encapsulated carboxyfluorescein separation. Osmosis of solutes into the 
liposomes may have resulted in the swelling of the liposomes due to the influx of solutes as 
opposed to compaction of the membrane via an efflux of water (Sabin, Prieto et al. 2006). Swelling 
in control liposomes generated using Avanti 40% PC may enhance the rigid defects of its lipid 
bilayer, resulting in the constant leakage observed over time (Figure 3.12 B) as the lipid bilayer is 
unable to cope through a lack of fluidity in the membrane. 
Furthermore, the spontaneous leakage of carboxyfluorescein from MscL-liposomes over 
time and the difference in rate between the different azolectin samples used to generate them should 
be considered (Figure 3.12 A and B). This may be due to lipid headgroups and the length of their 
acyl tail, which can affect MscL incorporation and its activation energy (Perozo, Kloda et al. 2002, 
Elmore and Dougherty 2003, Powl, East et al. 2003, Moe and Blount 2005, Powl and Lee 2007, 
Grage, Keleshian et al. 2011). Likewise an increase in membrane curvature may cause MscL to 
expand in order to minimize exposure of its hydrophobic !-helices to water due to the stretching of 
the lipid bilayer (Meyer, Gullingsrud et al. 2006, Powl and Lee 2007). Although a detailed analysis 
of the lipid components in Avanti 20% PC azolectin is not known, the stretching of the lipid bilayer 
due to osmotic differences may cause MscL activation resulting in leakage. As MscL-liposomes 
continue to leak due to osmosis, the control liposomes have minimized leakage due to the absence 
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of MscL, and the fluidity of the membrane allows for compensation of packing defects caused by 
the swelling. 
The higher rate of spontaneous leakage from MscL-liposomes generated with Avanti 40% 
PC may be due to the channel’s attempt to compensate for the defects in the lipid bilayer of this 
azolectin. As the Avanti 40% PC zero protein liposomes continuously leak due to a more rigid lipid 
bilayer, which as discussed earlier, does not allow compensation for packing defects, the ability of 
MscL to change conformations provides flexibility to the rigid lipid bilayer by adapting 
conformations that minimize exposure of lipid and MscL hydrophobic groups to water. This would 
result in open channels causing leakage. The variance across measurements for the Avanti 40% PC 
samples was also comparatively large (Figure 3.12 B). This may also be described by several 
factors contributing to spontaneous MscL activity such as channel incorporation and functionality. 
3.4.3 Effect of LPC 
From the electron microscopy studies (Figure 3.3, 3.4 and 3.5), it was determined that 0.5 
mM LPC was the maximum concentration that could be used without compromising the lipid 
bilayer integrity of the liposomes used in the fluorescence release assays. It was suspected that the 
compromised lipid bilayer integrity may have indicated partial solubilization of the liposomes by 
LPC as the recorded fluorescence levels were unlike solubilized liposomes that had been exposed to 
Triton X-100 detergent. Further analysis of the effect of LPC acyl chain length on 
carboxyfluorescein efflux from MscL-liposomes generated using Avanti 40% PC soy azolectin 
showed that there was a relationship between the release of carboxyfluorescein via MscL and the 
acyl chain length of LPC. This may be due to the critical micelle concentration (CMC) of the 
different individual LPC species used, which has been reported to be directly related to the acyl 
chain length of the LPC and the existence of double bonds within the tail (Ojala, Hirvonen et al. 
2007). 
CMC decreases with increasing LPC hydrophobicity (Stafford, Fanni et al. 1989) and 
hydrophobicity is affected by the degree of unsaturation and acyl chain length of the LPC (Smith 
and Jungalwala 1981). The addition of a double bond to a saturated acyl chain of an LPC has an 
equivalent hydrophobic effect as the removal of two methylene groups from the saturated acyl 
chain (Smith and Jungalwala 1981). This would mean that the CMC of LPC 16:0 (~7 µM (Stafford, 
Fanni et al. 1989)) is similar to LPC 18:1 (Ojala, Hirvonen et al. 2007) and is reflected in the 
electron microscopy studies on the effect of increasing LPC concentration on liposome membrane 
integrity (Figures 3.3, 3.4 and 3.5). Analysis of the electron micrographs revealed that LPC 18:1 
and 16:0 affect liposome stability at similar concentrations whereas LPC 12:0 requires a higher 
concentration before liposome stability is compromised. 
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CMC however, does not explain the differences observed in fluorescence release in the LPC 
assays conducted (Figure 3.8, 3.9 and 3.10). Given that MscL is gated in response to membrane 
tension and/or curvature, the differences in fluorescence release may be more appropriately 
explained through a curvature tuning formula 
P = V/la 
Where P is the critical packing parameter, V is the molecular volume occupied by the lipid tail, a is 
the area occupied by the head group; and l is the length of the lipid tail (Genc, Ortiz et al. 2009). 
The lower the P value, the more conically shaped the lipids are and with increasing P values, the 
lipids become more cylindrical (Genc, Ortiz et al. 2009). In this case, the area of the 
phosphatidylcholine headgroup, a, has been determined to be 0.717 nm2 (Kumar 1991, Israelachvili 
2011). 
The length of the lipid chain, l, can be calculated using 
l ' 0.154 nm + 0.1265(n-1) nm 
0.154 nm is the difference between the van der Waals radius of the terminal methyl group 
(~0.21 nm) and half the bond distance between the first carbon in the hydrocarbon tail bonded to 
that of the headgroup (~0.06 nm) (Tanford 1980, Stokes and Fennell Evans 1997, Myers 2005, 
Israelachvili 2011). 0.1265 nm is half the distance between carbon 1 and carbon 3 in a saturated 
hydrocarbon chain (in other words, it is the carbon-carbon bond length projected into a straight line 
coincident with net direction of the hydrocarbon tail) (Tanford 1980, Stokes and Fennell Evans 
1997, Myers 2005, Israelachvili 2011). 
The molecular volume occupied by the lipid chain, V, can be calculated using the formula 
V ' [27.4 + 26.9(n-1)] x 10-3 nm3 
27.4 x 10-3 nm3 is the molecular volume of the –CH3 group at the end of the hydrocarbon tail and 
26.9 x 10-3 nm3 is the volume of each corresponding –CH2 group (Kumar 1991, Stokes and Fennell 
Evans 1997). n is the number of carbons in the hydrocarbon tail (Tanford 1980, Stokes and Fennell 
Evans 1997, Myers 2005, Israelachvili 2011). Therefore, the critical packing parameter, P, of the 
LPCs used can be calculated (Table 3.3). 
Table 3.3. Calculated critical packing parameters of LPCs 12:0, 16:0 and 18:1. 
Criteria 
LPC 
Lipid chain length, 
l (nm) 
Molecular volume of 
acyl tail, V (nm3) 
Critical Packing 
Parameter, P 
LPC 12:0 1.5455 0.3233 0.29175 
LPC 16:0 2.0515 0.4309 0.29295 
LPC 18:1 1.9933a 0.4769b 0.30435 
a Lipid chain length was calculated by modifying the formula used to calculate length 
of lipid chain, l ' 0.1265(7) nm – 0.06 nm + cos 30° (0.21 nm + 0.1265(9) nm). 
b The molecular volume of LPC 18:1’s acyl tail was calculated by modifying the 
formula V ' [27.4 + 26.9(n-3) + 46] x 10-3 nm3. 46 x 10-3 nm3 is the molecular 
volume of CH=CH (Wiener and White 1992). 
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By comparing the P values of the individual LPCs, it can be seen that LPC 12:0 would 
induce a higher degree of local curvature in liposomal membranes due to its smaller P value 
compared to LPC 16:0. This corresponds with the fluorescence release profile seen in Figures 3.8 – 
3.11. The estimated P value for LPC 18:1 however, is larger than the P value of LPC 16:0 and 
would appear to be inconsistent with the intermediate fluorescence release profiles seen in MscL-
liposomes exposed to LPC 18:1, compared to those exposed to LPC 16:0 and LPC 12:0 (Figures 3.8 
– 3.11). 
The rationale applied for calculating the P value of LPC 18:1 shown in Table 3.3 was as 
follows. The cis double bond in LPC 18:1 introduces a bend in the acyl chain between carbons 8 
and 9, which affects the molecule’s linear dimensions. By taking this bend into account (assuming 
the widely observed average "kink" angle of 30 degrees) the estimated l value for LPC 18:1 was 
1.9933 nm, which agrees with calculated values of similarly chained lipids (Scrimgeour and 
Harwood 2007) and is shorter than LPC 16:0. What is more difficult to predict is the effect of 
unsaturation on V and specifically the influence of the bent acyl chain on the effective packing 
volume. It has been noted previously that a number of factors influence the P value of a lipid, 
including unsaturation of the acyl chain (Tanford 1980, Kumar 1991, Stokes and Fennell Evans 
1997, Israelachvili 2011) and so calculating an accurate P value for LPC 18:1 is difficult.  
 
Figure 3.13. Schematic of LPC chain length 
effects on hydrophobic mismatch within a lipid 
bilayer. Estimated chain lengths of LPC 12:0 = 
1.5455 nm, LPC 18:1 (9Z/cis conformation) = 
1.9933 nm and LPC 16:0 = 2.0515 nm. 
 
Indeed, despite exhaustive searches, it was not possible to find an example P value 
calculation for a molecule with an unsaturated hydrocarbon tail and so speculation as to the real 
effect of LPC 18:1 on membrane curvature is warranted. For example, the difference in lengths of 
all three LPCs introduces varying degrees of hydrophobic mismatch to the lipid bilayer of the 
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liposome (Figure 3.13). The mismatch caused by LPC 16:0 would be less than LPC 18:1 and 12:0. 
The larger hydrophobic mismatch caused by LPC 18:1 compared to LPC 16:0 would mean that 
LPC 18:1 induces a higher degree of curvature than LPC 16:0 and this effect ties in with the 
fluorescence release seen in Figures 3.8 – 3.11. The differences in fluorescence release could also 
be related to the increased polarity in the acyl chain that results from introduction of a double bond 
(Cook and McMaster 2002, Zakin, Zhang et al. 2007). Furthermore, the incorporation of an 
unsaturated lipid into the lipid bilayer of the MscL-liposomes results in a less ordered lipid bilayer 
(See section 1.2.2 Lipid Considerations for Liposome Application in Medicine) compared to the 
incorporation of a saturated lipid. This disorder, coupled together with the hydrophobic mismatch 
may cause MscL to adjust its conformation regularly in order to minimize the exposure of its 
hydrophobic TM !-helices to water, thus producing a higher fluorescence release in MscL-
liposomes exposed to LPC 18:1 compared to exposure to LPC 16:0. 
Assuming the estimated curvature of LPC 18:1 is not as high as LPC 12:0, the synergistic 
effects of curvature and disorder introduced by LPC 18:1 may also explain the similar fluorescence 
release profiles from MscL-liposomes exposed to LPC 18:1 and 12:0 between 0 – 60 minutes 
(Figures 3.10 iii – iv and 3.11 iii – iv). A difference in fluorescence release is later recorded at 2 – 4 
hours, where the fluorescence release of MscL-liposomes exposed to LPC 12:0 is double that of the 
MscL-liposomes exposed to LPC 18:1. This effect could be related to the difference in P values 
between LPC 12:0 and 18:1. The differences in fluorescence release between the zero protein 
control liposomes and MscL-liposomes exposed to LPC mix and 16:0 ranges between 1 % – 10 % 
over the four-hour period. This indicates that the curvature induced by LPC 12:0 and 18:1 is higher 
than that of both LPC mix and LPC 16:0. 
3.5 Conclusion 
In these studies, it has been determined that the lipid environment MscL is incorporated into 
affects its capacity to facilitate release of encapsulated carboxyfluorescein from liposomes. Release 
is also influenced by the membrane tension experienced by MscL, which in this case is generated 
through LPC. LPC addition to 50 nm and 100 nm extruded liposomes indicate that the size did not 
affect release of carboxyfluorescein from MscL-liposomes; however, leakage from control 
liposomes was minimized which may indicate that LPC was more effectively excluded from the 
lipid bilayer due to a higher packing order in smaller liposomes. As these experiments were 
conducted over a period of 30 minutes, a longer time course experiment may provide additional 
details. 
The rigidity of the lipid bilayer, influenced by transition temperature of the lipids, can affect 
the leakage of encapsulated liposomal content through the membrane due to packing defects (Kirby, 
Clarke et al. 1980, Maurer, Fenske et al. 2001). The magnification of these packing defects may be 
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the cause of a higher leakage of carboxyfluorescein from Avanti 40% PC liposomes compared to 
Avanti 20% PC liposomes under hypo-osmotic conditions. However, it has been shown that 
liposomes composed of tightly packed, high transition temperature saturated lipids mixed with 
cholesterol have a circulation time of several hours in vivo (Gabizon and Papahadjopoulos 1988, 
Webb, Harasym et al. 1995). For this reason, this mixture is preferred as a liposomal drug delivery 
system (Webb, Harasym et al. 1995, Maurer, Fenske et al. 2001). 
The difference in carboxyfluorescein leakage from MscL-liposomes generated with Avanti 
40% PC and Avanti 20% PC under hypo-osmotic conditions may be due to differences in lipid 
motion. A liquid-crystalline phase lipid can rotate rapidly along its long axis and diffuse rapidly 
within the lipid bilayer whereas a gel state lipid has inhibited motion (Cullis, Fenske et al. 1996). 
These differences are due to the order of lipid packing. A readily diffusible lipid membrane would 
be able to accommodate stretching under hypo-osmotic conditions, thereby reducing exposure of its 
hydrophobic constituents to water. MscL would also be able to assume an intermediate sub-
conducting state to minimize the water exposure (Meyer, Gullingsrud et al. 2006, Powl and Lee 
2007). A more rigid lipid bilayer would be less able to adjust itself, relying on the deformation of 
MscL to minimize hydrophobic exposure to water. A detailed analysis of the azolectins is required 
to determine if the headgroups or acyl chain length had an effect on the incorporated channels, as 
they are known factors affecting MscL activity (Perozo, Kloda et al. 2002, Elmore and Dougherty 
2003, Powl, East et al. 2003, Moe and Blount 2005, Powl and Lee 2007, Grage, Keleshian et al. 
2011).  
It was also shown that the asymmetric incorporation of LPCs (Perozo, Kloda et al. 2002) 
triggers the opening of MscL and leads to efflux of carboxyfluorescein. Patch clamp analysis of 
MscL lipid blisters (1:1000, protein : lipid (w/w) ratio) following addition of LPC 12:0 showed that 
the channels did not linger in an open conformation. Instead, a “flickering” between an open and 
closed state was observed (Figure S3.3) and may explain why 100% release of carboxyfluorecein 
was not attained. Also, although N-terminal Histidine (His-) tagged MscL is detectable in patch 
clamp analysis, the channels show minimal response in the fluorescence assays (Figure S3.1). This 
is most likely due to the fact that higher membrane tensions are required to activate N-terminal His-
tagged MscL compared to WT MscL (Martinac 2012). Consequently, insertion of LPC may be 
insufficient to fully activate the 6xHis-tagged MscL channels. 
3.6 Future Directions 
A detailed lipidomic analysis of the soy azolectins used in these experiments is required and 
can now be undertaken using Avanti Polar Lipids, Inc. services. Fatty acid methyl esters (FAME) 
analysis done on the Avanti 20% and 40% PC soy azolectins indicates that both azolectins have 
approximately similar fatty acid profiles indicating that hydrophobic mismatch between McsL and 
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the lipid bilayer was not the cause for the difference in carboxyfluorescein efflux. The major 
components consist of ~60% methyl linoleate (18:2), ~20% methyl palmitate (16:0), ~8% methyl 
oleate (18:1), ~ 6% methyl alpha linolenate and ~5% methyl stearate. However, this analysis does 
not provide detail on lipid headgroups, which have been implicated in affecting MscL activity 
(Perozo, Cortes et al. 2002, Elmore and Dougherty 2003, Moe and Blount 2005, Powl, East et al. 
2007, Powl and Lee 2007). Future analysis of the lipid constituents in azolectin would enable the 
determination of what other factors might be influencing fluorophore release via MscL. 
It is difficult to exert control over the number of functioning channels within the bilayer of 
liposomes. Similarly, it is difficult to activate, with any certainty, every channel through the 
application of membrane tension (Grage, Keleshian et al. 2011). Preliminary studies on the number 
of incorporated channels have been conducted using 5 nm Ni-NTA-Nanogold® (Nanoprobes, Inc.), 
which binds to His-tagged proteins, allowing for visualization of protein localization under electron 
microscopy (EM) conditions. The use of flash freezing and cryo-EM allows for visualization under 
near native states and through tagging His-MscL with 5 nm Ni-NTA-Nanogold® (Nanogold-His-
MscL), the Nanogold-His-MscL-liposomes can be visualised using cryo-EM and electron 
tomography (ET) techniques. Tomographic analysis of these MscL-liposomes has been undertaken 
in Chapter 4. 
Furthermore, preliminary investigations into MscL incorporation efficiency were also 
conducted using G22C MscL-liposomes. The G22C MscL mutants were chemically activated using 
2-(trimethylammonium)ethyl methanethiosulfonate (MTSET) by depositing positive charges into 
the MscL pore constriction. This may aid in determining the maximum amount of release 
achievable when all MscL channels are activated (van den Bogaart, Krasnikov et al. 2007, Powl, 
East et al. 2008, Birkner, Poolman et al. 2012). In order to determine channel incorporation 
efficiency, the 1:2000 protein : lipid ratio (w/w) was compared to 1:300. The results indicate that 
channel incorporation efficiency is similar in both conditions regardless of MscL concentration, 
resulting in similar levels of carboxyfluorescein release. These results are displayed in Figure S3.2. 
Although unlikely, due to the compensation through G22C MscL concentration, it should be stated 
that it can not be determined if limited channel activity is the cause for the low fluorescence release 
seen in both protein : lipid ratio (PLR) conditions; approximately 4 % in 60 minutes post MTSET 
exposure. This level of release was approximately 3 times lower than LPC fluorescence assay 
recordings on WT MscL-liposomes with 1:2000 PLR. Therefore, this may be due to both a limit in 
channel incorporation and channel activity. It should be noted that only the Avanti 20% PC 
azolectin has been trialled and further conditions still need to be tested such as those similar to the 
LPC experiments conducted in this Chapter in order to fully ascertain factors that may be affecting 
channel incorporation. 
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As 50 nm liposome extrusion was difficult to perform, the use of continuous sucrose 
gradients to isolate size fractionated liposomes, will be investigated in the next chapter. In the 
future, this technique will support further analysis of carboxyfluorescein release from 50 nm MscL-
liposomes. 
3.7 Supplementary Information 
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Figure S3.1. Relative fluorescence percentage 
release from liposomes (orange) and His-MscL-
liposomes (blue) generated using Sigma (14-23% 
PC) soy azolectin and stressed with an LPC mixture of 
varying acyl chain lengths. n = 3. Error bars are 
standard error of the mean. 
 
 
 
 
Figure S3.2. 5 mM MTSET used on zero-protein control liposomes and MscL-
liposomes generated using Avanti 20% PC azolectin. Varying protein : lipid ratios 
(w/w) were trialed using A) 1:2000 PLR and B) 1:300 PLR. The fluorescence assay was 
followed at 30 minute intervals for 1 hour. n = 2. Error bars are standard error of the mean. 
A  1:2000 PLR 
 
B  1:300 PLR 
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Figure S3.3. Patch clamp analysis of MscL incorporated into Sigma 14-23% PC blisters in the presence of 50 mM 
carboxyfluorescein. The application of pressure induces channel activation (1 channel (O1), 2 channels (O2), 3 channels (O3) and 4 
channels (O4) open). The addition of LPC causes spontaneous channel activity after 17 minutes, which is observed as a form of 
“flickering” without the requirement of pressure. 
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Chapter 4: Controlling Liposome Size and Stability through the 
Adjustment of Ions 
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4.1 Abstract 
In this chapter, a method has been developed for the isolation of MscL-reconstituted 
liposomes (MscL-liposomes) of defined sizes through the use of continuous sucrose gradients and 
the adjustment of ion types (K+, Mg2+, Cl- and SO4
2-) and concentrations. Experiments using MscL-
liposomes generated using soy azolectin demonstrate that the method is capable of resolving MscL-
liposomes in the range of 40 – 60 nm, for subsequent extraction, with a size distribution that is 
better than liposomes produced by extrusion. Cations play a role in liposome size distributions. 
Concentrations of more than 1 mM of Mg2+ resulted in precipitation of soy azolectin liposomes, an 
effect not observed in the presence of K+. The effect of the anions tested (Cl- and SO4
2-) appeared to 
be overshadowed by the cation effect. SO4
2- was able to offset precipitation of liposomes in the 
presence of Mg2+ and minimize the hydration force effect on liposomes in K+ solutions. The method 
to isolate and extract variously sized MscL-liposomes is expected to be useful for future electron 
microscopy structural studies of MscL channels within MscL-liposomes and characterization of a 
tightly controlled, uniform size prototype drug delivery system. 
4.2 Introduction 
Liposome size is an important factor to consider in the development of liposomal drug 
delivery systems. One reason for this is that liposome sizes <200 nm have a longer circulation time 
in vivo and can localize at disease sites such as tumours, infected and inflamed tissues due to an 
increase in vascular permeability at these sites (Morgan, Williams et al. 1985, Papahadjopoulos, 
Allen et al. 1991, Yuan, Leunig et al. 1994, Maeda 2012). The development of small unilamellar 
vesicles (SUVs) of approximately 50 nm in diameter is also important for the development of 
MscL-liposomes as the intrinsic curvature of the liposomal membrane, which is dictated by its size, 
is likely to distort the channel close to its triggering state. Furthermore, as has been postulated in 
MscL clustering experiments on large MscL-liposomes (~10 !m in diameter), a segregation of open 
and closed MscL into more energetically favourable states occurs when tension is applied to the 
liposomes due to hydrophobic mismatch (Grage, Keleshian et al. 2011) (see Chapter 1, section 1.8 
MscL Clustering). It is assumed that this event reduces the open probability of MscL (Grage, 
Keleshian et al. 2011). As a closed MscL channel has a diameter of 5 nm (Corry, Rigby et al. 2005), 
several hundred MscL channels can theoretically be reconstituted into a 10 !m diameter liposome. 
With a smaller sized MscL-liposome of 50 nm in diameter, the maximum number of reconstituted 
MscL channels is an order of magnitude less, thereby increasing the open channel probability. 
Liposomes do not form spontaneously and require energy for formation (Lasic 1990). There 
are several methods used in the production of unilamellar liposomes. These range from freeze-
thawing multi-lamellar vesicles, electroformation (Angelova and Dimitrov 1986, Dimitrov and 
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Angelova 1987, Bucher, Fischer et al. 1998), extrusion, and more recently, rapid changes in pH 
(Genc, Ortiz et al. 2009). Typically liposome sizes are controlled during the preparatory methods, 
with extrusion being the most widely used method when working with liposomes of defined sizes. 
However, liposomes are not thermodynamically stable and can coalesce over time forming larger 
aggregated bodies that eventually precipitate as stacks of large flat bilayers (Lasic 1990). The 
stability of liposomes is dependent on several factors and interplay between them. For example, 
stability of the lipid bilayer, which is affected by the packing of lipids into the lipid bilayer, can 
determine its fluidity and permeability. The stability of a liposome is also influenced by the 
transition temperature of its individual lipid molecules, which is affected by headgroups, acyl chain 
length and degrees of unsaturation (Cullis, Fenske et al. 1996). Stability would thus determine the 
rate of SUV fusion into larger vesicles (See Chapter 1, section 1.2.2 Lipid Considerations for 
Liposome Application in Medicine). Not all lipid or lyso-lipid species form bilayers, leading to the 
existence of micelles and inverted hexagonal (HII) phases.  
The state of the lipid bilayer in an aqueous solution is also influenced by the presence of ions, 
as ions have varying effects and binding constants with different lipid species. Cations in particular 
play an important role in the mechanical strength of the lipid bilayer (Bockmann, Hac et al. 2003, 
Fukuma, Higgins et al. 2007, Gurtovenko and Vattulainen 2008) and are capable of influencing the 
attractive and repulsive forces experienced by the liposomes (Meakin 1983, Lasic 1990, Sabin, 
Prieto et al. 2006, Roldan-Vargas, Martin-Molina et al. 2007, Ohki and Arnold 2008, Sabin, Prieto 
et al. 2010). 
4.2.1 Interaction between Ions, Lipids and Liposomes 
Physiological membranes are normally surrounded by a buffer that contains K+, Na+, Mg2+, 
Ca2+ and Cl- ions that vary in concentration inside and outside a cell. The effects of ions on lipids 
are still a point of discussion today. It has been determined that different ions vary in their effect on 
and binding constants to different lipids. The interactions between lipids and ions have been 
observed to affect the stability and structure of lipid bilayers as well as the incorporation of proteins 
into the bilayers. The resulting electrostatic charge from the lipid and ionic interactions can play a 
role in membrane fusion (Ohki and Arnold 2000), phase transition (Groves, Boxer et al. 2000, 
Rappolt, Pabst et al. 2001), vesicle aggregation and transport across the membrane. 
Typically liposomes with either negatively or positively charged surfaces would, in water, 
be expected to repel each other, although the high dielectric constant of water can screen this 
repulsion to a degree. Liposomes containing both positive and negative charges are expected to 
have a greater tendency to attract each other and coalesce or aggregate. Ions can therefore play a 
crucial role in stabilizing liposomal suspensions. For example low (i.e limiting) concentrations of 
Mg2+, which has a high charge density would be expected to result in the aggregation of negatively 
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charged liposomes. Increasing the Mg2+ concentration could however result in the provision of 
sufficient counterions for each charged lipid headgroup and so stabilize a uniform liposome 
suspension. For K+, which has a much lower charge density, a similar trend might be expected, 
however the required concentration range to achieve these effects might be expected to be higher 
(Barber and Chow 1979). 
4.2.2 DLVO Theory 
Liposomes tend to aggregate over time and this phenomenon is caused by van der Waals 
forces. Studies on controlling liposome size and stability rely on several theories that are still being 
expounded. One of the mainstream theories is the Derjaguin, Landau, Verwey and Overbeek 
(DLVO) theory (Derjaguin and Landau 1941, Verwey and Overbeck 1948). Derjaguin and Landau 
(Derjaguin and Landau 1941) independent of Verwey and Overbeek (Verwey and Overbeck 1948) 
developed the DLVO theory for colloidal stability. The theory states that the stability of a colloidal 
system in an aqueous solution is governed by two types of forces, which affect the interaction 
between the colloids (Derjaguin and Landau 1941, Verwey and Overbeck 1948). These forces are 
the attractive van der Waals force and the repulsive electrostatic force (Derjaguin and Landau 1941, 
Verwey and Overbeck 1948). The DLVO theory has had much success in the field of colloidal and 
bicolloidal science (Molina-Bolivar, Galisteo-Gonzalez et al. 1999, Sabin, Prieto et al. 2006). 
However, there have been limitations to its use, where differing lipid systems exhibit behaviours 
that deviate from the classical DLVO theory (Molina-Bolivar, Galisteo-Gonzalez et al. 1999). One 
such system involves bilayers, which due to complex behaviours deviate substantially from the 
smooth surfaces assumed in the theory, such as those with large scale undulations, small scale 
protrusions, complex head groups along with water and salt interactions (Gentilcore, Michaud-
Agrawal et al. 2010). This is further supported by studies conducted using atomic force microscopy, 
which has also shown the limitations of the DLVO theory (Molina-Bolivar, Galisteo-Gonzalez et al. 
1999). 
Investigations into the interaction of silica surfaces in aqueous solutions have shown that 
DLVO interactions agree in separations above a few nanometers, but a short-range repulsive force 
exists in smaller separations (<40 Å) (Chapel 1994, Vigil, Xu et al. 1994), and this was also seen in 
surfactant systems (LeNeveu, Rand et al. 1976). It is proposed that the forces observed here are 
generated by water interactions with the surface, giving rise to either compounds that exist in the 
presence of water (Chapel 1994, Vigil, Xu et al. 1994) or the modification of water structures at 
these surfaces. It is interesting to note that hydrophobicity has been described as a manifestation of 
water structure at these surfaces (Vogler 1998). It is generally accepted that structural forces that 
are repulsive are known as hydration forces and hydrophobic forces when they are attractive 
(Molina-Bolivar, Galisteo-Gonzalez et al. 1999). 
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In order to investigate the ionic effects on liposome size distribution, liposomes were 
generated in the presence of varying ionic components such as K+, Mg2+, Cl- and SO4
2-. In this 
chapter, focus is given to KCl salts, as they are the main ionic component used in patch clamp 
recordings. A method to separate MscL-liposomes according to specific sizes through the use of a 
continuous sucrose gradient was also developed, as small liposomes (50-100 nm) are desirable for 
future studies. Furthermore, liposome size is an important factor for structure analysis by cryo-EM. 
The thickness of the ice generated during the freeze process will limit incorporation of, or severely 
distort, liposomes that have a diameter greater than the ice thickness.  
4.3 Results 
In order to investigate the size and structure of extruded liposomes, electron microscopy 
(EM) methods were used. These analyses allowed for the direct visualization of liposome size and 
shape whilst also enabling the optimization of freezing protocols for future cryo-EM and cryo-
electron tomography (ET) studies. The extensive experiments conducted showed that extrusion 
produces a distribution of liposome sizes within the range of the filter pore size used (Figure 4.1).  
 
    
Figure 4.1 100 nm extruded liposomes and MscL-liposomes with excess 5,6-
carboxyfluorescein dye removed. A) 100 nm extruded liposomes without MscL. 
B) 100 nm extruded liposomes post MscL addition. Scale bar = 250 nm. 
 
As liposomes are not thermodynamically stable, the phenomenon of liposome aggregation 
and eventual fusion can result in larger liposomes and liposome aggregates. Since stability of the 
liposome membrane can play a role in spontaneous fusion of liposomes, the presence of detergents 
used to suspend MscL can not only allow for easier incorporation of membrane proteins into the 
lipid bilayer but may also affect liposome stability and the rate of larger liposome formation. These 
factors highlight the requirement for a method to separate uniformly sized MscL-liposomes for 
future studies. 
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4.3.1 Sucrose Gradients 
To resolve liposomes according to size, MscL-liposomes (Figure 4.1 B) were subjected to 
continuous sucrose gradient separation in the presence of different salts and salt concentrations (1 
mM, 10 mM, 50 mM and 100 mM KCl) as used in the liposome preparation (see Chapter 2, Section 
2.6 Continuous Sucrose Gradient), with the exception of 5,6-carboxyfluorescein. 
Figure 4.2 shows the result of subjecting an MscL-liposome population with encapsulated 
carboxyfluorescein to separation on a continuous sucrose gradient. The MscL-liposome population 
was resolved into several discrete bands and broader regions. The broad fluorescent regions were 
suggestive of a continuous range of MscL-liposome sizes while bands in other parts of the gradient 
were presumed to indicate that a majority of the MscL-liposomes were of a particular size. Analysis 
of fractions from various parts of the sucrose gradient by electron microscopy (negatively stained 
samples imaged in a JOEL 1011 transmission electron microscope at 80 KeV) revealed that these 
sucrose gradients were able to resolve liposomes from ~40-60 nm at the top of the gradient to a 
maximum diameter of 450 nm towards the bottom. 
Also evident in Figure 4.2 A-D is the effect of increasing KCl concentration on the 
migration and distribution of liposomes. Closer analysis of the micrographs indicated that at all KCl 
concentrations tested, the MscL-liposomes were successfully separated according to their various 
sizes with smaller MscL-liposomes located at the top of the sucrose gradient and larger ones located 
near the bottom. No sedimentation was seen at the bottom of the tubes. 
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Figure 4.2 Sucrose gradient images and negative stain 
micrographs of MscL-liposomes produced in KCl. 
Concentrations used are A) 1 mM, B) 10 mM, C) 50 mM and D) 
100 mM KCl. Scale bar = 50 nm. 
 
Interestingly, as the KCl concentration was increased there appeared to be a general pattern 
of bands migrating less distance through the gradient, and a reduction of broad region lengths in 
MscL-liposome dispersal through the sucrose gradients.  The top band in Figure 4.2 D, for example, 
was brighter than in Figure 4.2 A, and the corresponding lower bands were less abundant at higher 
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KCl concentrations. This suggested that the addition of KCl to the sucrose gradient reduced the 
degree of aggregation and coalescence. The electron micrographs showed that MscL-liposomes 
produced in a concentration of 1 mM KCl resulted in liposomes up to 450 nm in diameter isolated 
from the lowest band as compared to liposome sizes of up to 250 nm in diameter isolated from the 
lowest band in the 100 mM KCl sample. 
Further analysis of the electron micrographs identified the presence of MscL-liposomes with 
the diameter of interest (50 nm) at a specific, reproducible level in the gradient. Generally, 50 nm 
MscL-liposomes (highlighted by top electron micrographs in Figure 4.2 A-D and also displayed in 
Figure 4.4, highlighted by arrowheads) were consistently found just below a high fluorescent 
intensity band. A side-by-side comparison of the MscL-liposomes extracted at the 50 nm diameter 
level (first electron micrograph images for each sucrose gradient in Figure 4.2 A-D) is displayed in 
Figure 4.3. The MscL-liposomes appear to have a similar size distribution suggesting that this range 
is likely to represent the resolution of these gradients. 
 
 
Figure 4.3. Negative stain micrographs of MscL-liposomes extracted at levels 
determined to contain 50 nm diameter MscL-liposomes. Scale bar = 50 nm. 
 
More detailed measurements of the MscL-liposome diameters seen in the micrographs are 
shown as size distribution graphs in Figure 4.4. The graphs show that the majority of the extracted 
MscL-liposomes have a diameter between 30-60 nm. This size distribution may be due to the 
difficulty of extracting a thin band from the broad band on the sucrose gradient, as the mixing of 
smaller and larger liposomes during aspiration cannot be ruled out. Regardless, the size distribution 
is much narrower than that obtained by extrusion alone (Figure 4.1). 
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Figure 4.4. Size distribution of MscL-liposomes in various 
concentrations of KCl extracted from similar levels in the 
sucrose gradients (black arrowhead). A) 1 mM, B) 10 mM, C) 
50 mM and D) 100 mM KCl. 
 
In order to determine whether the size distribution of the negative stained MscL-liposomes 
seen on the electron micrographs was artefactually influenced by negative stain sample preparation, 
liposomes fractions were also analysed by cryo-electron microscopy (Figure 4.5). 
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Figure 4.5. A comparison of negatively stained and cryo electron micrographs of 
MscL-liposomes. The MscL-liposomes were prepared in 10 mM KCl conditions and 
extracted at the 50 nm diameter sucrose gradient level. Scale bar = 50 nm. 
 
Figure 4.5 shows that the size distribution was similar in both negative staining and cryo 
preparations and so was not an artefact of negative staining, but characteristic of the sample. 
4.3.2 Role of Monovalent Cations 
The results obtained from the KCl sucrose gradients indicated that the size distribution of 
MscL-liposomes was affected by the concentration of the salts in solution. To test whether anions 
had an effect on the distribution and migration of the MscL-liposomes, samples containing 1 mM, 
10 mM, 50 mM and 100 mM K2SO4 were applied to sucrose gradients (Figure 4.6). The overall 
banding pattern in the K2SO4 samples was similar to the KCl samples. Electron microscopy 
analyses of the extracted MscL-liposomes from the K2SO4 samples also confirmed that the sucrose 
gradients were successful in separating various MscL-liposome sizes. It is therefore reasonable to 
conclude that cations play an important role in maintaining the size of liposomes generated with soy 
azolectin compared to anions. This will be further supported in experiments involving divalent 
cations, which will be detailed later. 
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Figure 4.6. Sucrose gradient images and negative stain 
micrographs of MscL-liposomes produced in K2SO4. 
Concentrations used are A) 1 mM, B) 10 mM, C) 50 mM and D) 
100 mM K2SO4. Scale bar = 50 nm. 
 
As 50 mM K2SO4 should contain similar K
+ ionic concentrations as 100 mM KCl (though 
not the same; i.e. 50 mM K2SO4 = 100 mM K
+ and 50 mM SO4
2- vs. 100 mM KCl = 100 mM K+ 
and 100 mM Cl-), a side-by-side comparison of these sucrose gradients and their extracted MscL-
liposome micrographs was performed (Figure 4.7). Interestingly the banding patterns were similar; 
  79 
except for the fact that band intensities between the two salt conditions (highlighted by black 
arrowheads in Figure 4.7) were different and an additional faint band (highlighted by the grey 
arrowhead in Figure 4.7 A) observed in the presence of 100 mM KCl, was not seen in the 50 mM 
K2SO4 sample (Figure 4.7 B). The difference in band intensities may indicate a preference to form 
MscL-liposomes of a particular size under the respective solution conditions. 
 
    
Figure 4.7. Sucrose gradient images and electron micrographs of 
MscL-liposomes produced in A)100 mM KCl and B)50 mM K2SO4. 
Images modified from Figures 4.2D and 4.6C. Scale bar = 50 nm. 
 
A liposome fraction was extracted from the 50 mM K2SO4 sucrose gradient at the expected 
height for 50 nm liposomes and analysed by both negative stain and cryo-electron microscopy 
(Figure 4.8). 
 
 
Figure 4.8. Negative stain (left) comparison with cryo (right) electron 
microscopy of 50 nm MscL-liposomes produced in 50 mM K2SO4 and 
separated in a continuous sucrose gradient. Scale bar = 50 nm. 
 
Unlike the KCl liposomes, there was a difference between the 50 mM K2SO4 MscL-
liposomes imaged through negative staining and cryo-electron microscopy, respectively. As can be 
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seen, the negative stained MscL-liposomes were smaller than the MscL-liposomes preserved via 
vitrification. This difference in size may reflect fusion of MscL-liposomes over time, which may be 
attributed to the time required to prepare extracted MscL-liposomes from the sucrose gradient for 
snap freezing in liquid ethane. As vitreous ice produced in the presence of sucrose is unstable in 
cryo-electron microscopy, the sucrose must first be removed from the samples. Dialysis of sucrose 
from the 50 mM K2SO4 MscL-liposomes was performed at a 1:5000 dilution using 50 mM K2SO4, 
5 mM HEPES, pH7.2, overnight at 4°C. As sucrose introduces some viscosity to the solution in 
which the MscL-liposomes are suspended in, the process of dialysis may have allowed the 
liposomes to coalesce and fuse resulting in larger liposomes. The fact that this was not seen in KCl 
MscL-liposomes suggests that the rate and/or degree of liposome fusion may be differentially 
influenced by the presence of different anions. 
4.3.3 Role of Anions and Effects of Divalent Cations 
The influence of cations and anions on liposome size was further investigated using MgCl2 
and MgSO4; this is displayed in Figure 4.9. For a complete comparison, experiments conducted 
using KCl and K2SO4 were also included in the figure. All sucrose gradients were run under 
identical conditions although lipid batches were prepared on different days. At high concentrations 
(50-100 mM) the presence of both MgCl2
 and MgSO4 resulted in liposome precipitation (Figure 
4.9), in contrast to the KCl and K2SO4 samples. A lipid mass was clearly visible in these gradients 
(Figure 4.9 C & D vs. Figure 4.9 A & B) and this observation suggested that Mg2+ (rather than Cl- 
or SO4
2-) was the main cause of this precipitation, consistent with the higher charge density of the 
magnesium ion as compared to potassium (Barber and Chow 1979).  
A noticeable difference was also observed between samples prepared in the presence of the 
different anions. In the case of MgCl2 samples, a concentration of 10 mM was sufficient to cause 
precipitation (Figure 4.9 C, 2nd tube from the left) whereas liposomes generated in 10 mM MgSO4 
(Figure 4.9 D, 2nd tube from the left) did not precipitate and were separated using the continuous 
sucrose gradient. This confirms the observation seen in K+ samples that anions may play a role in 
the formation of liposomes, albeit one that appears to be overshadowed by the effect of cations. 
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Figure 4.9. Sucrose gradient comparisons of ion trials. The four ultracentrifuge 
tubes in each panel show increasing concentrations of salts used. From left to right 1 
mM, 10 mM, 50 mM and 100 mM of the salt of interest which were A) KCl B) 
K2SO4 C) MgCl2 D) MgSO4. 
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Figure 4.10. Sucrose gradient images and negative stain micrographs 
of MscL-liposomes produced in A) 1 mM MgCl2, B) 1 mM MgSO4 and 
C) 10 mM MgSO4. Scale bar = 50 nm. 
 
Liposome fractions extracted from gradients that showed no evidence of precipitation were 
analysed by negative stain electron microscopy (Figure 4.10). This analysis confirmed that MscL-
liposomes were formed in 1 mM MgCl2, 1 mM MgSO4 and 10 mM MgSO4. The migration of 
formed MscL-liposomes of these conditions through the continuous sucrose gradients yielded 
various MscL-liposome sizes similar to that of 1 mM and 10 mM K+ conditions. 
4.3.4 Further Characterization of MscL-liposomes separated by Sucrose Gradients 
As mentioned earlier in Chapter 3, it was difficult to exert control over the incorporation 
efficiency of MscL into liposomes and this issue may have limited the release efficiency of MscL-
liposomes in the carboxyfluorescein experiments summarized in Chapter 3. Here, an attempt was 
made to visualise the incorporation of MscL into liposomes using cryo-electron microscopy (EM) 
and cryo-electron tomography (ET) techniques. MscL is difficult to visualise directly by cryo-EM 
due to its small size (~85 kDa) and in particular the lack of any sizeable extra- or intra-cellular 
domain. Therefore, His-tagged MscL was labelled with 5 nm Ni-NTA-Nanogold®. 
Nanogold-His-MscL-liposomes were prepared and visualised under cryo conditions (-176 
°C). Figures 4.11 A and C shows representative cryo-electron micrographs of a Nanogold-His-
MscL-liposome. The Nanogold-His-MscL was visible as an electron dense particle. The position of 
the Nanogold particle was clearer in 3D tomographic data reconstructed from tilt series acquired for 
the same liposomes. Selected sections of these computed 3D reconstructions are shown in Figures 
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4.11 B and D. The Nanogold attaches to the His-tag of the MscL channel, which is located at the N-
terminus and under native conditions extends into the cytoplasm. As can be seen in both sets of 
panels, the Nanogold is located within the liposome's internal reservoir, and as this indicates the 
position of the MscL N-terminus this indicates that MscL is incorporating itself into the lipid 
bilayer of the artificial liposomes “right-side-in”.  
Also evident from these micrographs and 3D tomograms (Figures 4.11 A, B, C and D) is the 
fact that these MscL-liposomes appear to be multi-lamellar, however, a majority of the liposomes 
imaged appear as unilamellar liposomes but with no Nanogold (Figure 4.11 E and F). Rather than 
suggesting that MscL was not well incorporated into unilamellar liposomes, this is more likely 
related to the methods used to incorporate Nanogold. Nanoprobes, Inc. suggest that in order to 
successfully bind a high number of proteins with 5 nm Ni-NTA-Nanogold®, a 5 to 10 fold molar 
excess of the Nanogold should be used. However due to the high cost of carrying out this procedure 
on the scale required here, tagging of His-MscL with 5 nm Ni-NTA-Nanogold® was performed at a 
1-to-1 molar ratio. It therefore seems likely that a significant population of unlabelled His-MscL 
remains. 
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Figure 4.11. Cryo-electron micrographs of Nanogold-His-MscL-
liposomes (A and C) and their resulting tomograms (B and D). His-
MscL-liposome tomograms are shown in E and F. Scale bar = 50 nm. 
 
B 
C D 
E F 
A 
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4.4 Discussion 
Liposome production via extrusion produces liposomes of a varying size distribution 
largely, but not completely dictated by the exclusion limit of the filter pore being used. As the work 
conducted here utilized proteoliposomes incorporating a transmembrane channel-forming protein, 
the size distribution of the MscL-liposomes formed may have been further affected by the addition 
of MscL protein in phosphate buffered saline (PBS) and 1 mM n-dodecyl !-D-maltoside (DDM) 
(Figure 4.1). This is due to the (to some extent, unpredictable) effects of detergent on the stability of 
the liposome’s lipid bilayer as well as complex interactions involving van der Waals forces and 
electrostatic interactions. As a result, fusion of the MscL-liposomes may occur resulting in larger 
MscL-liposomes. A more uniformly sized population of MscL-liposomes was desirable, both from 
the point of view of future structural studies using cryo-EM and the development of prototype drug 
encapsulation systems incorporating MscL as a nanovalve. As such a method was developed to 
more finely separate MscL-liposomes according to their size using a continuous sucrose gradient. It 
should be noted that the encapsulation of carboxyfluorescein did not affect the migration of the 
liposome bands (Figure S4.1). 
It was shown that the presence of ions and ion concentration play a role in maintaining the 
stability of liposome suspensions and preventing fusion. Cations appeared to play a more prominent 
role in determining liposome size distribution compared to anions. Furthermore, within the 1-100 
mM concentration range, divalent cations appear to cause more precipitation of liposomes 
compared to monovalent cations. This precipitation of the liposomes corresponds with the reported 
fusogenic properties of divalent cations (Ohki and Arnold 2000, Roldan-Vargas, Martin-Molina et 
al. 2007, Sabin, Prieto et al. 2007, Sabin, Prieto et al. 2010). The effect of cations on liposome sizes 
can be explained by the close interaction between ions and lipid molecules. This is consistent with 
the existence of hydration forces that are now used to explain colloidal behaviour as an expansion 
of the DLVO theory. The next sections attempt to explain the different factors that affect liposome 
sizing in these conditions.  
4.4.1 Hydration Forces 
The DLVO theory is used extensively in colloidal and bicolloidal science due to its success 
in describing the interactions between particles separated within a few nanometers. However, 
deviation from the theory has been observed at surface distances of <40 Å, where short-range 
repulsive forces exist (Chapel 1994, Vigil, Xu et al. 1994). These short-range repulsive forces have 
been termed hydration forces and their discovery has allowed for expansion of the DLVO theory. In 
an aqueous solution, the hydration force between two surfaces is attributed to the hydration of 
adsorbed ions and ionic functional groups (Molina-Bolivar, Galisteo-Gonzalez et al. 1999). As 
these two surfaces approach and interact with each other, some removal of the water molecules 
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surrounding the ions and surface will occur, resulting in an increase in free energy, causing 
repulsion (Molina-Bolivar, Galisteo-Gonzalez et al. 1999). 
The strength and effect of cation-lipid interaction has been found to vary between differing 
types of cations and lipid molecules (Gurtovenko and Vattulainen 2008). This effect is also 
different compared to lipids and proteins in solution (Petsev and Vekilov 2000). The attraction of 
cations to the surface of a liposome has a large influence on the stability and ultimately the size of 
the liposomes in solution. This may be due to differences in ion permeability of the lipid bilayer 
(Hauser, Phillips et al. 1972, Sabin, Prieto et al. 2006). The permeability coefficient for anions 
through lecithin membranes is usually 50-200 times higher than for cations (water permeability is 
10-3-10-4 cm/s; anions ~10-1110-12 cm/s; cations ~10-12-10-14 cm/s) as anions are capable of forming 
short-lived complexes that shuttle them across the membrane bilayer (Sabin, Prieto et al. 2006). 
Therefore, as ions are attracted to the polar charge of the lipid bilayer, cations remain close to the 
lipid bilayer, forming a hydration barrier that counters the attractive van der Waals forces of other 
liposomes (Sabin, Prieto et al. 2006) when the distances separating them is <40 Å. Furthermore, 
cations are more hydrated than anions of the same valency due to their larger ionic radii 
(Israelachvili 2011) and the strength of hydration forces is due to the strength of the hydration 
energy of the cations involved (Molina-Bolivar, Galisteo-Gonzalez et al. 1999). Water permeability 
through lipid bilayers is still a subject of debate and it has been reported that the addition of 
cholesterol to a lipid bilayer decreases water permeability (Mathai, Tristram-Nagle et al. 2008). 
Therefore, cholesterol addition may also affect ion permeability. 
 
Figure 4.12. A schematic representation of a cation in close 
proximity to a lipid bilayer, resulting in a hydration force 
effect. This enables the existence of a water layer caused by the 
hydration of the cation with a thickness of a hydrated radius of 
the adsorbed ion. Figure and text adapted from (Sabin, Prieto et 
al. 2006) with permission from Springer. 
 
The results of studies conducted here can be satisfactorily explained by the interaction of K+ 
with zwitterionic and negatively charged lipid headgroups of the MscL-liposome’s lipid bilayer, 
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theoretically allowing for the extension of the hydrated radius thus prolonging the size differences 
of the MscL-liposomes. This short-range hydration force effect may explain the differences in 
liposome sizes observed with varying K+ concentrations, where an increase in K+ concentration 
would enable more K+ to interact with the lipid bilayers and a decrease in K+ concentration would 
limit the surface area covered. This effect coupled with increasing long-range electrostatic repulsion 
from increasing ion concentrations would limit adhesion between liposomes and possible fusion. 
4.4.2 Liposome Fusion in the Presence of Hydration Forces 
Liposomes are not thermodynamically stable and will eventually aggregate, fuse and 
precipitate into stacks of large flat bilayers (Lasic 1990). Liposome stability is dependent on a 
collective balance of attractive van der Waals forces and electrostatic repulsive forces. The 
extension of the DLVO theory to incorporate hydration forces for the short-range repulsion 
experienced by particles at the Angstrom level can aid in the understanding of liposomal 
aggregation.  
Early concepts outlining the interaction between hydrated particle surfaces envisioned the 
ordering of the polar water molecules in direct contact with surfaces. This effect would then cause a 
second and third layer of ordering generating a multi-layered hydration shell around hydrophilic 
surfaces, that oppose disruption and giving rise to the repulsion experienced as two particles 
approach each other. It has been proposed that surfaces such as lipid bilayers in water experience 
short-ranged repulsion due to entropic repulsion caused by the confinement of thermally mobile 
surface groups and contrary to earlier concepts, there is no multilayered hydration barrier 
preventing interaction between the surfaces except for the first layer of water molecules in direct 
contact with the surfaces (Israelachvili and Wennerstrom 1996). It has also been proposed that this 
hydration barrier may also contribute to an attractive force when certain conditions are met 
(Israelachvili and Wennerstrom 1996). When two layers of water each interacting with a flat surface 
approach each other in a symmetric manner, this will result in repulsion (Figure 4.13 b) 
(Israelachvili and Wennerstrom 1996). When the approach is staggered or asymmetric, attraction is 
experienced due to water dipoles that are farther away compensating for any repulsion experienced 
(Figure 4.13 c) (Lennard-Jones and Dent 1928, Israelachvili and Wennerstrom 1996). Attraction or 
repulsion is a result of a final net interaction between electrostatic dipolar and molecular structural 
effects, which may be continuously changing as two surfaces approach each other (Israelachvili and 
Wennerstrom 1996). As lipid bilayers are fluid with the existence of protrusions and undulations 
along with lipid headgroup rotations, the experience of repulsion and attraction between liposomes 
due to the symmetric and asymmetric approach of two or more liposomes may explain the 
thermodynamic instability of the system. 
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The addition of salts is thought to be able to delay and protect against the onset of liposome 
aggregation by increasing the dielectric constant of the solution and this hydration barrier. This 
effect is variable due to the variability of interactions between ions and lipid molecules (Petsev and 
Vekilov 2000, Gurtovenko and Vattulainen 2008). It is also further complicated by the fluid nature 
of the lipid bilayer, where the interaction of the hydration barrier may also meet the asymmetric 
interaction conditions mentioned before, resulting in the eventual precipitation of liposomes. It has 
been suggested that the examination of the surfaces of particles be taken into consideration when 
addressing the stability and water-surface interaction (Israelachvili and Wennerstrom 1996). 
 
 
Figure 4.13. Orientation of water-surface interaction. a) water molecules 
attracted to a hydrophilic surface forming an orientated layer of water molecules 
(thick arrows indicate water dipoles and thin lines in the right hand panel indicate 
electrostatic field lines). b) Two water-surface symmetric interactions, which 
results in electrostatic repulsion. c) Two water-surface asymmetric interactions, 
which can lead to attraction. Figure and text adapted from (Israelachvili and 
Wennerstrom 1996) reproduced with permission from Nature Publishing Group. 
 
The symmetry of interaction between water molecules on the surface of a lipid bilayer and 
with the water molecules on the surface of a different lipid bilayer may explain the occurrence of 
large liposomes at a high concentration of monovalent cations over time. If the collisions of 
liposomes between one another occurs asymmetrically, the liposomes can adhere to one another and 
eventually fuse, resulting in larger liposomes. 
4.4.3 Effect of Cations on Lipid Bilayers 
It has been suggested that effects on mechanical strength and liposome stability correlate 
with cation-lipid interactions (Israelachvili and Wennerstrom 1996, Rappolt, Pabst et al. 2001, 
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Bockmann, Hac et al. 2003, Sabin, Prieto et al. 2006, Gurtovenko and Vattulainen 2008). Ions in an 
aqueous media can be used to maintain the size and stability of liposomes through the provision of 
the appropriate type and concentration of counterions. The full effect of ion interactions with lipid 
molecules in a bilayer is likely a complex combination of both electrostatic repulsion and hydration 
forces and possibly other effects. Molecular dynamics (MD) simulations, NMR, X-ray 
crystallography and fluorescence correlation spectroscopy have reported that increasing salt 
concentrations decreases the lateral diffusion and rotational motion of lipid molecules within the 
lipid bilayer (Rappolt, Pabst et al. 2001, Bockmann, Hac et al. 2003, Gentilcore, Michaud-Agrawal 
et al. 2010). A study on the effects of NaCl on POPC bilayers using fluorescence correlation 
spectroscopy and MD simulations showed that Na+ bound tightly to the carbonyl oxygen atoms of 
the lipid on an average of three lipids to an ion, resulting in reduced mobility (Bockmann, Hac et al. 
2003). There was also an increase in bilayer thickness of ~2 Å which increases the order parameter 
of the fatty acyl chains (Bockmann, Hac et al. 2003). These MD simulations suggest that 
monovalent cations play a much larger role in membrane organization than previously estimated 
and that these interactions vary according to the type of ions and lipids involved (Bockmann, Hac et 
al. 2003, Gurtovenko and Vattulainen 2008).  
An increase in the mechanical strength of the lipid bilayer would also reduce the probability 
of liposome fusion due the reduced mobility of the lipid molecules within the bilayer and a greater 
propensity to coalesce with adjacent bilayers. 
Effect of Ions on Liposome Size 
MscL-liposomes produced with increasing concentrations of K+, exhibited a lower 
occurrence of larger sized liposomes and this was reflected in the migration distances of the distinct 
bands and broader regions of MscL-liposomes in the sucrose gradients (Figure 4.2, and 4.9A for 
KCl. Figure 4.6 and 4.9 B for K2SO4). As stated previously in Section 4.4.1 Hydration Forces, the 
availability of cations, which interact with the lipid bilayer may result in the formation of an 
extended hydration barrier that counteracts liposomal attraction due to the attractive van der Waals 
forces (Sabin, Prieto et al. 2006). However, as liposomes in aqueous solution can be described as a 
colloidal system, liposome stability can also be addressed through surface charge. In water, the 
surface charge of liposomes can be positive, negative or contain a mixture of both depending on the 
lipid composition. The Sigma soy azolectin used in this study contains an uncharacterized mixture 
of different lipid species. Major components, however, are estimated to be PC (zwitterionic) and PE 
(neutral). The MscL-liposomes generated here most likely contained lipids with a mixture of 
different charges. This can lend itself to an ionic attraction of liposomes and the use of ions can be 
applied to stabilize the system. However, there is no general model for liposome colloidal stability 
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as the surface of the membrane contains protrusions, undulations and the mobility of the lipid 
headgroups can affect aggregation and precipitation of the liposomes over time. 
The images displayed in Figure 4.9 showed that cation type and concentrations in solution 
not only affect liposome size but also precipitation. Precipitation of the MscL-liposomes was 
noticeable in MscL-liposomes produced in the presence of Mg2+ concentrations greater than 1 mM. 
The attraction of liposomes to each other may be due to the electrostatic attraction caused by 
differences in the dipole-dipole interactions between adjacent liposomes. As Mg2+ interacts with 
zwitterionic and negatively charged lipids in the liposomes, a difference in dipole moment is 
formed between the liposomes, which result in attraction. At low ion concentrations liposomes 
might be attracted to the same limiting ion. However, this effect can be overcome by increasing the 
concentration of Mg2+ until the liposome charge is screened. The effect of electrostatic attraction 
was not seen at 1 mM MgCl2, 1 mM MgSO4 and 10 mM MgSO4 (Figure 4.10) and may suggest that 
in these 1-10 mM range, sufficient ions are present to screen these attractions. 
The effect of liposome aggregation can also be explained through the fusogenic properties 
of divalent and trivalent cations (Roldan-Vargas, Martin-Molina et al. 2007, Sabin, Prieto et al. 
2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008). It is believed that the fusogenic ions cause 
a change in the surface properties of the lipid bilayer, causing it to become more hydrophobic (Ohki 
and Arnold 2000). These fusogenic ions cause a local dehydration of the membrane bilayer of the 
liposomes, reducing the hydration force repulsion, which results in adhesion leading to clustering 
(Ohki and Arnold 2000, Roldan-Vargas, Martin-Molina et al. 2007, Roldan-Vargas, Barnadas-
Rodriguez et al. 2008). Therefore, it may be conceivable that although precipitation of MscL-
liposomes was not observed at 1 mM MgCl2, 1 mM MgSO4 and 10 mM MgSO4, this may be a time 
dependent effect, which can be described by two different regimes of cluster aggregation. This will 
be discussed in detail in Chapter 5. 
It was also noticed that anions are capable of having an effect on liposome size and 
precipitation. This was first seen when comparing 100 mM KCl and 50 mM K2SO4 sucrose 
gradients (Figure 4.7), which should have approximately similar concentrations of K+; however, the 
band intensities show that liposome sizes are more pronounced in K2SO4 but with the passage of 
time and through the removal of viscous media, the MscL-liposomes fuse together forming larger 
liposomes (Figure 4.8). The effect of anions is further seen in the precipitation of MscL-liposomes 
in 10 mM MgCl2 but not in 10 mM MgSO4. This difference between Cl
- and SO4
2- may be a result 
of the electrostatic potential of SO4
2-, which is a larger ion than Cl-. SO4
2- may be able to neutralize 
the cation’s effect in attracting a hydration layer or being attracted to the lipid molecules in the 
membrane thereby negating the hydration force between two liposomes caused by cations. This 
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leads to the observation of larger liposomes and the offset of precipitation in samples made in the 
presence of SO4
2- in both the K+ and Mg2+ ions respectively. 
4.5 Conclusion 
The production of MscL-liposomes utilized an extrusion method followed by the addition of 
MscL suspended in detergent. The addition of detergent appears to yield MscL-liposomes of 
varying sizes. A method for isolating liposomes of a defined size through the use of continuous 
sucrose gradients has been developed and the effect of cations and anions on the formation of 
MscL-liposomes investigated. The results observed here can be interpreted in terms of the expanded 
DLVO theory, specifically by hydration forces and electrostatic effects caused by varying surface 
charges. The effect of cations is not only influenced by the valency of the ion but is also modulated 
by the anion species present. 
4.6 Future Work 
Future work for this area would be to test the use of 50 nm diameter MscL-liposomes with 
the fluorescence assay described in the previous chapter. As we have observed a variation in 
liposome formation in the presence of different ions, measurements of the zeta potential of 
liposomal suspension may provide further insight into this phenomenon. The zeta potential is the 
net electric potential of the surface charge of the particle, absorbed layer at the interface (hydrated 
counter ions) and a point in the bulk fluid away from the particle surface. This provides information 
on the electrostatic repulsion between particles in a colloidal suspension and allows for the 
prediction of the stability of the suspension. If the zeta potential has a large negative or positive 
value, the liposomes will repel each other. A low zeta potential will allow the liposomes to 
coalesce, as there is no force to repel them. This will also provide a method to determine the 
stability of MscL-liposome suspensions, which will further aid in the development of a nanovalve 
drug delivery system. 
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4.7 Supplementary 
   
Figure S4.1 Continuous sucrose gradient trial of MscL-liposomes 
generated in 100 mM KCl A) with and B) without  
carboxyfluorescein. A missing electron micrograph in (A) was a 
result of an error in sample extraction resulting in a loss of the sample. 
Scale bar = 50 nm. 
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Chapter 5: Controlling Liposome Size Through Lipid Molecules 
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5.1 Abstract 
The influence of cations on liposome formation is lipid-dependent and in this Chapter the 
effects of K+ and Mg2+ cations on liposomes of varying lipid compositions are studied. The 
different effects of cation-lipid interactions allowed for the observation of aggregation and fusion of 
the liposomes. This study showed that lipid components play a role in the generation of small sized 
MscL containing liposomes (MscL-liposomes) and that the cations available in the colloidal 
suspension determine the liposome stability over time. Liposome stability is governed through 
repulsive electrostatic (long range nanometer scale repulsion) and hydration forces (short range 
angstrom scale repulsion), that surround the liposome and through lipid-cation-water interactions 
these repulsive forces are enhanced. However, a high concentration of Mg2+ causes aggregation and 
ultimately fusion of the liposomes. The effect of Mg2+ varies according to lipid constituents 
available in the liposomes. The aim of this Chapter was to determine if the differences in lipid 
composition evident amongst the different azolectin mixtures used in the previous Chapters has an 
effect on liposome size uniformity. 
5.2 Introduction 
Small liposome size has been highlighted as a major contributor in the efficiency of 
liposomal drug delivery systems. Among the benefits in using small liposome sizes are a prolonged 
half-life and the ability for permeation of the vasculature in certain disease states. Although not 
observed in differently size extruded MscL-liposomes (Figure 3.2), it is speculated that the high 
curvature of small sized liposomes can lower the activation energy of MscL and increase the open 
probability of MscL channels (Perozo, Kloda et al. 2002, Grage, Keleshian et al. 2011, Tonnesen, 
Christensen et al. 2014). 
Control of liposome size is dictated by its preparatory methods. However, the size of the 
prepared liposomes is subject to change after preparation, where liposomes can aggregate, which 
can lead to fusion thus resulting in larger vesicles. Aggregation of liposomes can occur over time 
due to the thermodynamic instability of the liposomal system (Lasic 1990). This, however, can be 
delayed through repulsive hydration forces caused by an interaction of water molecules with lipid 
headgroups on the surface of the liposomes, which repel the attractive van der Waals forces 
experienced between liposomes with distances <40 Å between them. Repulsive forces between 
liposomes can be further amplified through the addition of ions, which contribute to electrostatic 
(long range) and hydration (short range) forces. Cations adhering to the lipid headgroups of 
liposomes can enhance the hydration force by extending the hydration barrier around the liposomes. 
However, lipid-cation interactions differ between different lipid species and cations involved, 
resulting in varying effects. 
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The extension of the hydration barrier by monovalent cations is subject to the hydration 
radius of the adsorbed cation (Sabin, Prieto et al. 2006). This is affected by the cation’s electrostatic 
attraction on water molecules where small ions cause a high degree of electrostatic ordering of 
water molecules compared to large ions where hydrogen bonding between water molecules is 
stronger (Hribar, Southall et al. 2002). Divalent and trivalent cations however are believed to 
compete with liposomes for water molecules (Ohki and Arnold 2000, Roldan-Vargas, Martin-
Molina et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008). This causes local dehydration 
of a liposome’s surface and can result in competition for interfacial water, thereby reducing the 
hydration force between close proximity liposomes (Ohki and Arnold 2000, Roldan-Vargas, 
Martin-Molina et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008). The dehydration of the 
liposome’s lipid bilayer is believed to cause liposome aggregation with the rate of aggregation 
dependent on the concentration of divalent and trivalent cations present in the colloidal suspension 
(Roldan-Vargas, Martin-Molina et al. 2007, Sabin, Prieto et al. 2007, Roldan-Vargas, Barnadas-
Rodriguez et al. 2008). 
5.2.1 Liposome Adhesion and Aggregation 
Adhesion between liposomes results in aggregation and as the concentration of the 
fusogenic ions increase so does the rate of aggregation (Sabin, Prieto et al. 2007). Studies on 
liposome aggregation and lipid bilayer fusion have been conducted through the use of fusogenic 
ions such as divalent and trivalent cations (Roldan-Vargas, Martin-Molina et al. 2007, Sabin, Prieto 
et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008). Aggregation has been observed in 
studies involving phosphatidylserine (PS) vesicles with Ca2+ and Mg2+ cations as well as several 
types of phosphatidylcholine (PC) vesicles with lanthanum ions (La3+) cations (Roldan-Vargas, 
Martin-Molina et al. 2007, Sabin, Prieto et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 
2008). Furthermore, the effects of the fusogenic ions vary across the range of lipid molecules used 
in the studies; where negatively charged lipids are screened with lower concentrations of cations, 
whereas zwitterionic lipids require a higher concentration of cations.  
Aggregation can be described by two different regimes, (i) the diffusion-limited cluster 
aggregation (DLCA) and (ii) reaction-limited cluster aggregation (RLCA) (Sabin, Prieto et al. 
2010). In DLCA, every collision between particles results in permanent contact resulting in a 
cluster growth (Meakin 1983). In RLCA, particle collision has to occur several times before 
permanent contact is achieved (Eden 1961, Sabin, Prieto et al. 2010). It is believed that when a 
threshold limit is met for fusogenic ion screening, a change in the surface properties of the lipid 
bilayer occurs causing it to become more hydrophobic (Ohki and Arnold 2000). These fusogenic 
ions then cause a dehydration of the membrane bilayer of the liposomes, reducing the hydration 
force repulsion between close proximity liposomes, which results in adhesion leading to clustering 
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(Ohki and Arnold 2000, Roldan-Vargas, Martin-Molina et al. 2007, Roldan-Vargas, Barnadas-
Rodriguez et al. 2008). It is proposed that dehydration of the lipid molecules in the presence of 
these cations plays an essential role in vesicle short-range interaction and conditions, which results 
in clustering (Roldan-Vargas, Martin-Molina et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 
2008). 
It is conceivable that hydration or dehydration of the lipid membrane can influence the 
regimes experienced by liposomes (Ohki and Arnold 2000, Roldan-Vargas, Martin-Molina et al. 
2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008) as an increase in fusogenic ion 
concentrations can modify liposomal aggregation from RLCA to DLCA (Sabin, Prieto et al. 2007). 
This change in aggregation kinetics is not seen in liposome interactions with monovalent cations. 
5.2.2 Indirect Effect of a Multivalent Ion on MscL Activity 
Ermakov and colleagues have reported an effect of multivalent ions on MscL activity 
(Ermakov, Kamaraju et al. 2010). They propose that MscL activity is affected by an indirect effect 
of ionic interaction with lipid molecules (Ermakov, Kamaraju et al. 2010). This has been observed 
between the multivalent ion, gadolinium (Gd3+) and a lipid bilayer consisting of the phospholipids 
phosphatidylcholine (PC) and phosphatidylserine (PS) (Ermakov, Kamaraju et al. 2010). Gd3+ has 
been shown by patch clamp recordings to inhibit the activity of reconstituted MscL. When Gd3+ is 
included in the recording buffer, no MscL activity is observed (Ermakov, Kamaraju et al. 2010). 
The effect of blocking mechanosensitive channel activity is not seen when MscL is reconstituted 
into zwitterionic lipids (PC) but effects are demonstrated when negatively charged lipids (PS) are 
incorporated into the lipid bilayer (Ermakov, Kamaraju et al. 2010). It has been suggested that 
negatively charged lipids have a high affinity for Gd3+ ions and other lanthanides (Petersheim and 
Sun 1989, Ermakov, Kamaraju et al. 2010). 
A study conducted in the presence of La3+ shows that both the carboxyl and phosphate 
group of PS participate in ion coordination (Petersheim and Sun 1989). A tight ion coordination 
induces condensation and cross-linking, which leads to compaction of the lipid bilayer (Ermakov, 
Kamaraju et al. 2010). This is suggested to be the most probable cause of the reported inhibition of 
MscL activity as the pulling of the lipid headgroups together generates higher pressure in the 
hydrocarbon tails, stabilizing a closed state in the MscL channel (Ermakov, Kamaraju et al. 2010). 
 
In Chapter 4, the ionic effects on MscL-liposomes generated using a soy azolectin (Sigma 
11-25% PC) that has been widely used in patch clamp studies was investigated. However, as was 
determined in Chapter 3, MscL-liposomes generated with different soy azolectins have varying 
levels of carboxyfluorescein release. This is likely related to the different types of lipid constituents 
present in the soy azolectins used. As different lipid molecules also have differing cation 
  97 
dependencies, it is conceivable that the varying lipid nature of azolecin may exhibit different 
propensities to form liposomes of defined sizes, dependent on ionic properties of the solution and 
geometric properties of the constituent lipids. This characterization of the behaviour of azolectin 
mixture is important, as it impacts the cost effectiveness of future liposome-based experiments, 
such as the development of prototype liposome-nanovalve systems. Azolectin is significantly 
cheaper to obtain than pure synthetic lipids and the cost of using the latter in experiments on this 
scale would be substantial. 
5.3 Results 
As the effect of cations differs with differing lipid molecules, the effects of K+ and Mg2+ on 
liposomes created using different soy azolectins and an egg yolk azolectin were first investigated. 
Lipid components of the azolectins used are listed in Tables 5.1 and 5.2: 
 
Table 5.1. Major lipid headgroups from the different azolectins used. Information 
was sourced from company websites. M indicates major component but percentage is 
not known. Azolectin catalogue numbers Sigma 11-23% PC (#P5638), Sigma egg yolk 
(#P5394), Avanti 40% PC (341602G) and Avanti 20% PC (541601G). 
Lipid head 
Azolectin 
PC PE PI PA LPC Notes 
Sigma 14-23% PC 14-23% M - - - inositol phosphatides 
Avanti 40% PC 40% 16% 11% - - Unknown 33% 
Avanti 20% PC 24% 18.6% 11.5% 4.3% 4.6% Unknown 37% 
Sigma Egg Yolk ~60% ~40% - - -  
 
Table 5.2. Fatty acid components of sigma sourced azolectin. 
Avanti fatty acid information was not available. Information 
obtained from company websites. 
Fatty Acid 
Azolectin 
16:0 18:0 18:1 18:2 18:3 
Sigma (14-23% PC) 13% 4% 10% 64% 6% 
Sigma Egg Yolk 33% 13% 31% 15% - 
 
The compositions of the azolectins used in our studies have varied lipid headgroups and acyl 
tail lengths. As these are not correlated together and are mostly rough estimates of major 
components, the complete identities of the lipids are not known. However, the composition of the 
lipids does provide some insight into the effects of the lipid-cation interactions on liposomes. 
5.3.1 Liposome Aggregation and Fusion 
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Figure 5.1. Titration of 100 nm extruded liposomes 
generated by using different azolectins mixed with 
different concentrations of MgCl2. The liposomes were 
incoporated with PE-rhodamine and visualised using a 
confocal microscope. Differing aggregation and fusion 
effects were seen with different types of liposomes. Avanti 40% PC and Sigma egg yolk 
azolectin liposomes after 24 hours are shown in an image panel inset. After 48 hours, 
Avanti 40% PC liposomes exposed to 1 mM (left image) and 100 mM (right image) 
MgCl2 are also displayed. Scale bar = 5 µm. 
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Due to the varying lipid constituents that make up the different azolectin batches and the 
effect different cation species have on specific lipid molecules, MgCl2 was titrated into liposomes 
generated using different azolectin batches in order to identify resulting structural changes that 
would affect electron microscopy (EM) studies. Confocal microscopy was used initially to screen 
for large-scale structural effects, namely aggregation and fusion of liposomes that may occur (based 
on the results obtained in Chapter 4) with increasing MgCl2 concentrations. In order to visualise the 
liposome forming behaviour under confocal microscopy conditions, the liposomes were conjugated 
with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl). 
Precipitation of soy azolectin (Sigma 14-23% PC) was obvious to the naked eye (Figure 5.1, image 
of Eppendorf tubes). When viewed under a confocal microscope, the precipitation was further 
evident from what appeared to be masses of giant vesicles fused together. In comparison, there was 
minimal or no precipitation for liposomes generated using Avanti 40% PC and egg yolk azolectin 
even at concentrations as high as 0.1 M MgCl2. 
Liposome fusion was more extensive for the Sigma 14-23% PC than the Avanti 20% PC 
liposomes at 20-30 mM MgCl2. At these concentrations, solutions of Avanti 20% PC did not turn 
completely clear as compared to the Sigma 14-23% PC which were largely devoid of suspended 
dye. This may indicate the presence of a higher proportion of negatively charged lipids in the Sigma 
soy azolectin, a conclusion that ties in well with the reported effects of divalent and trivalent cations 
on negatively charged lipids (Roldan-Vargas, Martin-Molina et al. 2007, Sabin, Prieto et al. 2007, 
Roldan-Vargas, Barnadas-Rodriguez et al. 2008, Ermakov, Kamaraju et al. 2010). 
The Avanti 40% PC exhibited a small degree of precipitation between 20-50 mM of MgCl2; 
however, confocal microscopy analysis showed that the liposomes aggregated but did not fuse 
together (Figure 5.1). Furthermore, at 100 mM MgCl2 the liposomes did not aggregate and 
precipitate immediately. This was interpreted as being the result of an equilibrium being achieved 
between the lipid-cation interactions. However, under these conditions, aggregation was observed 
over time - after 24 and 48 hours (Figure 5.1 inset) - indicating that the aggregation properties of 
Mg2+ were not completely overcome at this concentration. At 20-50 mM MgCl2, the aggregation 
appeared to increase over time as judged by confocal imaging analysis. This is most likely the result 
of slow precipitation as a result of an increasing degree of liposome aggregation. Fusion was not 
evident and may provide an indication of the fluidity of the lipid bilayer and the transition 
temperature of the azolectin. Avanti 40% PC liposomes may have a higher transition temperature 
than its other soy azolectin counterparts. No aggregation of liposomes was observed at 1 mM 
MgCl2 conditions and this observation was consistent with the results obtained in Chapter 4 where 
Mg2+ may have screened the charges of the liposomes. 
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Precipitation and fusion was not observed in egg yolk azolectin under the concentration 
range of MgCl2 evaluated here. Occasional large bodies of lipids were observed as they pass 
through the field of view. Unlike Avanti 40% PC, aggregation did not occur over time which may 
indicate a lack of negatively charged lipid head groups in this azolectin. As the main component of 
egg yolk azolectin is the zwitterionic PC and the neutral PE, the attraction between the divalent 
cations and these lipids would be predicted to be weak. AFM studies have reported that the 
interaction between PC and monovalent cations results in a lipid-ion network and this network is 
capable of migration, indicating that the ions are mobile with these lipids (Fukuma, Higgins et al. 
2007). This mobility shows that the binding between cations and PC is weak and without negatively 
charged lipids, the effect and binding of cations is minimal (Ermakov, Kamaraju et al. 2010). 
5.3.2 Egg Yolk Azolectin 
Approximately 40% of egg yolk azolectin is comprised of PE lipid, which is a major 
component of E. coli membranes (Oursel, Loutelier-Bourhis et al. 2007). The composition of egg 
yolk azolectin may allow for a higher incorporation of MscL into its lipid bilayer, as was suggested 
from the screening of aggregation and fusion effects by confocal microscopy, MscL-liposome 
formation and the effects of cations on egg yolk azolectin were further compared. It should be noted 
that an indication that the extrusion process has worked in producing liposomes is the change from 
a cloudy emulsion to a clear solution at the end of the process. The cloudy emulsion at the start of 
the extrusion process consists of various liposome sizes, multilamellar liposomes and lipid 
aggregates. As the extrusion process takes place, the breakdown of these bodies and reformation 
into liposomes via a filter produces a clear final suspension. Liposomes produced using egg yolk 
azolectin did not produce a clear solution after extrusion. This was observed in both the presence of 
KCl and MgCl2. 
Analysis by negative stain electron microscopy revealed that egg yolk azolectin produced 
clumps of lipids in both KCl (Figures 5.2 A and C) and MgCl2 (Figure 5.3 A and C) at varying 
concentrations and not liposomes. Interestingly though, the addition of MscL (1:2000 protein to 
lipid (w/w) ratio) to these extruded egg yolk lipid clumps in the presence of KCl, led to the 
formation of MscL-liposomes (Figure 5.2 B and D). MscL-liposome formation was more 
pronounced at 100 mM KCl (Figure 5.2 D) compared to 1 mM KCl (Figure 5.2 B). The effect of 
liposome formation through the incorporation of MscL in the presence of KCl may indicate that 
residual bacterial annular lipids surrounding the hydrophobic transmembrane domain of MscL may 
have been incorporated into the MscL-liposomes, thereby enabling stronger cation-lipid 
interactions. This may explain the difference between MscL-liposome formation in both the 1 mM 
and 100 mM KCl, as a higher concentration of K+ would result in a larger hydration force (Figure 
5.2 B and D). 
  101 
 
Figure 5.2. Egg Yolk azolectin liposome comparison before and after MscL (1:2000 
protein : lipid w/w ratio) was added. Liposomes were made in the presence of A) 1 
mM KCl, B) 1 mM KCl with MscL, C) 100 mM KCl and D) 100 mM KCl with MscL. 
Scale bar = 250 nm. 
 
The effect of MscL addition was not repeatable in liposomes exposed to MgCl2 (Figure 5.3 
B and D). This observation further reinforced the argument that the presence of bacterial annular 
lipids enabled the formation of MscL-liposomes and the presence of these incorporated bacterial 
lipids can subject the MscL-liposomes to aggregation and fusion caused by multivalent cations. It 
should be noted that, the amount of co-purified lipids could be reasonably expected to vary between 
protein purifications. As the transition temperature of the lipid components also influences the 
stability of liposomes (Sabin, Prieto et al. 2006), a low transition temperature for the egg yolk 
MscL-liposomes might allow them to remain in fluid state leading to the formation of the observed 
lipid clumps upon exposure to Mg2+, and the absence of precipitation. 
  102 
 
Figure 5.3. Egg Yolk azolectin liposome comparison before and after MscL (1:2000 
protein : lipid weight ratio) was added. Liposomes were made in the presence of A) 1 
mM MgCl2, B) 1 mM MgCl2 with MscL, C) 100 mM MgCl2 and D) 100 mM MgCl2 
with MscL. Scale bar = 250 nm. 
 
5.3.3 Continuous Sucrose Gradient Separation of MscL-Egg Yolk Azolectin Liposomes 
As shown in Figure 5.2, electron micrographs of negatively stained MscL-egg yolk 
liposomes generated in the presence of KCl, the addition of MscL aids in the formation of egg yolk 
liposomes however, the MscL-liposomes suspension remained cloudy. It was hypothesised that this 
may have indicated a sensitivity of the MscL-liposomes to lipid transition temperature, resulting in 
unstable MscL-liposome formations. In order to investigate this hypothesis further, size 
fractionation experiments were conducted to determine if MscL-liposomes generated using egg 
yolk azolectin could be successfully separated according to size. 
The size fraction experiments were performed using continuous sucrose gradient methods 
(as developed in Chapter 4) to separate MscL-egg yolk liposomes using varying concentrations of 
KCl and MgCl2. The results obtained from these experiments further reinforced the hypothesis that 
the MscL-egg yolk liposomes were unstable. MscL-egg yolk liposomes did not produce any visible 
banding with the lipid emulsion preferring to remain at the top of the sucrose gradient (shown in 
Figure 5.4). This also shows that the sucrose gradient is affected by liposome formation and 
stability. 
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Figure 5.4. MscL-liposomes made using egg yolk azolectin with A) KCl and B) 
MgCl2 salts. From left to right in each panel, the salt concentration was varied 
from 1 mM, 10 mM, 50 mM to 100 mM. 
 
 Monovalent cation (K+) conditions were the subject of focus as divalent cations (Mg2+) had 
been shown to have an undesirable effect on the aggregation kinetics of MscL-liposomes generated 
with egg yolk azolectin (Figure 5.3) and soy azolectin liposomes (Figure 5.1). Electron micrographs 
of extracted fractions taken from the diffuse fluorescent bands (approximately ! of the way up the 
gradient in Figure 5.4), as well as the lipid emulsion that remained at the top of the sucrose 
gradients, showed that the addition of MscL and the increasing concentration of KCl aided in 
liposome formation. This was particularly evident from analysis of the top fraction extracted from 
each gradient, where an increasing number of relatively large but nonetheless liposome-like 
structures were seen as the KCl concentration increased (see top electron micrographs of each panel 
in Figure 5.5). MscL-liposomes extracted from the diffuse fluorescent band exhibited diameters that 
were <50 nm (see middle and last electron micrographs of each panel in Figure 5.5). 
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Figure 5.5. Electron micrographs of MscL-liposomes made 
using egg yolk azolectin in the presence of KCl and 
separated using continuous sucrose gradients. A) 1 mM, B) 
10 mM, C) 50 mM, D) 100 mM KCl. Scale bar = 50 nm. 
 
5.3.4 Lipid Effect on the Formation of Liposomes 
It was speculated that liposomes of varying sizes generated from azolectin may be 
comprised of different lipids – specifically that the intrinsic membrane curvature required to form 
liposomes of a particular size may dictate the distribution of lipids within each liposome size 
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fraction. If correct, this hypothesis would tie in with the proposal that utilizing lipid molecules of 
defined geometries could be an effective strategy for fine tuning liposome size (Genc, Ortiz et al. 
2009, Israelachvili 2011). Therefore, in order to test the effects of combining different lipid blends 
on the formation of liposomes, soy azolectin (Sigma 14-23% PC), known to form liposomes 
through the extrusion process, was mixed with egg yolk azolectin, shown previously not to form 
liposomes after extrusion (Figure 5.2 and 5.3, panels A and C). It was additionally hoped that the 
mixture of both lipids may provide a suitable lipid formulation for generating uniformly sized 
MscL-liposomes as egg yolk azolectin was capable of forming MscL-liposomes that are <50 nm in 
diameter (shown in Figure 5.5) but are unstable while soy azolectin forms stable heterogeneous 
liposomes. Shown in Figure 5.6 are representative electron micrographs of liposomes produced by 
combining the two azolectins in variable ratios (w/w). 
 
 
Figure 5.6. Electron micrograph images of egg yolk azolectin liposomes titrated 
with increasing soy azolectin concentrations. A) 1% soy, B) 10% soy, C) 25% soy, 
D) 50% soy, E) 75% soy and F) 90% soy. Percentages were measured by weight. 
Liposomes were produced in 10 mM KCl, 5 mM HEPES, pH7.2. Scale bar = 250 nm. 
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The electron micrographs show that as soy azolectin was titrated into the egg yolk azolectin 
mixture, formation of liposomes was enhanced, further reinforcing earlier conclusions that the type 
of lipids used influenced the formation of liposomes. Electron microscopy analysis had already 
determined that the presence of monovalent and divalent cations had no noticeable effects on egg 
yolk liposome formation (Figure 5.2 and 5.3, panels A and C) but were capable of influencing egg 
yolk MscL-liposomes (Figure 5.2 and 5.3, panels B and D). Here focus was given to 10 mM KCl in 
order to produce liposomes with a larger size distribution range in the soy and egg yolk azolectin 
combination experiments, guided by the results observed in Figure 4.2. It was hypothesised that 
these conditions would aid in obtaining a higher resolution using the current continuous sucrose 
gradient method, due to minimal hydration force caused by the limited availability of cations (K+) 
surrounding the liposomes (see results in Chapter 4). It was conceivable based on data from Chapter 
4 that with increasing concentrations of K+, the migration of the bands and broad regions would 
occur over a shorter distance. 
Shown in Figure 5.7 are images of the sucrose gradients obtained for MscL-liposomes 
produced using egg yolk azolectin titrated against increasing concentrations of soy azolectin (w/w). 
As can be seen in Figure 5.7, the cloudy emulsion (100% egg yolk liposomes, left panel) progressed 
further into the sucrose gradient with increasing concentrations of soy azolectin. 
 
 
Figure 5.7. Titration of MscL-liposomes produced using egg yolk azolectin 
with soy azolectin titration (w/w ratio) in 10 mM KCl. From left to right 0%, 
1%, 10%, 25%, 50%, 75%, 90% and 100% soy azolectin. 
 
 Following imaging by negative stain electron microscopy, it was determined that azolectin 
mixtures of 10% soy : 90% egg yolk and 25% soy : 75% egg yolk (red arrowheads in Figure 5.7) 
produced a reasonable yield of small sized liposomes (Figure 5.6 B and C). Further analysis of the 
mixed MscL-soy and egg yolk liposomes in this fraction showed a size distrubtion of approximately 
  107 
20-30 nm diameter. A more detailed analysis of the liposome composition of these mixtures is 
documented in Figure 5.8. Large bodies that appear to be fluid in nature, similar to those seen in the 
100% egg yolk liposomes (Figure 5.2 A and C) were found mixed with the desirable small sized 
liposomes. This may indicate that soy azolectin was capable of stabilizing the formation of egg yolk 
liposomes; however, at the ratios of 10% and 25% soy azolectin mix, the resulting membranes 
formed were still subject to fusion, presumably due to the transition temperature of egg yolk 
azolectin which is -15 °C (Sigma website). However, it should be noted that these large bodies were 
present in fractions isolated from the levels just below the migrated band on the sucrose gradient 
(highlighted with red arrowheads in Figure 5.8), indicating that it may be possible to separate them 
from MscL-liposomes. 
      
Figure 5.8. Sucrose gradient and negative stain comparison between egg yolk 
azolectin, 10% soy : 90% egg yolk azolectin and 25% soy : 75% egg yolk 
azolectin (w/w ratio) MscL-liposomes. Red arrowheads indicate large bodies 
isolated from the sucrose gradients. Scale bar = 50nm. 
 
Following the observed behaviour of egg yolk azolectin, the effect of MscL incorporation as 
well as the effect of including cholesterol on liposome formation was tested. This was to test the 
hypothesis that MscL incorporation and increasing the membrane packing order through the 
addition of cholesterol aids in the formation of liposomes. For these experiments, a neutral low 
transition temperature lipid was employed, in this case, 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) obtained from Avanti Polar Lipids (cat #850375). DOPC has a tail length of 18 carbon 
atoms with one double bond and a transition temperature of -20 °C (Cullis, Fenske et al. 1996). 
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Negative stain electron microscopy of liposomes produced from DOPC showed poorly 
defined liposomes (Figure 5.9 A); however, the addition of MscL to these liposomes improved the 
definition and formation of DOPC liposomes (Figure 5.9 B). DOPC mixed with cholesterol, which 
is known to increase the lipid packing order of lipid bilayers, also improved the formation of 
liposomes (Figure 5.9 C and E). Addition of MscL to cholesterol-DOPC liposomes showed no 
further effects on the liposomes (Figures 5.9. D and F). 
 
 
Figure 5.9. Liposomes generated using DOPC in 100 mM KCl. A) 100% DOPC 
B) MscL-100% DOPC C) 90% DOPC : 10% cholesterol, D) MscL-90% DOPC : 
10% Cholesterol, E) 70% DOPC : 30% cholesterol, F) MscL-70% DOPC : 30% 
cholesterol. Scale bar = 250 nm. 
 
5.4 Discussion 
Results in this chapter show that, lipid composition has a clear effect on liposome formation 
and fusion. The tests involving liposomes produced from differentially sourced azolectin mixtures 
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and titrated with Mg2+ showed different degrees of aggregation and fusion dependent on the 
azolectin source. Mg2+-dependent aggregation was presumed to be caused by the presence of 
negatively charged phospholipids, which would be electrostatically attracted to the divalent cations, 
increasing the propensity to form aggregates. Consistent with this, aggregation caused by Mg2+ was 
concentration dependent and the absence of negatively charged lipids in egg yolk azolectin, where 
no Mg2+-dependent aggregation was observed, showed that these lipids are likely to have been a 
major contributor to this observed effect of divalent cations. These observations are consistent with 
other reports on the behaviour of divalent and trivalent cations in studies with lipid emulsions 
(Sabin, Prieto et al. 2007, Ermakov, Kamaraju et al. 2010). 
5.4.1 Liposome Fusion 
Membrane dehydration promotes close contact between the lipid bilayers of liposomes in 
close proximity and has been seen as a prerequisite to membrane fusion (Aranda, Teruel et al. 
2003). There are several factors that enable lipid vesicle fusion (Ohki and Arnold 2000). Among 
those that affect liposome fusion in this context are lipid-cation interaction, temperature, lipid 
bilayer fluidity and surface conditions such as the existence of protrusions and undulations (Sabin, 
Prieto et al. 2007, Roldan-Vargas, Barnadas-Rodriguez et al. 2008). These factors have been 
highlighted as playing a role in the repulsive or attractive forces experienced by two liposomes 
(Israelachvili and Wennerstrom 1996). The area of adhesion between two liposomes results in 
membrane deformation at these regions of interaction creating a highly curved membrane region at 
the rim of the area of adhesion, which becomes the site of fusion (Figure 5.10) (Ohki and Arnold 
2000, Ohki and Arnold 2008). The highly curved regions have a higher surface energy compared to 
the rest of the liposome and fusion results in order to lower the surface energy yielding an overall 
more energetically favourable state (Ohki and Arnold 2008). Experiments conducted by Ohki and 
Arnold (Ohki and Arnold 2008) using a fluorescence fusion assay indicated that the more severe the 
deformation, the more readily fusion occurs between liposomes (Ohki and Arnold 2008). 
Therefore, as liposome aggregation is influenced by the temperature of the colloidal 
suspension (Sabin, Prieto et al. 2010) and molecular exchanges between the membranes of adhering 
liposomes results in fusion, the transition temperature of the lipid affects aggregation and fusion. 
This is due to the effect of transition temperature on ordered arrangement of the lipids (see Chapter 
1, section 1.2.2, Lipid Considerations for Liposome Application in Medicine). 
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Figure 5.10. A schematic presentation of two small 
unilamellar vesicles adhering to one another. Arrows 
indicate the rim of the adhesion site. Image from (Ohki 
and Arnold 2008) reproduced with permission from 
Elsevier. 
 
Liposome aggregation was observed at 10 mM MgCl2 for liposomes prepared from Avanti 
20% PC and Sigma 14-23% PC. Aggregation was not observed at a solute concentration of 1 mM 
MgCl2 in agreement with a change from RLCA to DLCA aggregation kinetics with increasing 
concentrations of fusogenic ions (Sabin, Prieto et al. 2007). At higher concentrations, liposome 
fusion occurs in both these soy azolectins. Liposomes of Sigma 14-23% PC and Avanti 20% PC 
exhibited varying degrees of fusion and precipitation as observed in the Eppendorf tube assays 
summarized in Figure 5.1 at concentrations of 20 mM and 30 mM MgCl2. This may have been due 
the presence of larger quantities of negatively charged lipids (PS and PI) in Sigma 14-23% PC but 
could also be due to the manufacturer-reported presence of 4.6% LPC in the Avanti 20% PC 
mixture. Liposomes that have LPC constituents have been reported to be able to resist lipid fusion 
by stabilizing the membrane defects that exist at the adhesion sites due to their single tailed 
structure (Ohki and Arnold 2008). 
 Aggregation, but not fusion, was immediately observed in liposomes generated from Avanti 
40% PC in the presence of 20-50 mM MgCl2 (Figure 5.1). This too agreed with a change in 
aggregation kinetics due to the increasing concentrations of Mg2+. The absence of detectable vesicle 
fusion in the Avanti 40% PC liposome suspension may be due to the stability of the liposomes 
which in turn is affected by the transition temperature of the lipid constituents that make up Avanti 
40% PC, a property known to affect fusion. The onset of further aggregation after 24 hours at 20-50 
mM MgCl2 is consistent with DLCA aggregation kinetics, specifically further collisions of 
liposomes with aggregate clusters causes the clusters to grow. The observed aggregation of Avanti 
40% PC liposomes at 10 mM and 100 mM MgCl2 concentrations after 24 hours is consistent with 
reported RLCA regime behaviour, where several collisions are required in order for liposomes to 
adhere to one another (Eden 1961, Sabin, Prieto et al. 2010). The initial absence of fusion observed 
at 100 mM MgCl2 suggests that equilibrium of the colloidal system has been reached, where surface 
charges on the liposomes have been screened. However, as aggregation still occurred over time, the 
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effect of fusogenic ions on hydration force may still be prevalent. This may indicate that the 
aggregation kinetics of Avanti 40% PC liposomes changes from DLCA to RLCA aggregation with 
increasing MgCl2. This may also indicate that the types of lipids involved also affect aggregation 
kinetics, a hypothesis requiring further analysis in order to be more fully addressed. Aggregation of 
the Avanti 40% PC liposomes is likely related to Mg2+ interaction with the negatively charged PI 
lipids in the azolectin and to some extent the zwitterionic PC, which is known to interact weakly 
with cations (Fukuma, Higgins et al. 2007). 
The titration of MgCl2 with egg yolk azolectin, which is composed of PC and PE showed no 
visible signs of aggregation at these concentrations. As PE is a neutral lipid, this indicates that the 
weak interactions between PC and cations are not capable of causing aggregation and fusion at 
these concentrations. Further analysis of egg yolk azolectin showed that it did not favour liposome 
formation (Figure 5.2 and 5.3, panels A and C). This may be due to the high amounts of PE lipid 
(~40%) that favours formation of the HII hexagonal phase (inverted micelle) rather than forming a 
lipid bilayer. However, the lack of liposome formation may also be related to the low transition 
temperature of the azolectin, which is -15 °C (according to the supplier, Sigma). Both the transition 
temperature of the lipids and the geometry of the lipid molecules present have merit as the addition 
of MscL to the extruded egg yolk azolectin did produce liposomes that were affected by 
monovalent (Figure 5.2 B and D) and divalent cations (Figure 5.3 B and D) indicating a 
stabilization effect occurs upon incorporation of MscL. This can be reasonably attributed to the 
presence of residual bacterial annular lipids surrounding the hydrophobic transmembrane regions of 
MscL incorporating themselves into the azolectin and is explained in the next section. 
5.4.2 Effect of Lipid Molecules on Liposome Formation 
As mentioned in the introduction, the transition temperature, and ionic interaction as well as 
the charge of the lipid influences liposome size stability. Furthermore, as mentioned in Chapter 1, 
Section 1.2.1 Lipids and Liposomes, the size of the lipid headgroup and the area of its occupied 
chain can affect curvature of the liposome. This is summarized in Figure 5.11. 
 It was observed that extruded egg yolk azolectin, which otherwise formed unstable 
liposomal structures, could be stabilized by inclusion of MscL, a phenomenon that was attributed to 
the incorporation of bacterial annular lipids that had co-purified with the MscL protein from E. coli. 
This may explain differences seen in liposome forming behaviour and aggregation of MscL-egg 
yolk liposomes titrated with monovalent (Figure 5.2) and divalent (Figure 5.3) cations. The residual 
bacterial annular lipids diffuse quickly into the surrounding lipids as MscL is incorporated (Powl, 
East et al. 2007). The effect of the cations on the egg yolk azolectin may be enhanced through the 
addition of these bacterial lipids. Likewise, the incorporation of MscL may have an influence on the 
stability of the lipid bilayer as it would also have a critical packing shape and hydrogen bonding 
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between the PE lipids of egg yolk azolectin and MscL may have also been a contributing factor to 
liposome formation (Perozo, Kloda et al. 2002, Elmore and Dougherty 2003, Moe and Blount 2005, 
Powl, East et al. 2007). Hydrogen bonding between PE lipids may also explain liposome formation 
in MscL-DOPC liposomes as up to 80% of E. coli membrane consists of PE lipid, which may have 
been incorporated into the DOPC lipid bilayer as co-purified MscL annular lipids (Dowhan 1997, 
Lee 2004, Gidden, Denson et al. 2009). 
 
 
Figure 5.11. Schematic of the packing parameter and 
structures formed. Image taken from (Genc, Ortiz et al. 
2009), permission from The American Chemical Society. 
 
Size fractionation of MscL-egg yolk liposomes in the presence of KCl and MgCl2 (Figure 
5.4) resulted in a reduced migration of the MscL-liposomes through the sucrose gradient. Electron 
microscopy analysis of extracted MscL-liposomes from the sucrose gradients revealed improved 
liposome formation with increasing concentrations of KCl (Figure 5.5), which may have been due 
to increases in hydration and electrostatic repulsion force experienced with increasing K+ 
concentrations. This was another indication that the bacterial annular lipids may play a role in the 
formation of egg yolk liposomes. However, the fluid nature of the egg yolk lipid constituents, due 
to its low transition temperature, may have allowed the liposomes to be suspended in a state where 
fusion and separation occur constantly. This would explain the formation of the cloudy emulsion 
band observed at the top of the sucrose gradients, rather than the expected behaviour that resulted 
from large, persistent liposome aggregates observed in Chapter 4. 
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5.4.3 Effect of Soy Azolectin on Egg Yolk Azolectin 
The synergistic effect of lipids on the formation of liposomes was investigated through the 
titration of egg yolk azolectin with soy azolectin (Sigma 14-23% PC), which was known to form 
liposomes through extrusion. Electron micrographs (Figure 5.6) showed that increasing 
concentrations of soy azolectin led to improved formation of MscL-egg yolk liposomes. A 
noticeable improvement was seen in mixtures containing 25% soy azolectin (w/w ratio) and above 
(Figure 5.6 C, D, E, F). Mixtures that contain 0%-1% soy azolectin contained coalesced and fused 
masses of lipid (Figure 5.6 A). The mixture containing 10% soy azolectin produced small 
liposomes, however, the liposomes may be constantly changing as the electron micrographs showed 
that the formed liposomes coalesced together with limited definition between the membranes 
separating the liposomes (Figure 5.6 B). 
MscL was incorporated into these liposomes and size fractionated. As can be seen in Figure 
5.7, MscL-egg yolk liposome size separation, improved with increasing soy azolectin content. This 
further indicated that liposome formation and transition temperature stability was dependent on the 
lipid constituents. Electron micrographs of the MscL-liposomes composed of 10% soy : 90% egg 
yolk and 25% soy : 75% egg yolk azolectin showed that these mixtures produced small liposomes 
within the size range of 20-50 nm in diameter (Figure 5.8 B and C). It was observed that coalesced 
and fused lipids were extracted at a particular distance through these gradients (Figure 5.8 
highlighted with red arrows) indicating that unstable MscL-liposomes were also capable of being 
separated via sucrose gradients. This may be due to an uneven distribution of lipids and/or MscL 
channels within the lipid bilayer, thereby affecting the stability of the liposomes. 
5.4.4 Membrane Packing 
In order to test the effect of membrane packing order on liposome formation, DOPC and 
cholesterol were used. DOPC has a transition temperature of -20 °C (Cullis, Fenske et al. 1996) and 
cholesterol is known to increase the membrane packing order of a lipid bilayer. It was observed that 
the extruded DOPC lipid showed a coalesced lipid aggregate and following the addition of MscL, 
liposome formation was improved (Figure 5.9 A and B). This confirmed earlier results, which 
indicated that the addition of MscL and the bacterial annular lipids around the protein aided in 
liposome formation. These liposomes were produced with 100 mM KCl, which would result in a 
larger hydration force compared to 10 mM KCl due to the concentration of K+ cations, however, 
liposome formation did not take place with pure DOPC. 
The addition of cholesterol to DOPC at 10% and 30% (w/w) displayed a noticeable effect on 
liposome formation, but there were no visible differences between each cholesterol condition 
(Figure 5.9 C and E). Likewise, the addition of MscL to the cholesterol-DOPC liposomes also 
showed no visible effect (Figure 5.9 D and F). It can be reasonably concluded that cations do not 
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aid in the formation of small unilamellar liposomes rather serving to maintain liposome stability. 
The effect of the critical packing parameters of lipid molecules and the stabilizers such as 
cholesterol and poly-ethylene glycol (PEG) likely plays a more important role in the formation of 
liposomes. It should be noted that the effects of stabilizers on MscL channels however have not 
been thoroughly studied. A recent study by Nomura and colleagues showed that cholesterol causes 
an increase in required pressure needed to activate MscL (Nomura, Cranfield et al. 2012), which 
would be an undesireable effect for candidate nanovalve drug delivery systems. This effect could, 
however, be compensated for through the use of gain-of-funcion (GOF) MscL mutants, with 
relaxed channel gating thresholds.  
5.5 Conclusion 
The experiments outlined here have investigated the effect of cations and lipid molecules on 
the formation of uniformly sized liposomes and have determined that lipid constituents exhibit an 
important role in the size of the resulting liposomes formed. The incorporation of stabilizers such as 
cholesterol, also aided in the formation and improved definition of liposomes. In studies focusing 
on content leakage and membrane fluidity, cholesterol has been reported to act as a lipid bilayer 
stabilizer (Kirby, Clarke et al. 1980, Lee, Lee et al. 2005, Sonnen, Bakirci et al. 2005, Cui, Bouisse 
et al. 2012, Redondo-Morata, Giannotti et al. 2012). This would explain the improved liposome 
formation and definition observed here. It was also observed that although cholesterol aids in the 
formation of liposomes, it does not affect liposome size and thus uniformity. 
The effect of cation-lipid interactions determines the rate of aggregation between liposomes 
and ultimately determines the final stability of the liposome suspension over time (Ohki and Arnold 
2000, Sabin, Prieto et al. 2006, Sabin, Prieto et al. 2010). Cation-lipid interactions and effects also 
vary with different cations and lipid species involved. As a final note, the effect of divalent 
fusogenic cations on egg yolk azolectin was not observed in these studies due to the high 
availability of neutral PE and zwitterionic PC in the azolectin. As cations have been reported to 
have a weak affinity for PC lipids (Fukuma, Higgins et al. 2007), an effect might be observable 
through the use of trivalent cations, which has been reported to cause aggregation between DPPC 
liposomes (Sabin, Prieto et al. 2007). It might be conceivable that degradation of lipids due to 
oxidation may also play a role in liposome aggregation over time; however this falls beyond the 
scope of this project. Significantly, the majority of previous studies conducted on cation-lipid 
interactions have focused on the effects on single types of lipid (Ohki and Arnold 2000, Sabin, 
Prieto et al. 2006, Roldan-Vargas, Martin-Molina et al. 2007, Sabin, Prieto et al. 2007, Ohki and 
Arnold 2008, Roldan-Vargas, Barnadas-Rodriguez et al. 2008, Sabin, Prieto et al. 2010) while the 
experiments conducted here clearly show that synergistic effects also need to be considered. The 
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experiments conducted here demonstrate that a mixture of different lipid types can produce 
uniformly sized MscL-liposome. 
5.6 Future Work 
A full analysis of the lipid components in the azolectin used can now be undertaken as a 
service through Avanti Polar Lipids, Inc., Alabaster, Alabama. Determination of the components 
would provide further insight into the cause of the effects seen in this chapter. Likewise, 
identification of the liposome extracts from the sucrose gradient of MscL-liposomes created 
through soy and egg yolk azolectin mixes (10% and 25% soy) may provide a detailed insight into 
the production of small uniform liposomes using lipid components. Measurements of the zeta 
potential of the resulting liposomes would also provide details on the rate of aggregation of the 
liposomes produced and thus provide information on long-term storage of the MscL-liposomes. 
Long-term storage of MscL-liposomes however is not an immediate priority for future planned 
electron microscopy studies as most liposomes are used immediately after preparation. 
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6.0 Concluding Remarks 
Liposomes are widely used as a drug delivery system in chemotherapy and fungal 
treatments (Ng, Wasan et al. 2003, O'Shaughnessy 2003, Wolff 2003) while expansion in the uses 
of liposomes as a therapeutic platform has seen further applications including in vaccine delivery, 
gene therapy and utilization in the pulmonary route of administration, which circumvents the need 
for injections (Usonis, Bakasenas et al. 2003, Jeschke and Klein 2004, Bovier 2008, Lay, Callejo et 
al. 2009, Even-Or, Joseph et al. 2011, Sharif, Hynes et al. 2012, Willis, Hayes et al. 2012, Alhariri 
and Omri 2013). Although liposomes are considered as one of the “next generation” methods of 
drug delivery, several factors currently limit the widespread use of liposomes in modern medicine. 
Among these factors are the release kinetics of liposomal drug delivery systems where an absence 
of detailed and specific release profiles of liposomes have limited their use in drug delivery 
(Waterhouse, Tardi et al. 2001, Cui, Li et al. 2007, Qian, Li et al. 2012). In order to address this 
issue, several methods are currently being studied in order to improve the release kinetics of 
encapsulated drugs from liposomes (see section 1.4.3 Improving the Efficacy of Liposomal Drug 
Delivery Systems). 
The E. coli mechanosensitive channel of large conductance (MscL) is one of the most 
widely studied mechanosensitive channels (Martinac 2001, Perozo, Cortes et al. 2002, Martinac 
2004, Sukharev and Corey 2004, Koçer, Walko et al. 2005, Yefimov, van der Giessen et al. 2008). 
Interest in utilizing MscL as a nanovalve in liposomal drug delivery systems stems from the 
channel’s ability to produce a non-speficic, 3 nm pore when activated and its ability to maintain 
functionality even after the harsh conditions of purification and incorporation into non-native lipid 
bilayers (Häse, Le Dain et al. 1995, Cruickshank, Minchin et al. 1997, Betanzos, Chiang et al. 2002, 
Perozo, Cortes et al. 2002, Kung 2005, Battle, Petrov et al. 2009, Corry, Hurst et al. 2010). 
Furthermore, MscL channels have also been shown to allow the passage of small protein molecules 
of ~6.5 kDa through its open channel pore (van den Bogaart, Krasnikov et al. 2007). Current 
investigations into encapsulated cargo efflux from liposomes via MscL have been conducted on 
mutant MscL channel which respond to either pH changes, UV light or a chemical stimulus 
(Yoshimura, Batiza et al. 2001, Perozo, Kloda et al. 2002, Corry, Rigby et al. 2005, Koçer 2007, 
Koçer, Walko et al. 2007, van den Bogaart, Krasnikov et al. 2007, Powl, East et al. 2008, Corry, 
Hurst et al. 2010, Birkner, Poolman et al. 2012). These studies have shown that open mutant MscL 
channels can function as nanovalves for the efflux of liposomal encapsulated cargo. 
The direct application of these studies into a clinical setting however is undetermined as 
applying a stimulus such as a chemical reagent or UV light has other risks associated with it. 
Response to pH changes such as the change of the normal physiological pH 7.4 to the extracellular 
environment of pH 6.5 around a tumour is a narrow difference and may not elicit an accurate 
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response. Furthermore, the highest pH difference is located in the tumour interstitium and not close 
to the vasculature thus limiting the effectiveness of a pH response in this manner (Boyd and Fong 
2012). Other pH stimuli involve the uptake of liposomes into the endosomal compartment to trigger 
release however the acidic environment of the endosome may degrade the released drug cargo. 
These factors highlight the need for an MscL-liposome that will respond to changes in the lipid 
bilayer pressure profile. 
 
MscL response to LPC 
MscL is known to respond to changes in membrane tension via the application of membrane 
deformation in patch clamp studies (Sukharev, Blount et al. 1994, Häse, Le Dain et al. 1995, 
Sukharev, Sigurdson et al. 1999, Moe and Blount 2005). This ability of MscL to sense changes in 
the trans bilayer pressure profile of the lipid bilayer may allow the channel to be directly applied to 
several existing liposomal drug delivery systems such as immunoliposomes and in liposomes 
administered via the lungs. 
In this thesis, wild type (WT) E.coli MscL was used to study the efflux of 5,6-
carboxyfluorescein (carboxyfluorescein) from MscL-liposomes in response to an applied membrane 
deformation. It was shown here that MscL-liposomes are capable of responding to changes in 
membrane tension applied by the asymmetric insertion of LPC to deform the outer leaflet of the 
lipid bilayer of MscL-liposomes (Perozo, Kloda et al. 2002). This resulted in the efflux of 
carboxyfluorescein from MscL causing an increase in fluorescence. The efflux of 
carboxyfluorescein from MscL was also affected by the critical packing parameter of LPC, which 
equates to a more conical or cylindrical shaped LPC molecule (see section 3.4.3 Effect of LPC). 
The shape of LPC affects the degree of curvature of MscL-liposomes’ lipid bilayer and this 
variation in curvature results in different levels of lipid bilayer stress causing different levels of 
carboxyfluorescein efflux. These studies show that the efflux of carboxyfluorescein from MscL-
liposomes can be affected by the varying degrees of curvature induced by the addition of LPCs with 
varying critical packing parameters. 
 
Effects of lipids on MscL 
The functionality of MscL has been well characterised in soy azolectin lipid bilayers. Here 
studies on the effect of annular lipids surrounding MscL were also investigated by using various 
batches of soy azolectin. The full effect of lipid species on the activation energy and incorporation 
of MscL is still a source of debate with the latter being documented (Elmore and Dougherty 2003, 
Moe and Blount 2005, Meyer, Gullingsrud et al. 2006, Powl, East et al. 2007, Powl and Lee 2007, 
Powl, East et al. 2008, Grage, Keleshian et al. 2011, Nomura, Cranfield et al. 2012). The 
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experiments conducted here show that the lipids that comprise the lipid bilayer of MscL-liposomes 
affect the efflux of encapsulated carboxyfluorescein via MscL in under both hypo-osmotic 
conditions and following LPC addition. However, it is unknown if a decrease in activation energy 
of the channels or a higher incorporation of MscL into the different azolectins is the cause of these 
observations. A fatty acid methyl ester (FAME) analysis conducted on two of the soy azolectins 
used (Avanti 20 % PC and 40 % PC), indicate that the acyl lengths and degree of unsaturation of 
the azolectin lipids is approximately similar, however a higher carboxyfluorescein release was 
recorded from MscL-liposomes composed of Avanti 40 % PC. This may indicate that lipid head 
groups play a major role in carboxyfluorescein efflux through MscL but may also be due to 
membrane packing defects in Avanti 40 % PC liposomes. 
 
Electron Microscopy 
In order to investigate MscL incorporation efficiency into liposomes, cryo-electron 
microscopy (cryo-EM) and tomography (cryo-ET) studies on cryo-preserved MscL-liposomes were 
conducted. 5 nm Ni-NTA-Nanogold® was used to label Histidine tagged MscL (His-MscL) prior to 
liposome incorporation. The Nanogold particles served as markers to determine the presence of 
Nanogold-His-MscL incorporated into liposomes (Nanogold-His-MscL-liposomes) under cryo-EM 
conditions. Previous commercially available Ni-NTA-Nanogold® had a diamater of 1 nm, which 
was too small to be identified due to the signal-to-noise ratio of the low dose cryo-EM technique 
required to image cryo-preserved samples. The currently available 5 nm Ni-NTA-Nanogold® is 
capable of being resolved using these methods with results presented here of Nanogold labelling of 
His-MscL-liposomes under cryo-EM and cryo-ET conditions. The use of Nanogold-tagging 
techniques provided information on MscL incorporation into extruded liposomes as well as its 
orientation within the lipid bilayer, which was determined to be “right-side-in” where the 
periplasmic loop of the channel faces the external environment of the liposome. The nanogold also 
served as a fiducial marker, allowing 3D reconstruction of tilt-series images acquired using cryo-
ET. It is anticipated that these methods will in future enable the visualization and potential fine-
tuning of the MscL-liposome system through further structural studies. 
Not all His-MscL-liposomes were successfully tagged, and an issue that required 
consideration in this study was the cost of Nanogold and the high concentrations required to 
efficiently label His-MscL (5 to 10 fold molar excess as suggested by Nanoprobes, Inc.). The use of 
continuous sucrose gradients may allow for the separation of Nanogold-His-MscL-lipsomes from 
untagged His-MscL-liposomes thereby maximizing the amount of visible fiducial markers in cryo-
ET. Further work is required to optimize this. It is also possible to substitute Nanogold-His-MscL 
with colloidal gold when performing 3D reconstruction of MscL-liposomes. This substitution 
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would ideally be performed in conjunction with the use of new higher resolution cameras such as 
the TemCam-F816 8K x 8K CMOS camera (TVIPS GmbH). The use of this higher resolution 
camera has enabled Liao and colleagues (Liao, Cao et al. 2013) to determine the strucure of the 95 
kDa, TRPV1 ion channel at 3.4 Å resolution by cryo-EM on a 200 keV Transmission Electron 
Microscope. 
 
Size of MscL-liposomes 
Patch clamp studies on MscL lipid blisters (~14 !m in diameter) using LPCs have shown 
that MscL channels fluctuate between an open and closed state when stressed with LPC. It is 
uncertain if this fluctuation is present in 100 nm extruded MscL-liposomes and if it prevents the full 
release of the encapsulated carboxyfluorescein. The fluctuations between the open and closed states 
of MscL exposed to LPC in patch clamp studies may be caused by the stepwise structural changes 
that occur when MscL responds to membrane deformation. 
MscL responds to membrane deformation through a series of structural changes that 
ultimately result in an open channel pore (Häse, Le Dain et al. 1995, Cruickshank, Minchin et al. 
1997, Betanzos, Chiang et al. 2002, Perozo, Cortes et al. 2002, Perozo, Kloda et al. 2002, Meyer, 
Gullingsrud et al. 2006). This series of structural changes of MscL in response to membrane 
deformation results in a stepwise reduction of the activation energy required to open the channel 
(Perozo, Cortes et al. 2002, Grage, Keleshian et al. 2011). The curvature of the lipid bilayer that 
MscL is incorporated into is thus capable of lowering the channel activation energy by trapping the 
channel in a near open state (Perozo, Cortes et al. 2002). As the MscL lipid blisters required for 
patch clamp analysis are considerably larger than the extruded MscL-liposomes, it is possible that 
the fluctuation between the open and closed states of MscL exposed to LPC in lipid blisters is a 
result of fully closed and thus higher activation energy MscL channels being exposed to local 
membrane deformation. This may not be the case in extruded MscL-liposomes as the relatively 
small size of the liposomes may have poised the incorporated MscL in a structurally rearranged 
state in order to compensate for the lipid bilayer curvature. This may therefore result in lowered 
activation energy of MscL (Perozo, Cortes et al. 2002, Tonnesen, Christensen et al. 2014). 
Reduction of the activation energy of MscL incorporated into a high curvature lipid 
membrane was, however, not evident from the carboxyfluorescein efflux experiments conducted on 
50 nm and 100 nm extruded MscL-liposomes, where no observable difference in fluorescence 
release levels was seen. However, the leakage of carboxyfluorescein from the zero protein control 
liposomes was approximately 3 times less in 50 nm compared to 100 nm extruded liposomes. As 
mentioned in Section 3.4.1 MscL and Efflux, it is possible that several factors could contribute to 
the similar efflux levels seen between 50 nm and 100 nm extruded MscL-liposomes and the 
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different efflux levels between the zero protein control liposomes. Future experiments would 
therefore require the investigation of MscL incorporation efficiency into liposomes, isolation of 
uniformly sized MscL-liposomes and the 3D reconstruction of MscL-liposomes. These future 
experiments may allow for a more comprehensive evaluation of the influence of MscL-liposome 
size on carboxyfluorescein efflux as well as 3D visualization of MscL incorporation and the effects 
of LPC on MscL-liposomes. The first step in enabling the study of these factors was the 
optimization of continuous sucrose gradients, ionic effects as well as the influence of different 
lipids on MscL-liposomes’ size and formation. 
 
Size Fractionation 
The generation of MscL-liposomes via extrusion through a 100 nm pore sized filter has been 
determined to yield a distribution of sizes ranging from 50-500 nm. Therefore, methods to generate 
and isolate uniformly sized MscL-liposomes were trialled as several factors can contribute to the 
variation in MscL-liposome size. One of these influential factors is the method of liposome 
extrusion. The extrusion of a mixture of liposome sizes in a suspension to generate liposomes of a 
defined size is achieved by forcing liposomes through a filter. Liposomes that are larger than the 
filter pore being used break as they are forced through the filter pores and reform within the pore 
thus resulting in the formation of liposomes that are similar in diameter to the pore size being used 
(Gompper and Kroll 1995, Hunter and Frisken 1998, Mui, Chow et al. 2003). This process is 
dependent on the flow rate of liposome suspension through the filter. If the flow rate is too slow, the 
liposomes deform and pass through the filter without changing in size (Hunter and Frisken 1998). If 
the flow rate is too fast, the process of liposome breakage and reformation can cause lipids to 
accumulate around the filter pore causing a reduction in pore size thus resulting in the production of 
liposomes smaller than the defined filter pore (Gompper and Kroll 1995, Hunter and Frisken 1998, 
Mui, Chow et al. 2003). Another factor that can affect MscL-liposome size is the addition of MscL 
to liposomes. MscL is maintained in solution in the presence of detergent, in this case n-Dodecyl !-
D-Maltopyranoside (DDM). The addition of detergent can cause liposome size variation due to the 
weakening of the lipid bilayer.  
The optimization of continuous sucrose gradient procedures summarized here has allowed 
for the isolation of uniformly sized MscL-liposomes. This will likely aid future studies focused on 
determining the effect of MscL-liposome size on carboxyfluorescein efflux when stressed with LPC 
and will also provide electron microscopy (EM) data on lipid bilayer stress when exposed to LPC. 
Further work on MscL incorporation efficiency using a preferred liposome size will also be 
conducted. Current EM studies conducted on these MscL-liposomes have confirmed the isolation of 
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MscL-liposomes according to size, MscL orientation along with visualization of liposome 
lamellarity. 
As azolectin is the most widely used lipid in MscL functionality studies, it was also used in 
the studies conducted in this thesis. The mixture of different lipids that exist in azolectin can affect 
liposome size through their geometry and capcity to interact with ions in solution. Through studies 
involving continuous sucrose gradients, the characterization of the effect of ions and their 
subsequent concentration has been observed to influence the formation and size distribution of 
MscL-liposomes produced using varying sources of azolectin lipids, with cations exhibiting a larger 
effect on liposome size and precipitation. Variation in cation species and concentrations can enable 
the formation of a wider size distribution of MscL-liposomes. This will enable further studies on the 
effects of high curvature and activation energy of MscL in carboxyfluorescein efflux studies as 
conditions can be adjusted to suit size distributions of MscL-liposomes of interest. A detailed lipid 
analysis of MscL-liposomes extracted from the sucrose gradients will also allow for identification 
of the types of lipids that constitute MscL-liposomes of defined sizes and enabling the replacement 
of azolectin with pure lipids, which may ultimately lead to a method to produce uniformly sized 
MscL-liposomes without the use of size fractionation methods. 
The development of small unilamellar liposomes for use in drug delivery is key to both the 
prolonging of liposome half-life in vivo and accumulation at disease sites, which have increased 
vascular permeability (Morgan, Williams et al. 1985, Papahadjopoulos, Allen et al. 1991, Yuan, 
Leunig et al. 1994, Maeda 2012). It is also speculated that as WT MscL is capable of detecting 
changes in the trans bilayer pressure profile via changes in lipid bilayer curvature, producing MscL-
liposomes with decreasing diameters would enable the channel to be opened more readily due to 
increasing lipid bilayer curvature. This is caused by the step-wise progression of MscL through 
different states before reaching its open conformation when lipid bilayer curvature is applied 
(Perozo, Cortes et al. 2002). It is therefore beneficial for any future application of MscL-liposomes 
into a drug delivery setting to satisfy the criteria of prolonged half-life, accumulation into disease 
sites and ease of MscL activation. 
 
Effect of Lipids on Liposome Size 
The criteria for the future application of MscL-liposomes can be addressed by their size. It 
has been established that lipid molecules can affect liposome size through their critical packing 
parameter. This critical packing parameter is determined by the volume of the lipid’s head group, 
acyl chain length and degrees of unsaturation present (see Section 1.2.1 Lipids and Liposomes). 
Further lipid effects on liposome size also result from the interaction of cations with lipid 
headgroups, which leads to electrostatic and hydration force effects. Hydration force can affect 
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liposome size and stability over time and this effect varies between different lipids and cations due 
to the varying degrees of attraction between each other (Petsev and Vekilov 2000, Gurtovenko and 
Vattulainen 2008). The selection of lipids and cations may therefore be a useful tool in fine-tuning 
the production of liposomes within a specific size range and further isolation of liposome sizes can 
be conducted through the use of continuous sucrose gradients if required. The studies conducted 
here have formed MscL-liposomes within a 50 nm size range through the use of various azolectin 
mixtures. A lipid analysis of the lipids that make-up these MscL-liposome sizes may yield a method 
to generate uniformly sized MscL-liposomes without the need for size separation. 
The addition of cholesterol, which is known to be a lipid bilayer stabilizer, has also been 
observed to aid in the formation of liposomes but has no effect on liposome size. This was observed 
in EM experiments involving 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, 18:1) lipids, 
which do not form liposomes following extrusion, however the addition of cholesterol has been 
observed to enable the formation of liposomes. This effect may be due to the stiffening of the lipid 
bilayer by cholesterol, which can also increase MscL activation energy (Nomura, Cranfield et al. 
2012). An increase of MscL activation energy is ultimately unfavourable for the future development 
of MscL-liposome drug delivery systems; however an increase in lipid bilayer curvature by 
decreasing MscL-liposome size may help to offset this issue and further studies are needed to 
determine the effect of cholesterol on MscL-liposome size and MscL activation via LPC addition. 
 
Effect of Lipids on 5,6-Carboxyfluorescein Efflux 
It has been argued that the activity of MscL is affected by the properties of the annular lipids 
that are tightly associated with the channel (Perozo, Cortes et al. 2002, Elmore and Dougherty 2003, 
Moe and Blount 2005, Powl, East et al. 2007, Powl and Lee 2007). These properties, range from 
electrostatic effects of lipid headgroups to the length of lipid acyl chain lengths and how it affects 
MscL directly. 
Although there is no general consensus as to how lipids affect MscL activity, it was 
observed in the fluorescence studies conducted here that MscL-liposomes produced with different 
batches of soy azolectin released varying levels of carboxyfluorescein when stressed with LPC. 
Fatty Acid Methyl Ester (FAME) analysis of two of the soy azolectin batches used to generate 
MscL-liposomes indicates that the composition of acyl chain lengths in the azolectins was 
approximately similar. This suggests that lipid head groups may be the main cause of different 
carboxyfluorescein efflux levels, which may be linked to the lipid headgroups affecting MscL 
activation energy (Elmore and Dougherty 2003). A lowering of the activation energy of MscL 
would allow the channel to achieve a fully open pore with low concentrations of LPC. Further 
analysis on the effect of lipid headgroups on MscL is required as current studies have only been 
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conducted using molecular dynamic simulations (Elmore and Dougherty 2003) and the lipid 
analysis of these different soy azolectin batches will highlight particular lipid headgroups that are 
capable of influencing MscL activity. 
6.1  Future work 
Lipid formulations play a crucial role in the production and medical application of current 
liposome technology. This is due to lipid formulations being capable of influencing liposome drug 
encapsulation efficiency during production, half-life after administration and method of release. 
During the development of medical liposome technology, the influence lipids have on these factors 
must be considered. The studies conducted in this thesis represent part of a broader program of 
research directed at ultimately developing a stimulus-triggered nanovalve as the cornerstone of a 
novel liposomal drug delivery system, thereby improving the efficiency of liposome-encapsulated 
drug release. This would allow liposome researchers to focus mainly on drug encapsulation 
efficiency, half-life and site specificity, with the latter unrelated to lipids. It is intended that the 
future application of these MscL-liposomes will be used in tandem with antibody-coupled MscL 
mutants with antibodies bound to specific functional moieties within the MscL structure. For 
example, the periplasmic loop of the MscL channel is thought to act as a spring that resists channel 
opening (Ajouz, Berrier et al. 2000, Tsai, Liu et al. 2005) and so coupling antibodies to this region 
of the MscL structure may induce sufficient torque to trigger MscL channel activation upon antigen 
recognition, as well as imparting a passive targeting efffect. Further application of the membrane 
deformation response of MscL-liposomes may be realised in drug delivery via the pulmonary route 
of administration where lung surfactants are orientated with their tail regions towards the air. It is 
conceivable that the lung surfactants may be able to function similarly to L-!-
lysophosphatidylcholine (LPC) used in the studies here and activate MscL-liposomes on the surface 
of the lungs. 
The use of nanovalves in liposomal drug delivery systems would improve on several 
existing liposome technologies, as it would allow for a more accurate determination of encapsulated 
drug release rates, which would in turn lead to an improved quality of life for patients (Waterhouse, 
Tardi et al. 2001, Cui, Li et al. 2007). This is also coupled with the argument that currently 
implemented liposomal drug release mechanims, namely pH triggered liposomes used in 
chemotherapy, are inefficient due to low pH differences between normal physiological conditions 
and the acidic conditions found within a tumour mass (Boyd and Fong 2012). Also, as the size of 
liposomes used in drug delivery has a major effect on the half-life of liposomes after administration, 
the development of small unilamellar MscL-liposomes would have two major benefits; a prolonged 
half-life in vivo along with a likely lowering of the MscL channel activation energy. MscL-
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liposomes should ideally be <100 nm in diameter in order to evade an immune system response and 
have lowered MscL activation energy. 
It should also be noted that the MscL system lends itself to a tuneable activation energy, 
which can be lowered or indeed increased through the engineering of MscL gain of function (GOF) 
or loss of function (LOF) mutants (Li, Wray et al. 2004, Anishkin, Chiang et al. 2005). Studies 
involving gain of function mutants would allow for the development of an MscL nanovalve that 
would maintain its cargo release efficiency even if liposome properties and lipids were adjusted. 
This adjustment may be in the form of liposome size or lipid constituent changes, in order to 
maximize drug encapsulation or further improve immune system evasion. 
From the work conducted in this thesis, it has been shown that MscL channels that have 
been incorporated into small unilamellar liposomes are capable of being activated through 
increasing lipid bilayer curvature. Furthermore, it has also been shown that the generation of 
uniformly sized liposomes and MscL acitivity is lipid sensitive. This work will further progress 
current research on the utilization of MscL channels as a nanovalve as a majority of the conditions 
tested here have not been previously reported. The future direction for the development of a 
nanovalve based liposomal drug delivery system should first fully investigate the effect of the lipid 
environment on MscL activity and its incorporation efficiency. Advancements in these areas would 
enable a maximization of encapsulated cargo release from MscL-liposomes. Progression of the 
studies conducted on generating uniform liposome sizes using azolectin mixes and ionic effects 
should also be furthered as the generation of small uniform liposomes would be beneficial to any 
application of a nanovalve based liposome. These improvements can then be coupled with GOF or 
LOF MscL mutants that have been identified as potential nanovalve candidates to further enhance 
MscL-liposomes’ release efficiency. Following this, comparisons between conventional liposome 
based medications with nanovalve-based liposomes can then be conducted using in vitro or in vivo 
assays. As liposome technology is widely used in chemotherapeutic applications, an in vivo assay 
may involve the use of transgenic mice that have been bred with a particular tumour and 
carboxyfluorescein loaded MscL-liposomes. The efficiency of cargo release can be monitored 
through exposure of the tumour and fluorescent imaging (Mordon, Desmettre et al. 1995). Other 
studies may also involve the use of transgenic diabetic mice and insulin as a drug cargo as MscL 
has previously been shown to facilitate the release of encapsulated insulin from liposomes (van den 
Bogaart, Krasnikov et al. 2007). 
Technology transfer between liposome researchers and large-scale manufacturers is one area 
of medical liposome technology development that is currently lacking (Wagner and Vorauer-Uhl 
2011). This can be attributed to several factors that require further development, implementation 
and quality control in the manufacturing process. Although there are several different large scale 
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manufacturing methods available to the pharmaceutical industry, the selection of a manufacturing 
method is reliant on the type of lipids that will be used as lipids can determine the encapsulation 
efficiency of a drug, site accumulation, cargo release efficiency and half-life of the liposomes. As 
the release efficiency of a nanovalve based liposome will be addressed by its incorporated MscL 
channels, this will allow manufacturers to focus on the development of other methods of liposome 
production. Furthermore, a majority of the production methods require the use of filtration as a 
sterilization or size homogenization technique (Wagner and Vorauer-Uhl 2011). This ties in well 
with the methods used in this thesis as any potential large-scale proteoliposome production can 
utilize already established manufacturing methods. 
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